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1. INTRODUCTION 
Reproduction is essential for the perpetuation of the species. In mammals, the 
acquisition of reproductive ability and its subsequent maintenance in adulthood is 
subjected to the coordinated participation of numerous central and peripheral signals 
that regulate the so-called hypothalamic-pituitary-gonadal (HPG), also known as 
neuroendocrine reproductive, axis. The regulatory signals controlling this axis range 
from environmental cues, as photoperiod or stress conditions, to endogenous signals, 
as circulating hormones or metabolic factors.  
1.1. HYPOTHALAMIC-PITUITARY-GONADAL AXIS  
The HPG axis is organized at three major levels: 1) the hypothalamus, where a 
small group of neurons synthesize and release, in a pulsatile manner, the decapeptide 
gonadotropin-releasing hormone (GnRH) [1, 2], the key hierarchical element of the 
HPG axis; 2) the anterior pituitary or adenohypophysis, where gonadotrope cells are 
stimulated by GnRH to synthesize and release the gonadotropins, luteinizing hormone 
(LH) and follicle-stimulating hormone (FSH); and 3) the gonads, testes and ovaries, 
which, in response to gonadotropins, generate gametes from puberty onwards 
(gametogenesis), and are responsible for the synthesis and release of sex steroids and 
peptide hormones (hormonogenesis). In turn, gonadal hormones operate via negative 
and positive feedback loops, the latter exclusive of females, to regulate the GnRH 
secretion from the hypothalamus and gonadotropin secretion from the pituitary [3-5] 
(Figure 1). 
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Figure 1. Schematic presentation of the hypothalamic-pituitary-gonadal (HPG) axis. 
 
1.1.1. HYPOTHALAMUS 
The hypothalamus acts as the central regulator of endocrine glands through 
neurotransmitters and neuropeptides secreted by different neuronal populations. 
The hypothalamus is located at the base of the diencephalon, between the 
thalamus and the third cerebral ventricle (3V). The front side is delimited by the lamina 
terminalis and the caudal edge of the mammillary bodies [6]. From a functional point 
of view, hypothalamic neurons are grouped into different nuclei distributed in three 
regions: 1) the rostral or supraoptic region; 2) the middle or tuberal region; and 3) the 
caudal or mammillary region [6]. The major hypothalamic nuclei and their location in 
the different areas are described below (Figure 2).  
The rostral area includes different nuclei as the preoptic area (POA), the 
anterior hypothalamic area, the supraoptic nucleus (SON) and the paraventricular 
nucleus (PVN). Neurons of the SON and the OVN mainly project toward to the 
neurohypophysis [7]. The POA is considered a key area in the control of the 
reproductive axis, since it contains the most of the GnRH neurons.  
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The medial area contains the lateral hypothalamic area (LHA), the arcuate 
nucleus (ARC), the ventromedial nucleus (VMN) and the dorsomedial nucleus (DMN). 
Neurons of the medial area project towards the capillaries of the median eminence 
(ME) where they release their secretions to the portal system which carries them into 
the adenohypophysis [7, 8]. 
The caudal region mainly consists of the mammillary bodies whose endocrine 
function is less known. 
  
Figure 2. Schematic presentation of the major hypothalamic nuclei. 
 
 In the hypothalamic areas and nuclei are synthetized a large number of 
hormones which are release into the hypophyseal portal system to control the 
secretion of the different pituitary hormones [9]. Among them, given their importance 
in this Thesis, we highlight the following: corticotropin-release hormone (CRH), which 
acts on pituitary corticotrophs to stimulate the secretion of adrenocorticotropic 
hormone (ACTH); and GnRH, the hypothalamic decapeptide that stimulates the 
synthesis and release of LH and FSH from the gonadotropes in the adenohypophysis 
[1]. This hormone will be described in detail in the following section. 
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1.1.1.1. GONADOTROPIN-RELEASING HORMONE  
GnRH (also known as luteinizing hormone-releasing hormone, LHRH) is a 
decapeptide (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2) which was first isolated in 
the 70s of the past century from the hypothalamus of pig and sheep [10, 11]. As 
remarkable feature, the N- and C-terminal domains are evolutionarily conserved; they 
are involved in binding and activation of the GnRH receptor. Several structural variants 
of GnRH have been identified in diverse vertebrates [12]: GnRH-I, GnRH-II and GnRH-
III.  
GnRH-I, termed as GnRH in the present Thesis, is known as the mammalian 
hypothalamic variant. It has an essential role in the control of the HPG axis as final 
effector of the set of central and peripheral regulators involved in the neuroendocrine 
control of reproduction [13].  GnRH is also present in amphibian and primitive fish 
species. 
GnRH-II, also known as chicken GnRH, is the midbrain variant and is present in 
most vertebrate species, including human. It appears to be involved in the regulation 
of sexual behavior, food intake and energy balance [14].  
GnRH-III, also known as salmon GnRH, has been identified in olfactory and 
telencephalic brain regions of several species of fish and reptiles and appears to play a 
role as a hypophysiotropic factor [15].  
GnRH neurons arise in the olfactory placode and migrate to the rostral 
hypothalamus areas during development, specifically to the middle septum, the 
diagonal band of Broca and the POA. Most of them extend their axonal projections to 
the capillary plexus of the ME where GnRH is released as highly synchronized pulses 
[16].  
In humans, GnRH is synthesized from a single gene which encodes the pre-pro-
GnRH, a precursor of 92 amino acids (aa) [17, 18] (Figure 3). In this precursor protein, 
the decapeptide is preceded by a signal peptide of 23 aa and followed by a Gly-Lys-Arg 
sequence, essential for proteolytic processing and carboxyl terminal amidation. The 
last 56 aa residues are designated as GnRH-associated peptide [19]. The biologically 
active conformation of GnRH contains a fold in the central region of the molecule 
(Gly6) [20]. 
Introduction 
 
 
5 
 
GnRH secretion profile is not constant over development. In rodents and 
humans, GnRH secretion is increased during late fetal and early neonatal period and 
subsequently decreases, remaining at low levels until puberty [21]. The onset of 
puberty is characterized by a gradual increase in the frequency and amplitude of 
pulses of GnRH secretion into the hypophyseal portal system [12]. Thus, an adequate 
pulsatile secretion of GnRH is obligatory for proper attainment and maintenance of 
reproductive function. 
The biological actions of GnRH are conducted after its binding with GnRH-R, a G 
protein-coupled receptor (GPCR). The NH2- and COOH-terminal domains, on the 
extracellular and intracellular side respectively, contribute to receptor binding and 
activation, whereas the central region appears to be involved in spatial configuration 
and conformational changes after ligand binding. The number of GnRH-R in the 
pituitary are regulated by GnRH itself or gonadal steroids, rising before the 
preovulatory surge of gonadotropins and during pregnancy and lactation [22]. 
 
Figure 3. Schematic representation of mammalian GnRH. NH2-terminal [10] and COOH-terminal [19] 
domains are involved in the receptor binding and activation, whereas the central region, Gly
6
, is 
involved in spatial configuration and conformation of GnRH molecule. Taken from [23].  
 
1.1.2. PITUITARY  
The pituitary or hypophysis, is a pea-sized endocrine gland located in a cavity of 
the sphenoid bone called sella turcica, and is functionally connected to the 
hypothalamus by the ME via a small tube called the pituitary stalk (Figure 4). It is 
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composed of two functionally distinct structures, namely adenohypophysis and 
neurohypophysis, which differ in their embryological origin and their capacity to 
synthesize hormones. 
  The adenohypophysis arises from ectoderm of the pharyngeal roof (oral cavity) 
where there is a pocket called Rathke's pouch [3]. It is subdivided into three parts: pars 
distalis, pars tuberalis, these two parts constitute the anterior lobe of pituitary, and 
pars intermedia, located between anterior and posterior lobes.  
 The anterior lobe contains two basic types of cell, non-hormonal-secreting cells 
and hormonal-secreting cells. These last ones are responsible to synthesize and release 
different hormones whose secretion is controlled by hypothalamic hormones. Among 
them we highlight the following: gonadotropes, which synthesize and release LH and 
FSH [24]; and corticotropes, which synthesize a major precursor protein called 
proopiomelanocortin (POMC) which generates, through proteolytic cleavage, several 
biologically active peptides including ACTH, endorphins and melanocyte stimulating 
hormone (MSH). The physiological role of POMC and POMC-derived peptides will be 
further detailed in section 1.6. 
 The intermediate lobe contains the melanotroph cells which synthesize MSH 
from POMC. In human fetal life, MSH is secreted and causes the release of melanin 
pigment in skin melanocytes. However, this area is normally very small or entirely 
absent in adulthood.  
 The neurohypophysis develops from neural ectoderm from the floor of the 
diencephalon [3]. It is subdivided into: pars nervosa, pars infundibularis and the ME. 
The first two parts comprise the posterior lobe of pituitary. Two hormones are stored 
and released in the neurohypophysis, OT and ADH [25]. Both of them are synthesized 
by hypothalamic neurons whose cell bodies are located in the SON and in the PVN.  
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Figure 4. Diagram of hypothalamic-pituitary vasculature. 
 
1.1.2.1. GONADOTROPINS: LH AND FSH 
LH, FSH, human chorionic gonadotropins (hCG) and thyroid stimulating 
hormone (TSH), are structurally related peptides and they belong to the family of 
glycoprotein hormones [26]. In adenohypophysis, LH and FSH are produced by 
gonadotropes and TSH by tyrotropes, while hCG is synthesized in the placenta. 
These hormones are composed of two noncovalently bound subunits: a 
common α subunit, an identical polypeptide structure of 92 aa and encoded by a single 
gene located on human chromosome 6; and an unique β subunit, which confers 
biological specificity to each hormone. The β subunit molecule is encoded by genes 
present on different chromosomes, except LH-β and hCG-β subunits that are arranged 
in a gene cluster structure (one LH-β gene and six hCG-β genes) present on 
chromosome 19 [27]. The different β subunits contains between 111-145 aa in humans 
[28]. In rodents, gonadotropins exhibit human-like structural features, while there is 
no production of placental chorionic gonadotropins.  
Gonadotropins exert their biological actions by binding to GPCRs [29]. Both LH 
and hCG share the same receptor (LH/hCG receptor or LH-R), while FSH binds to a 
specific receptor (FSH-R) [26]. Gonadotropin receptors, via activation of adenylate 
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cyclase, induce the rise of intracellular cyclic adenosine monophosphate (cAMP) levels, 
and as result, the activation of protein kinase A (PKA) [30]. Additionally, it was found 
that these receptors can also activate other signaling pathways, such as phospholipase 
C (PLC) which induces an increase of intracellular Ca2+ [31]. Have been reported that 
the prolonged stimulation of LH-R and FSH-R produces a receptor desensitization, via 
downregulation and functional uncoupling of the receptor from G proteins [32].  
Although LH-R expression was observed in extragonadal tissues [33, 34], 
gonadotropins receptors are mainly expressed in gonads. In ovaries, LH-R are 
expressed in theca cells and lutein cells [2], and mediate LH-induced steroid hormone 
synthesis, ovulation and corpus luteum formation. In testes, this receptor is expressed 
in Leydig cells where LH stimulates testosterone (T) production. As regards the FSH-R, 
they are expressed in the ovarian granulose cells and in the testicular Sertoli cells, 
suggesting a role in gametogenesis and follicular development.  
1.1.3. GONADS 
The gonads include the testes in males and the ovaries in females and play a 
dual role in both sexes: 1) generating and releasing of mature gametes from germ cells 
(gametogenesis), and 2) synthesis and secretion of steroid and peptidergic hormones 
(hormonogenesis) that regulate, among other actions, the production of these 
gametes. 
1.1.3.1. TESTES 
The mammalian testes are paired oval structures whose main functions are the 
production of sperm and the androgen synthesis. Testes have a heterogeneous cell 
structure and are organized in two compartments: the interstitial or intertubular 
compartment and the tubular compartment, formed by the seminiferous tubules [35] 
(Figure 5). Interactions between the different cells populations are required for the 
proper development of gonadal functions. 
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Figure 5. Illustration of testis organization which consists of the Leydig cells which are found in clusters 
within the interstitial tissue between seminiferous tubules. 
 
 In the testicular interstitial compartment, the following cell types can be 
identified: Leydig cells, macrophages, lymphocytes, stromal fibroblast cell and 
endothelial cells [36]. The main interstitial cell type are Leydig cells and their major 
function is the synthesis of T from cholesterol in response to LH [37]. Intratesticular T is 
required to stimulate spermatogenesis, while a substantial fraction is secreted into the 
systemic circulation where a majority of T binds to plasma proteins such as albumin 
and globulins, mainly to the sex hormone-binding-globulin (SHBG). 
 The androgenic effects of T in peripheral tissues require its metabolization, via 
the enzyme 5α-reductase, into dihydrotestosterone (DHT). By contrast, the central 
actions of T are carried out as such or after its aromatization to estradiol. The most 
important functions of androgens are: regulation of LH and FSH secretion from the 
gonadotropes by negative feedback mechanisms at hypothalamic and pituitary level; 
sexual differentiation of central nervous system (CNS) before birth and during neonatal 
period; stimulation of the spermatogenesis; and acquisition and maintenance of 
secondary sex characteristics after puberty [38].  
 In the seminiferous tubules germ cell and Sertoli cells are located [36] (Figure 
5). Germ cells, under FSH and T influence, will develop into mature sperm. Sertoli cells 
support germ cell nutrition and their development [39], and also they respond to FSH 
stimulation inducing the synthesis of proteins such as activins and inhibins, which 
regulate FSH release at pituitary level, or the testicular androgen-binding protein 
(ABP). In the seminiferous tubules, FSH and T regulate the interaction between the 
Sertoli cells and germ cells [40-42]. 
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1.1.3.2. OVARIES 
The main functions of the ovaries are the production of fertilizable gametes 
(oogenesis) and the synthesis of sex steroids such as estrogens, progesterone (P), and 
to a lesser degree, 17α-hydroxyprogesterone, androstenedione, estrone and T. In 
addition, ovaries also contribute to maintaining optimal hormonal conditions during 
early stages of gestation.  
The first level of follicular organization is the primordial follicle, which is formed 
by a primary oocyte surrounded by a monolayer of folicullar cells called granulosa 
cells.  This primordial follicle undergoes a series of successive transformations leading 
to the formation of primary follicle, where the oocyte increases in size and begins to 
accumulate polysaccharides between the oocyte and granulosa cells. Secondary 
follicles are characterized by an increase of granulosa cells, which will determine the 
production of the main estrogen in females, the 17β-estradiol (E2), and by the 
recruitment of interstitial cells that will originate the theca interna. Tertiary or antral 
follicles are characterized by an increase of granulosa cell layers and the recruitment of 
more additional interstitial cells that form a layer surrounding the theca interna, 
leading to the theca externa and the formation of follicular antrum. The preovulatory 
follicle or de Graaf follicle, after LH-mediated follicular rupture, allows the exit of 
secondary oocyte from the ovary at ovulation (Figure 6). In women, ovulation occurs 
approximately every 28 days. 
 
Figure 6. Diagram showing anatomical structure of the ovary. The ovarian cycle consists of 
the follicular phase, ovulation, and luteal phase. Modified from [43]. 
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 Although LH and FSH are crucial in the follicular growth, others paracrine 
factors are involved in the modulation of follicular growth: E2, growth factors such as 
insulin-like growth factor I and II (IGF-I and II), epidermal growth factor (EGF), tumor 
necrosis factor α and β ( TGF-α and β) and fibroblast growth factor β (FGF-β); gonadal 
peptides (inhibins, activins and follistatins); and cytokines such as interleukin 1 (IL-1) 
and TNF- α [44-46].   
Female rats have cyclic variations in their reproductive activity and changes in 
vaginal epithelium every 4 days. Thus, estrous cycle of the rats is characterized by the 
following phases in terms of vaginal cellularity: diestrus-1 or metestrus (D-1), diestrus-
2 (D-2), proestrous and estrus, which are consequences of the changes in ovarian 
steroid secretion (Figure 7). Ovulation occurs in estrus phase as result of the 
preovulatory gonadotropin surge in the afternoon of proestrous [47, 48]. In the female 
mouse, the duration of the estrous cycles varies from 4 to 6 days depending on the 
laboratory mouse strains. 
 
Figure 7. Hormonal profile during the estrous cycle in rat. Phases of the estrous cycle: D-1: diestrus-1 or 
metestrus; D-2: diestrus-2; PRO: proestrous; y Estrus. E2: estradiol. P: progesterone. Modified from [49].  
 
1.2. REGULATION OF HPG AXIS 
  GnRH neurons are considered the key hierarchical element in the 
neuroendocrine control of reproduction, since they act as the final integrators of 
central and peripheral signals and major output pathway for the brain control of 
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reproductive function. For this reason, the proper functioning of HPG axis depends on 
the correct regulation of GnRH neuronal activity.  
1.2.1. CENTRAL REGULATORS  
The control of GnRH secretion to the portal system depends on the integration 
of stimulatory and inhibitory central signals. Among them, we highlight the following: 
1.2.1.1. STIMULATORY SIGNALS  
 Kisspeptins   
Kisspeptins are considered, especially in mammalian species, as essential 
primary regulators of GnRH neurons at the hypothalamus and one of the most potent 
stimulators of the HPG axis. Given the special focus of this Thesis, kisspeptins will be 
described in detail in section 1.4.  
 Excitatory amino acids (EAA) 
The major excitatory neurotransmitter of the CNS is glutamate (Glu) [50] and its 
actions are mediated by two receptor types: ionotropic and metabotropic receptors. 
Ionotropic Glu receptors (iGluRs) are ion channels and are classified according to their 
ligand binding affinities in: NMDA (N-Methyl-D-Aspartate), AMPA (α-Amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid) and KA (kainate) receptors [51, 52]. 
Electrophysiological techniques have revealed that these receptors may coexist in 
different neuronal populations [53]. Metabotropic Glu receptors (mGluRs) are GPCRs, 
with eight different subtypes, classified in three groups. The first group (mGluR1 and -
R5) activates PLC, while members of the second (mGluR2 and -R3) and the third group 
(mGluR4, -R6, -R7 and -R8), except mGluR6 (that activates a cGMP phosphodiesterase) 
are negatively coupled to adenylate cyclase [54, 55]. 
GnRH neurons express iGluRs in their axon terminals in the ME [56, 57]. Data 
obtained in vivo indicated that intracerebroventricular (icv) administration of iGluRs 
agonists induce LH release [58] and in vitro studies have been demonstrated Glu direct 
actions on LH release in the pituitary [59]. Also, NMDA and non-NMDA receptors 
agonists and antagonists are able to increase or reduce, respectively, the pulsatile 
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GnRH/LH secretion, in both male and female rats [60-62]. In this context, dual-labeling 
studies have shown that GnRH neurons express AMPA, NMDA and kainate receptors in 
a heterogeneous manner, however, the importance of different iGluR signaling on 
GnRH neurons remains unclear. Thus, whereas in vivo studies have indicated the 
importance of NMDA signaling within the whole of the GnRH neuronal network, 
electrophysiological studies have showed that AMPA/kainate receptors predominate 
over NMDA receptors in adult GnRH neurons [53, 63].  
In addition, Glu mediates partially the effects of gonadal steroids on GnRH 
secretion. Thus, immunohistochemistry (IHC) studies demonstrated the colocalization 
of steroid hormone receptors (estrogen receptor α and β, ERα and ERβ; and androgen 
receptor, AR) and NMDA and non-NMDA receptors in several hypothalamic nuclei that 
are involved in the control of GnRH secretion [64]. The importance of glutamatergic 
pathway mediated by mGluRs on GnRH neurons remains incompletely defined, 
although stimulatory effects on GnRH secretion have been reported [65, 66].  
 Neurokinin B 
Neurokinin B (NKB), a member of the tachykinin family, is a neuropeptide of 10 
aa encoded by TAC3 gene in humans and Tac2 gene in rodents. The tachykinins have a 
common carboxyl terminal aa sequence Phe-X-Gly-Leu-Met-NH2, where X is a 
hydrophobic residue decisive for the activation of its receptor. Tachykinins act on three 
types of GPCRs, called NK1R, NK2R and NK3R [67]. 
NKB exhibits a high-affinity binding for NK3R [68]. NK3R is encoded by TACR3 
gene in humans and Tacr3 gene in rodents. Given the wide cerebral distribution of 
NKB/NK3R system, in recent years, NKB has been proposed to be involvement in the 
control of multiple function systems, such as motor cortex and reproductive function 
[69, 70]. On the latter, IHC analysis, initially conducted in rats and mice revealed NK3R 
expression in the axon of GnRH neurons, supporting the hypothesis that NKB have a 
potential direct effect on these neurons [71]. Recent data, however, have questioned 
the functional relevance of direct KNB actions on GnRH neurons. In this sense, IHC 
analyses in sheep have demonstrated the existence of NK3R in POA and several 
hypothalamic regions as ARC and, although GnRH neurons and fibers were in proximity 
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to NK3R-containing fibers, the lack of NK3R in GnRH neurons suggested that the 
actions of NKB on GnRH secretory activity are mediated indirectly, [72]. 
Despite the variable effects of NKB on LH secretion reported in initial studies 
[70, 73], recent works carried out in different species (such as sheep, rat and monkey) 
indicate a stimulatory effect of NKB on GnRH/LH secretion [69, 70]. Furthermore, the 
NKB/NK3R system has been recently implicated in the regulation of reproductive axis 
in humans, as inactivating mutations in TAC3/TAC3R have been found in cases of 
hypogonadotropic hypogonadism (HH) [74]. As regards the latter, phenotypic 
discordance between mice and humans have been proposed due to subfertility has 
been reported in Tacr3−/− mice [75]. Thus, although capable of fertility, these animals 
have central reproductive defects. In this sense, it has been suggest that NKB may 
activate other tachykinin receptors to partially stimulate GnRH release, in the absence 
of Tacr3, demonstrating that other tachykinin pathways are important in regulating 
GnRH function [76].  
 Galanin  
Galanin (GAL) is a neuropeptide of 29 aa (30 aa in humans), highly conserved 
between species [77]. Its effects are mediated by three types of GPCRs: GAL-R1, -R2 
and -R3 [78]. It has been described that GAL plays an important role in the regulation 
of gonadotropin releasing hormone [1] release. Thus, the central administration of GAL 
enhances GnRH release and increase LH levels in ovariectomized (OVX) rats [79] and it 
was also confirmed that GAL stimulates GnRH secretion by in situ hybridization (ISH) 
analyses [80]. Moreover, it has been reported in different species, including the rat 
and sheep, that GAL may act in a subpopulation of GnRH neurons through the GAL-R1 
and that its effects is influence by levels of circulating gonadal steroid [81, 82]. 
 Galanin-like peptide (GALP) 
GALP, so named for a 10-amino acid region of sequence identity to GAL, is 
highly conserved between mice, rats and humans [83]. Despite the common amino 
acid sequence shared by GAL and GALP, these peptides are derived from separate 
genes [83].  In the mammalian species, expression of GALP is expressed in the ARC and 
is implicated in the neuroendocrine regulation of metabolism and reproduction [83, 
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84]. In this regard, it has been described that chronic central administration of GALP 
increases LH release in male rats [85, 86].  Notably, this peptide is positively regulated 
by several factors related to energy metabolism such as leptin [84]. In addition, it has 
been demonstrated that GALP may play a role in readjusting energy balance under 
changing nutritional circumstances [87]. Thus, this data suggested that GALP is 
involved in the integrated control of metabolism and reproduction [88]. 
 Catecholamines 
It is well-known that catecholaminergic signaling (adrenaline and 
noradrenaline; NA), via α1- and β-adrenergic receptors, plays an important role in the 
direct activation of GnRH neurons [89]. The first evidence that suggested the 
catecholaminergic control of GnRH secretion was obtained after observation that the 
elimination of NA neurons in the brainstem, as well as the blockade of α-adrenergic 
receptor, decreased the pulsatile LH secretion [90]. In addition, it was demonstrated 
the presence of α-adrenergic receptors in GnRH neurons and in a GnRH neuronal cell 
line, namely the GT1-7 [91]. Specifically, adrenaline seems to be involved in the 
stimulation of pulsatile and preovulatory GnRH surge, while NA is more related to the 
control of LH pulse frequency [92]. 
 Nitric oxide  
Nitric oxide (NO) is a gaseous neurotransmitter, synthesized by nitric oxide 
synthase (NOS), known for its important role in regulating neuronal transmission. 
Recently, it has been implicated in the neuroendocrine control of reproduction and in 
the regulation of GnRH neuronal activity [93, 94]. In addition, it has been 
demonstrated that kisspeptin neurons directly act on NO-synthesizing neurons in the 
POA to promote preovulatory neuronal NOS activation and that these interactions 
modulate LH secretion [95]. Support this statement, the infusion of a NOS inhibitor, L-
NAME, in POA or ME, causes the disruption of estrous cyclicity in rats [96]. However, L-
NAME has been also shown to enhance LH secretion at some conditions suggesting 
some inhibitory action of NO. Moreover, it has been reported that neurons 
synthesizing NO in the POA act as mediators of the stimulatory effects of leptin to the 
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reproductive axis [97]. The role of NO signaling as intermediate pathway in the actions 
of leptin in GnRH neurons will be further described in section 1.5.1. 
1.2.1.2. INHIBITORY SIGNALS 
 GABA 
GABA is the most abundant inhibitory neurotransmitter of CNS and its effects 
are mediated by two types of GABA receptors: ionotropic (GABAA and GABAc) and 
metabotropic (GABAB) [98]. Most of the actions described for GABA and its receptors in 
GnRH neurons and GT1-7 neuronal line indicate that this neuropeptide regulates GnRH 
secretion both directly and indirectly [99]. While pharmacological studies attribute an 
inhibitory effect of GABA on GnRH release, electrophysiological studies in adult female 
mice suggest that GABA may also have excitatory effects [100]. Subsequent studies in 
the GT1-7 neurons showed a biphasic action of GABA on GnRH secretion, where initial 
stimulation is followed by a prolonged inhibition [101]. The administration of selective 
GABAA and GABAB agonists in vivo indicate that the actions of GABA are mediated 
mostly by GABAA receptor, exerting an inhibitory effect of the preovulatory and 
pulsatile GnRH/LH secretion [102]. 
 Endogenous opioids  
The endogenous opioid peptides (EOPs) are classified into three groups: 
enkephalins, β-endorphins (β-END) and dynorphins (Dyn). They exert their effects in 
the CNS interacting with three receptor types: μ, κ and δ, acting β-END and Dyn via μ-
receptor and κ-receptor, respectively [103].  
EOPs are potent physiological inhibitors of GnRH/LH secretion. Thus the β-
END/μ-receptor system appears to play a role in the control of the GnRH/LH surge 
[104], while the Dyn/κ-receptor system has demonstrated an inhibitory effect on the 
GnRH secretion acting as mediator of the negative feedback exerted by P on pulse LH 
frequency [105]. Since the expression of EOPs receptors has been not detected in 
GnRH neurons, but they are located in POA and others hypothalamic areas [106], it has 
been suggested that the inhibitory effects of β-END and Dyn on GnRH neurons could 
be mediated through interneurons [90]. Moreover, it has been demonstrated that a 
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population of Kiss1 neurons of the ARC coexpress Dyn and NKB genes and also NK3R 
and κ-receptor. NKB and Dyn act autosynaptically in these neurons to regulate the 
pulsatile secretion of kisspeptin [70]. The role of these neurons will be described in 
section 1.4.5 
 Neuropeptide Y (NPY) 
NPY, a peptide of 36 aa highly conserved between species, is one of the most 
abundant neurotransmitters in the mammalian CNS [107], being considered a key 
modulator in the control of reproductive function. It is expressed in the ARC and in the 
brainstem, being its expression partially regulated by estrogens. The NPY effects are 
mediated by five types of GPCRs called Y1, Y2, Y4, Y5 and Y6. Among these, Y1 and Y5 
receptors have been implicated in NPY actions on the HPG axis. The Y5 receptor is 
expressed in GnRH neurons and it is involved in the inhibitory effect of NPY on LH 
secretion [108, 109]. The Y1-positive fibers are found in close apposition of GnRH 
neurons in the POA [110]. It has been reported that central administration of a Y1 
receptor antagonist in juvenile rats or monkeys stimulates LH release and advances the 
timing of puberty onset [111, 112]. Moreover, it has been reported that Y1 knock-out 
(KO) mice showed an advance in the timing of puberty onset in unfavorable metabolic 
conditions [113]. The inhibitory effect of NPY on GnRH/LH secretion has been 
demonstrated in both male [114] and female rats [115, 116]. However, contradictory 
effects of NPY in the control of HPG axis have been reported depending on the 
endocrine state, receptor subtype activated and the pattern of administration (acute 
or chronic). In this sense, it has been demonstrated that central administration of NPY 
in pubertal female rats is able to induce an advance in the normal age of vaginal 
opening (VO), an external index of puberty onset, and that NPY administration in 3V 
stimulates LH release at this age [117]. In addition, it was demonstrated that the 
central infusion of NPY in OVX females supplemented with E2, stimulates LH response 
[118]. A crucial role for the NPY in the mechanisms involved in the regulation of GnRH 
neuronal activity by metabolic factors has been also reported. This role will be further 
described in section 1.5.2. 
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 Melatonin 
Melatonin is a tryptophan-derived hormone produced in the pineal gland and 
related with the photoperiodic reproduction. It has been considered an inhibitory 
neurotransmitter for puberty, as a result of the observation of precocious puberty in 
humans with pineal tumors [9]. Melatonin levels increase in dark conditions, limiting 
the sexual behavior in many species. Even so, the nocturnal LH increase in prepubertal 
stage that happen in many animals, including primates, is favored by the expression 
pattern of melatonin during postnatal development, which is high during neonatal and 
early childhood period and then decreases until adulthood, allowing this night 
activation of reproductive axis [119]. 
 Gonadotropin-inhibiting hormone  
For many years it was believed that GnRH was the common final via through 
the hypothalamic signals controlling gonadotropins secretion. In 2000, was discovered 
a hypothalamic neuropeptide of 12 aa (SIKPSAYLPLRF-amide) that, acting directly into 
pituitary, inhibits gonadotropins secretion in birds [120] and for this reason was called 
gonadotropin-inhibiting hormone (GnIH).  
In recent years have been identified GnIH homologs of the avian peptide in 
other vertebrate species including mammals, reptiles, amphibians and teleosts. Since 
of they share a common C-terminal sequence, Arg-Phe-NH2 (RFamide), they are 
included in the family of RFamide-related peptides (RFRPs). In mammals, two GnIH 
peptides, RFRP-1 and RFRP-3 [114, 121], have been identified, the latter is considered 
the functional mammalian ortholog for avian GnIH. 
In rats and hamsters, the cell bodies of RFRPs neurons are mainly located in 
DMN and their fibers appear to contact with GnRH neurons, suggesting important 
functional interactions between both systems. In sheep and hamsters, RFRP-IR fibers 
have been located in ME [122]. 
RFRP-3 acts via two types of GPCRs: GPR147, also termed neuropeptide FF 
receptor type 1 or NPFF-R1, that is the receptor for RFRPs [121]; and GPR74 or NPFF-
R2, which has the less affinity [25]. Those receptors are widely distributed in the CNS 
(including GnRH neurons), pituitary and gonads [123].  
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The icv or intraperitoneal (ip) administration of avian GnIH reduces LH levels in 
OVX hamsters [124], while icv administration of RFRP-3 has the same effect in rats 
[125]. Moreover, studies have been demonstrated that RF9, a selective NPFF-R1 
antagonist, induces a strong increase of LH secretion [126], thus supporting the role of 
RFRPs as central regulators of reproductive axis in mammals. However, recent 
evidence also suggested that not all the gonadotropin-releasing effects of RF-9 derive 
from their ability to block NPFF receptors [127]. 
 Gonadotropins 
Gonadotropins exert an inhibitory control of their own synthesis through short 
feedback loops at hypothalamic level and paracrine mechanism acting over adjacent 
gonadotrope cells at the pituitary level [128]. 
1.2.2. PERIPHERAL REGULATORS 
The function of the HPG axis is specifically regulated by several peripheral 
signals; among them the signals produced by the gonads and metabolic signals play 
especially relevant roles. 
1.2.2.1. GONADAL REGULATORS 
Two groups of gonadal regulators may be distinguished according to their 
steroid or peptidergic nature: 
 Gonadal steroids 
Sexual steroids (estrogens, androgens and P) are mainly synthesized in gonads, 
and to a lesser extent, in adrenal glands, brain (neurosteroids) and other tissues. 
Gonadal steroids and neurosteroids exert a wide variety of effects on CNS, being 
remarkable their role in the control of HPG axis, where they play a dual role. On one 
hand, they participate in the control of sexual differentiation of the brain and on the 
other, they modulate the GnRH/gonadotropin secretion and the activation of neural 
circuits involved in mating and breeding behavior [129, 130]. 
Gonadal steroid actions are mediated by their interaction with intranuclear 
receptors called androgen receptor (AR), progesterone receptors A and B (PR-A and 
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PR-B) and estrogen receptor α and β (ERα and ERβ). The interaction of estrogens with 
ERs activates intracellular signaling cascades [131]. It has been reported also that some 
estrogen effects are mediated by their interaction with ionotropic and metabotropic 
receptors localized in the cell membrane [132].  
ERs are widely distributed in the CNS (including the hypothalamus) and 
pituitary. In the hypothalamus, ERs are expressed in relevant nuclei involved in the 
control of energy homeostasis and also in nuclei implicated in the control of 
reproductive function, including the ARC and the anterior ventral periventricular area 
(AVPV) [131, 133].  
Nowadays, it has been proposed that androgens and estrogens, which interact 
with AR and ERs in the ARC, exert their negative feedback effects on LH and FSH 
secretion, while estrogens, which interact with ERs in the AVPV, participate in the 
positive feedback effects on LH release in female rodents [134]. The direct actions of 
estrogens on GnRH neurons are mediated by ERβ, the only ER subtype expressed in 
these neurons, while estrogen actions in GnRH neurons mediated through ERα must 
be indirect [135, 136]. In this sense, it has been reported that estrogen positive 
feedback to generate the preovulatory gonadotropin surge was normal in ERβ KO 
mice, but was absence in ERα mutant mice, demonstrating that ovulation is driven by 
estrogen actions upon ERα -expressing neuronal afferents to GnRH neurons [137]. 
 Gonadal peptides 
Gonadal peptides (inhibins, activins and follistatins) are hormones that regulate 
gonadotropins release at the pituitary level and exert a paracrine action within the 
gonads.  
Inhibins are proteins produced by Sertoli cells in the testes and by granulosa 
cells in the ovary. Two types of inhibin have been identified: inhibin A and inhibin B. 
Both are heterodimeric proteins consisting of two subunits joined by disulfide bonds: a 
common α subunit and an unique β subunit, being βA to inhibin A (α, βA) and βB to 
inhibin B (α, βB) [138]. Inhibins can selectively inhibit FSH secretion in pituitary 
gonadotropes [139] and also exert a paracrine action on the gonads.  
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Activins are heterodimeric glycoproteins composed of two inhibin β subunits. It 
Three types of activins have been identified: activin A (βAβA), activin B (βBβB) and 
activin AB (βAβB). They stimulate FSH secretion at pituitary level and exert a paracrine 
action on the gonads, stimulating folliculogenesis in the ovaries [140]. 
Follistatins are single-chain glycoproteins with a molecular weight between 31 
and 49 kDa [141]. The follistatin gene encode two isoforms, follistatin 315 (315 aa) and 
follistatin 288 (288 aa), resulting from alternative splicing of the precursor messenger 
mRNA; the 315 aa variant can be subsequently degraded to follistatin 303. Follistatin 
315 and 288 inhibit specifically the secretion of pituitary FSH both in vitro and in vivo, 
via the blockade of activins [142]. Similarly to activins, follistatins are synthesized in 
various tissues, including the ovaries and pituitary, where they exert a paracrine action 
[143]. 
1.2.2.2. METABOLIC REGULATORS 
Reproductive function is a costly process in terms of energy consumption and it 
is not essential for survival at the individual. Thus, sophisticated mechanisms have 
been selected during evolution to allow specific inhibition of the HPG axis in 
unfavorable energetic conditions. For this reason, reproductive axis is highly sensitive 
to metabolic and energy status of the organism. The different metabolic factors 
responsible for conveying the metabolic information to the CNS and modulating the 
reproductive capacity will be described in detail in the section 1.5. 
1.2.2.3. OTHERS PERIPHERAL REGULATORS 
Other peripheral signals, such as adrenal and thyroid hormones, can influence 
gonadotropin secretion. Thus, it has been described that glucocorticoids inhibit directly 
the synthesis and release of GnRH and, in addition, an increase in glucocorticoids levels 
was followed by a decrease in LH secretion in OVX sheep [143].  On the other hand, it 
has been reported that thyroid dysfunction affects GnRH secretion, as evidenced by 
the fact that thyroidectomy and hypothyroidism in rats exert an inhibitory effect on 
GnRH secretion [144].  
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1.3. PUBERTY 
 Puberty is defined as the transition period from juvenile stage to adulthood 
during which the reproductive capacity is reached. Puberty must be understood not as 
a one-time event but as a sequence of events leading to full activation of the 
reproductive axis and the acquisition of reproductive competence. A biological 
hallmark of puberty is the elevated secretion of gonadal steroid hormones, which 
result in the development of secondary sex characteristics, such as the growth of 
genitalia, the appearance of pubic hair in both sexes and facial hair in boys, and breast 
development in girls, among others. Frequently, puberty are used synonymously with 
adolescence, however they are not the same. Adolescence is essentially referred to 
humans and is considered the period between childhood and adulthood, 
encompassing not only reproductive maturation, but also cognitive, emotional, and 
social maturation, which leads to the acquisition of adult cognition and social 
behaviors [145] 
 During the infantile, juvenile and prepubertal ages, the HPG axis remains 
completely silent in humans and partially silent in rodents. This is because the 
secretory activity of GnRH neurons is low and insufficient to support gonadal growth. 
The onset of puberty and so, the maturation of the HPG axis, are characterized by a 
gradual increase in the frequency and amplitude of pulses of GnRH secretion [12]. 
GnRH directs the synthesis and secretion of pituitary gonadotropins, which stimulate 
the gonadal hormones production and gametogenesis.  
1.3.1. NEURONAL AND NON-NEURONAL NETWORKS CONTROLLING 
PUBERTY ONSET 
As mentioned above, the key event required for puberty to occur is an increase 
in pulsatile GnRH release from GnRH neurons. In primates, these neurons are mostly 
located in the MBH, while in rodents most of them reside in the POA [146]. Numerous 
studies have been described that, together with the decrease of sensibility to negative 
feedback of gonadal steroids, the pubertal increase in GnRH secretion depends on 
coordinated changes in neuronal and non-neuronal communication [147, 148], 
consisting of a coordinated increase in excitatory inputs from central and peripheral 
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origin, combined with a decrease in inhibitory inputs [149]. GnRH secretion is 
stimulated by excitatory aa, such as Glu, and by the Kiss1/Gpr54 system. The inhibitory 
input to GnRH neurons is provided by GABAergic, opiatergic neurons or the product of 
RFRP gene, which may act directly on GnRH neurons or indirectly via inhibition of 
neurons involved in the stimulatory control of GnRH secretion, such as kisspeptin 
neurons [150-152]. However, very recent data from our group indicate that NPFFR1 KO 
mice, do not show detectable alterations in the onset of puberty, suggesting that, a 
decreased in GnIH signaling is not mandatory for the normal timing of puberty onset 
[153].  
It has been proposed that, in addition to neuronal inputs, the pubertal 
activation of GnRH secretion also requires information from non-neuronal cells, such 
as glia [154] and endothelial cells [155, 156]. GnRH nerve terminals are separated from 
the vascular wall of the portal system in the ME by glial structures belonging to either 
astrocytes or tanycytes, specialized ependymoglial cells of the ME which line the 
ventral portion of the 3V. Tanycytes may convey information not only between 
themselves and GnRH nerve terminals, but also between GnRH terminals and 
endothelial cells of ME [157]. It has been demonstrated that GnRH secretory activity is 
modulated, at least in part, by specific cell-cell signaling molecules. Thus, glia-neuronal 
interactions in the ME regulate GnRH release by the production of different signals, 
including growth factors, such as epidermal growth factor (EGF)-related peptide, 
transforming growth factor α (TGF-α), and neuroregulins (NGRs), that act directly and 
indirectly on GnRH neurons [147, 154, 157], whereas endothelial cells of ME employ 
NO [95, 157] (Figure 8).  
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Figure 8. Schematic representation of trans-synaptic and glial inputs to the GnRH network. Modified 
from [129].  
 
Several studies have suggested that no single pathway or cellular subset is only 
responsible for the neuroendocrine control of puberty, but there are many genes 
involved in this control [147, 158]. In support this idea, the Ojeda’s laboratory has 
proposed that puberty is controlled by a set of genes hierarchically arranged within 
functionally connected networks where GnRH is the final effector [159]. According to 
this hypothesis, the highest level of network control is provided by transcriptional 
regulators directing controlling key subordinate genes of the network (such as those 
operating within kisspeptin, GABAergic, glutamatergic, opioid, and RFRP neurons) in 
addition to genes expressed in glial cells [147]. Recently it has proposed the concept 
that a more dynamic and encompassing level of integrative control of puberty is 
provide by mechanism of transcriptional repression of genes that are stimulatory to 
the puberty [160, 161]. In addition, microRNAs (miRNAs) have the ability to modulate 
gene expression at multiple hierarchical levels [162, 163], thus they may act as 
regulatory system able to integrate the different networks involved in the control of 
puberty. Recent genome-wide association studies (GWAS) have demonstrated an 
association of a sequence variation in Lin28b (a gene encoding an RNA-binding protein) 
with early menarche [164-167]. In this line, Lin28-related genes (including Lin28b) have 
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been shown to bind to the terminal loops of precursors of the let-7 family of miRNAs, 
blocking their processing into mature miRNAs [168]. Given the importance of 
Lin28/let-7 system in this thesis, their potential role in the timing of puberty will be 
described in more detail in section 1.7.   
1.3.2. PERIPHERAL AND ENVIRONMENTAL SIGNALS FOR THE CONTROL 
OF PUBERTY 
 It is well established  that activation of the HPG axis during puberty and its 
maintenance in adulthood, are very sensitive to the action of peripheral endogenous 
and environmental factors, which interact with central regulators to control the onset 
of puberty [146]. These are all permissive signals and vary with species and sex, and 
provide information about the availability of resources and conditions necessary for 
successful reproduction. Among these factors, internal metabolic cues such as leptin, 
ghrelin and insulin, relay information about the status of energy reserves and the 
metabolic state of the organism to CNS [169]. Of note, before the discovery of leptin 
role in pubertal HPG axis activation, many observations in humans and rodents had 
pointed out the need for a minimum of energy reserves to achieve reproductive 
competence. Soon after the discovery of leptin in 1994, it has shown that low leptin 
levels (hypoleptinemia) induce a delay in the acquisition of reproduction, while high 
leptin levels (hyperleptinemia) produce an advance in the age of puberty onset [170].  
 In addition to metabolic cues, environmental factors such as weather or stress 
conditions and photoperiod (circadian rhythms) [171]also contribute to determine the 
timing of sexual maturation [172]. In this sense, several studies in humans 
demonstrated a relationship between the hours of light/season and the timing of 
menarche. For example, girls living in countries with a large number of daylight hours 
and warmer temperatures acquired puberty an earlier ages than the girls who live in 
Nordic countries, with fewer daylight hours and lower temperatures [173]. However, 
in humans and other mammals, which can breed through the year, these factors are 
much less important than in animals with fertile periods linked to the season 
(seasonally breeders). 
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 Finally, epidemiological studies in humans and experimental data in rodents 
suggest that exposure during the initial stages of development to some natural or 
synthetic compounds with estrogen mimetic activity (termed as endocrine disruptors) 
may also influence the age of pubertal onset [174]. 
 As a summary, a schematic representation of the main elements, mentioned 
above, involved in the control of puberty onset is provided below (Figure 9).   
 
Figure 9. Schematic representation of the major elements involved in the control of puberty onset. 
GnRH neurons, which receive trans-synaptic and glial inputs, release GnRH to the hypophyseal portal 
blood system. In turn, GnRH leads the pulsatile secretion of gonadotropins, LH and FSH that stimulate 
the maturation and regulate the function of the gonads. These major hormonal elements are connected 
via negative and positive feedback regulatory loops. Moreover, the function of the HPG axis is under the 
regulation of several peripheral signals, such as gonadal steroids or metabolic hormones. Some of the 
central inhibitory (red) and excitatory (blue) regulators of the HPG axis are also shown. Modified from 
[175].  
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1.4. Kiss1/Gpr54 SYSTEM 
 As a means of introduction, in this section we will describe the major elements 
of the Kiss1/Gpr54 system and how the identification of the physiological role of 
kisspeptins and its receptor, Gpr54, in the control of GnRH secretion have led to 
significantly advance our knowledge of central mechanisms involved in the control of 
puberty and reproduction.  
  In order to unify criteria regarding the nomenclature used in this Thesis, we 
note here that we use KiSS1 and Kiss1 to denote the gene and its transcripts (mRNA) in 
primates and rodents, respectively. The protein products of KiSS1/Kiss1 genes will be 
designated as kisspeptins. On the other hand, the receptor of kisspeptins will be 
referred as GPR54 and Gpr54 in primates and rodents, respectively, while GPR54 and 
Gpr54 will be used to name the corresponding genes/mRNA. To refer to the 
ligand/receptor system without references to any given species, the term Kiss1/Gpr54 
will be used.  
1.4.1. HISTORICAL BACKGROUND  
The elements (genes and peptides) of this ligand/receptor Kiss1/Gpr54 system 
were separately identified between 1996 and 2001, but their close association with 
reproductive physiology came later [176, 177]. In 1996, KiSS1 gene was originally 
identified as a metastasis suppressor gene in a melanoma cell line and the mRNA KiSS1 
as a selectively overexpressed transcript in tumor cells with low invasiveness [178]. For 
this reason, the KiSS1-derived peptide was initially named as metastin. Independently, 
in 1999 Gpr54 was identified in the rat brain as an orphan receptor with a significant 
sequence similarity (>40%) with the transmembrane regions of GAL receptors [179]. 
Subsequently, the human ortholog of Gpr54 was cloned, and named AXOR12 or 
hOT7T175 [180].  Finally, in 2001 three independent groups functionally linked the 
Gpr54 receptor to Kiss1 gene and metastin, defining the so-called Kiss1/Gpr54 system 
[171, 181]. One of this report identified several isoforms derived from Kiss1 with 
capacity to bind Gpr54 and termed then kisspeptins [171].  
It was not until late 2003 when the first evidence of the role of this system in 
the control of reproductive function was published. In this year, two independent 
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reports documented the presence of deletions and inactivating mutations of the 
GPR54 gene in patients suffering idiopathic hypogonadotropic hypogonadism (iHH). 
Such findings in humans were reinforced by the report that mice engineered with lack 
functional Gpr54 were a complete phenocopy of affected patients [182, 183]. All 
together, these observations suggested a crucial role for this system in the regulation 
of HPG axis. 
At present, several transgenic (Tg) mouse lines have been generated with 
mutations in the Gpr54 gene and in the Kiss1 gene [184] to reproduce the HH in 
humans. The nomenclature for these Tg lines is based on the guidelines established by 
the International Committee on Standardized Genetic Nomenclature for mice 
(http://www.informatics.jax.org/mgihome/nomen/index.shtml). 
 The Gpr54 and Kiss1 mutant mouse lines show similar phenotypes indicating 
the absence of compensation by other ligands. All of them are characterized by a lack 
of normal pubertal maturation and infertility, showing poor development of the 
gonads with low gonadotropin circulating levels (HH) compared with their respective 
wild type controls [185]. Males showed disrupted spermatogenesis [183] and females 
displayed a delay in VO and a disruption of the normal cyclic changes associated with 
the estrous cycle [183, 186, 187]. In addition, both Gpr54 and Kiss1 KO had lower BW 
than WT, selectively after puberty [183, 186-189].  
1.4.2. MAJOR ELEMENTS: Kiss1, KISSPEPTINS AND Gpr54 
The human KISS1 gene contains three exons and two introns [190]. An 
alternative genomic organization, with four exons (the first two being noncoding 
exons), has been also proposed [191]. The first exon consists of 111 pair of bases and it 
is not translated, the second exon contains 141 nucleotide (nt), with the star codon at 
position 39, and the third exon consists of 322 translated nt, followed by the 
translational stop codon and the polyadenylation sequence [190]. The mouse Kiss1 
gene contain only two translated exons, which correspond to the last two exons of the 
human gene. The first exon encoded the signal peptide and part of prepro-kisspeptin 
protein and the second encoded the remaining of the precursor protein including the 
sequence to kisspeptin-10 (Kp-10) [187] (Figure 10). 
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Figure 10. Squematic representation of kisspeptins generation from the Kiss1 gene in rodents. Different 
kisspeptins are generated by proteolytic cleavage a common precursor, prepro-kisspeptin, encoded by 
the Kiss1 gene. The coding region is composed by two exons, which is close to the Golt1a gene. The 
prepro-kisspeptin contains a central 52 aa region, kisspeptin-52. Lower molecular weight forms of 
kisspeptins include Kp-14, Kp-13, and Kp-10. Adapted from [192]. 
 
Kisspeptins are derived from the differential proteolytic processing of a single 
precursor. In the human, the kisspeptin precursor (prepro-kisspeptin) comprises 145 
aa, with a 19 aa signal sequence, two potential dibasic cleavage sites (at aa 57 and 67), 
and one site for terminal cleavage and amidation (at aa 121–124) [171, 181], which 
generate the biologically active kisspeptins (Figure 10). Indeed, proteolysis of prepro-
kisspeptin gives rise to a 54 aa peptide (kisspeptin-54, Kp-54), which has been 
considered the major product of the KiSS1/Kiss1 genes. In addition, other peptide 
fragments of the kisspeptin precursor, such as Kp-14, Kp-13, and Kp-10, have been also 
identified [171, 181]. All they share the C-terminal region of the Kp-54 molecule, 
where they contain an Arg-Phe-NH2 motif characteristic of the RF-amide peptide 
family.  
 In rats and mice, the largest proteolytic product of the kisspeptin precursor is 
composed of 52 aa (kisspeptin-52, Kp-52) [193]. Although the degree of sequence 
homology of the precursor protein between rodents and humans is 54%, the Kp-10 
sequence is highly conserved, varying only one aa, Phe, which is substituted by Tyr 
residue, at position 10, in rodent Kp-10 sequence [194]. 
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The Gpr54 gene exhibits a high degree of sequence homology between 
different species. This gene contains 4 introns and 5 exons and codes for a protein of 
396 aa, which includes an extracellular amino-terminal domain, responsible for ligand 
binding, followed by seven transmembrane domains and an intracellular carboxyl-
terminal domain, which associate to G-protein [171]. The high degree of conservation 
of mRNA and protein sequence among species is indicative of the evolutionary 
importance of this receptor system. 
1.4.3. EXPRESSION OF Kiss1/Gpr54 SYSTEM 
 The Kiss1/Gpr54 system distribution has been studied in a wide variety of 
species and, although its localization and patterns of expression may vary among 
them, in general it is closely related to the neuroendocrine regulatory centers of 
reproductive function. 
 The first human studies demonstrated KiSS1 mRNA expression in placenta, 
pancreas, small intestine, liver, testis and brain, with a scattered distribution 
throughout the CNS, including the basal ganglia and the hypothalamus [178, 180, 181]. 
Hypothalamic Kiss1 expression was also demonstrated by initial studies in other 
mammalian species, including non-human primates [135, 195, 196]. Although 
kisspeptin-IR fibers has been located in POA, SON, PVN and DMN [177], studies in 
rodents have shown that the two main populations of Kiss1 neurons are located in ARC 
[70, 197, 198] and in the rostral periventricular area of the 3V (RP3V), which includes 
the AVPV and the periventricular nucleus (PeVN) [195, 196]. In the ARC, a majority of 
Kiss1 neurons co-express NKB and Dyn and consequently they have been called KNDy 
neurons [69, 199]. With regard to the population of Kiss1 neurons in the RP3V, it 
shows a clear sexual dimorphism in AVPV, with females having many more Kiss1 
neurons than males [200].  
 Although hypothalamic Kiss1 neurons localization is coherent with its role as 
neuroendocrine regulator of reproductive function, the ARC and AVPV populations of 
Kiss1 neurons display important anatomical differences in terms of projections to 
GnRH neurons. Thus, direct appositions between Kiss1 and GnRH neurons were 
initially reported only for Kiss1 neurons from the AVPV [201]. In this regard, studies in 
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the sheep suggested that ARC Kiss1 neurons do not significantly project to the 
ventromedial POA, whereas the kisspeptidergic afferents to GnRH neurons are 
originated from the population located in the POA [202]. However, recent studies in 
mice have shown that ARC Kiss1 neurons project to the POA, where most cell bodies of 
the GnRH neurons are located, thus making plausible their direct interaction with 
GnRH neurons [203]. It should be noted that most of the studies indicate that ARC 
Kiss1 neurons, and specifically KNDy neurons, project to the ME, where the axon 
terminals of GnRH neurons are placed, suggesting the existence of interneuronal or 
even non-synaptic communications between these two neuronal populations [197, 
204]. These anatomical differences, in terms of fiber projections, strongly suggest 
important functional divergences between these two Kiss1 neuronal populations.  
 The Gpr54 distribution is similar to that described for Kiss1. Thus, Gpr54 
expression is mainly found in placenta, pancreas, liver, skeletal muscle, gonads, 
pituitary and in different areas of the CNS such as the cerebral cortex, cerebellum, 
putamen, thalamus, hypothalamus and spinal cord [135, 177, 195, 196, 205]. Also, 
expression of Gpr54 mRNA has been detected both in mouse GnRH neurons [206] and 
in rat pituitary [205]. 
1.4.4. MECHANISMS OF ACTION OF KISSPEPTINS 
 Kisspeptins exert their effects by the binding to Gpr54, a Gαq/11-coupled 
receptor, which leads to the activation of PLC, with the subsequent stimulation of the 
hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol 1,4,5-
trisphosphate (IP3) which, in turn, evokes the mobilization of intracellular Ca2+ and 
influx of extracellular Ca2+ [171, 180, 207, 208]. In addition, the activation of Gpr54 
induces diacylglycerol (DAG) formation following by protein kinase C (PKC) activation 
which causes activation of protein kinases, such as ERK1/2 and p38 [171, 207].  
1.4.5. ROLE OF Kiss1 NEURONS IN THE REGULATION OF GONADOTROPIN 
SECRETION 
By the end of 2004, shortly after the first reports about the reproductive 
consequences of Gpr54 inactivation in humans and mice, different groups 
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independently reported the potent stimulatory effect of Kp-10 and Kp-54 on LH 
secretion in female and male rodents [209-212]. Moreover, subsequent studies 
demonstrated that kisspeptin administration, both central and systemically, is able to 
elicit LH and FSH secretion in different stages of development and in different 
physiological states such as pregnancy and lactation in different species, including rat, 
monkey and human [207, 209, 213-217].  
 It is noted that the effects of kisspeptins on gonadotropin secretion differ in 
terms of duration and sensitivity. In this sense, studies carried out in male rats have 
demonstrated a rapid (within 5 to 15 min) and robust (up to 10-fold increase over 
basal levels) responses in terms of LH release after icv injection of Kp-10, while FSH 
responses were a bit delayed (from 30 min onwards) and of lower relative magnitude 
(approx. 2-fold increase) after similar dose. Moreover, LH and FSH responsiveness to 
Kp-10 is different, with EC50 of 2 and 400 pmol doses for LH and FSH, respectively [214, 
216, 218, 219]. These differences can be explained because the pattern of secretion is 
more constitutive for FSH than for LH [220] and because the FSH secretion is 
selectively regulated by gonadal peptides such as inhibins [221]. 
 Another aspect of the pharmacology of kisspeptins is the appearance of 
desensitization of gonadotropin responses following repeated or continuous exposure. 
Thus, it has been observed that the stimulatory effects of continuous infusion of Kp-10 
in rats, after an early phase of LH hypersecretion, disappeared after 48 h of the 
beginning of treatment [222, 223]. 
1.4.5.1. REGULATION OF PULSATILE GnRH SECRETION 
Substantial experimental data, obtained mainly in rodents, sheep, and 
primates, have supported that the actions of kisspeptins are conducted via activation 
of GnRH neurons at the hypothalamus. Thus, it has been demonstrated that the effects 
of kisspeptins are completely eliminated by pretreatment with GnRH antagonists in 
rats, mice, and monkeys [211, 214, 219]. In this line, evidence for a direct effect of 
kisspeptins on GnRH neurons came from the observation that kisspeptins induced the 
expression of c-fos, as a marker of early cellular activation, in GnRH neurons in rodents 
[211] and evoked a potent depolarization responses in GnRH neurons [213, 224]. In 
Introduction 
 
 
33 
 
addition, studies using GT1-7 cells, where expression of Gpr54 gene has been 
documented, have shown an increase on GnRH secretion after kisspeptin 
administration [224].  
Recently, it has been proposed that signals from ARC Kiss1 neurons participate 
in the regulation of pulsatile GnRH secretion [192]. This idea was reinforced by studies 
in female rats, showing that continuous infusion of kisspeptins antagonist in the ARC 
significantly suppresses the GnRH pulses [225]. 
As mentioned above (see section 1.4.3.), a population of Kiss1 neurons of the 
ARC coexpress NKB and Dyn (KNDy neurons), and for this reason, the possibility that 
these three peptides may jointly participate in the control of the pulsatile GnRH 
secretion has drawn quite some attention. The most widely accepted hypothesis 
proposes that NKB and Dyn may operate as positive and negative modifiers, 
respectively, of the pulsatile release of kisspeptins by KNDy neurons in the ARC [70, 
198] (Figure 11). According to this model, which is supported by the anatomical 
demonstration of interconnections among KNDy neurons, these neuropeptides would 
act autosynaptically on ARC KNDy neurons to modulate kisspeptin release on GnRH 
nerve terminals at the ME. Note that while expression and functional data support this 
hypothetical model, some anatomical features of this network are not yet totally 
clarified, such as, whether the projections of ARC KNDy neurons to GnRH are direct, 
and if so, whether they target the soma or/and nerve terminals [70, 226]. 
 
 
Figure 11. Schematic model to explain the role of ARC KNDy neurons in the control of pulsatile GnRH 
secretion. KOR (κ-opioid receptor), Dyn receptor; NK3R, NKB receptor; GPR54, kisspeptin receptor. 
Taken from [175]. 
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The interest to characterize the role that the Kiss1/Gpr54 system play in the 
regulation of reproduction led to the A.E. Herbison laboratory in association with the 
G. Schütz laboratory to generated two Tg mice models: the GnRH-Cre;Gpr54f/f model, 
which present a specific ablation of Gpr54 on GnRH neurons; and the Gpr54-/-;Tg 
model, generated via a selective reintroduction of Gpr54 expression on GnRH neurons 
of Gpr54 KO mice. The phenotype of the latter has been characterized in our 
laboratory [153]. These Tg mice models provide a useful tool to further understand the 
function of Gpr54 and kisspeptins in mammalian reproduction in vivo. 
1.4.5.2. THE NEGATIVE FEEDBACK CONTROL OF GONADOTROPIN SECRETION 
 The first evidence for the involvement of hypothalamic Kiss1 neurons in the 
negative feedback of gonadotropins by gonadal steroids was obtained from rodent 
studies in models of gonadectomy (GNX), with or without sex steroid replacement. The 
elimination of gonadal factors in adult male and female rats evoked a robust increase 
in Kiss1 mRNA levels, which was also accompanied by an increase in circulating 
gonadotropin levels. By contrast, the replacement with sex steroids, T in 
orchidectomized (ORX) male rats and E2 in OVX female rats, blockade the increase of 
both Kiss1 expression levels and gonadotropin levels following the GNX [135, 196, 212, 
217]. In addition, ISH studies in rats and mice have been demonstrated that 
hypothalamic Kiss1 mRNA expression changes indicated above take place specifically in 
the ARC. These observations have been confirmed subsequently in other mammalian 
species, including humans [227-229]. 
 In relation to the receptors involved, almost all Kiss1 neurons express ERα, as 
well as PR y AR [199, 230], while only a part express ERβ [135]. Functional genomics 
and pharmacological studies have demonstrated that ERα is the main mediator of the 
negative feedback that estrogens exert in ARC Kiss1 expression [135, 136]. In this way, 
it has been recently documented that the selective lack of ERα in ARC kisspeptidergic 
neurons was followed by an increase of Kiss1 mRNA expression in prepubertal mice 
[231]. In addition, studies about the effect of T and DHT, a non-aromatizable androgen, 
on GnRH release, suggest that the control of ARC Kiss1 expression is mediated via AR 
and ERα (after the aromatization of T) [135].  
Introduction 
 
 
35 
 
1.4.5.3. ROLE OF Kiss1/Gpr54 SYSTEM IN THE CONTROL OF PREOVULATORY 
GnRH/LH SURGE  
 As described above, besides the ARC population of Kiss1 neurons, a second 
population of Kiss1 neurons in the AVPV, which also express ERα, has been reported in 
rodents [196]. It has been demonstrated that, contrary to the ARC, neurons at the 
AVPV displayed decreased Kiss1 mRNA levels after GNX and increased expression 
following sex steroid replacement. Moreover, expression analyses in cyclic and E2-
primed OVX female rats demonstrated that there is an increase in Kiss1 mRNA 
expression at the AVPV during the preovulatory LH surge [134, 232]. Additionally, 
pharmacological studies have documented that selective blockade of ERα blunted the 
endogenous preovulatory LH surge and induced a suppression of LH responses to 
exogenous Kp-10, when administered during the proestrous [233]. All these 
observations have consolidated the notion that Kiss1 neurons in the AVPV mediate the 
stimulatory effects of estrogen (positive feedback) on gonadotropin secretion in 
rodents (Figure 12). 
 
Figure 12. Schematic representation of the regulatory effects of gonadal steroids (E2, P and T) on Kiss1 
neurons in rodents. Estrogen (E2) input exerts a predominant inhibitory action on KNDy neurons in the 
ARC, which contributes to negative feedback control of GnRH (left). In contrast, the stimulatory effects 
of E2 to induce the preovulatory surge of gonadotropins (positive feedback) are mediated by Kiss1 
neurons in the AVPV. Adapted from [175]. 
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1.4.6. Kiss1 NEURONS IN THE CONTROL OF PUBERTY ONSET 
 As highlighted previously, puberty is the crucial developmental period when 
reproductive capacity is achieved. A key event in the onset of puberty is the 
progressive increase of the neurosecretory activity of GnRH neurons [147, 172]. It is 
thought that pubertal changes in the pattern of GnRH secretion are the result of the 
combined increase in excitatory inputs and decrease in inhibitory inputs projecting to 
GnRH neurons [147, 234]. In this context, recent data have documented an important 
role of kisspeptins in the control of puberty in mammals.  
 The first evidence for the essential role of kisspeptin signaling in the control of 
puberty onset came from the studies describing the impaired pubertal progression and 
sexual immaturity of humans and mice with genetic inactivation of GPR54/Gpr54 [183, 
188]. Later, in order to characterize the physiological significance of the Kiss1 system in 
puberty onset, hypothalamic expression analyses of the mRNA of both Kiss1 and Gpr54 
were implemented at different stages of postnatal maturation. Studies in male and 
female rats showed a clear increase in Kiss1 and Gpr54 mRNA levels in the 
hypothalamus during pubertal progression [212]. This phenomenon was later 
confirmed in non-human primates, where it was shown that Kiss1 and Gpr54 mRNA 
expression in the hypothalamus of female monkeys increases approximately threefold 
during the transition from the juvenile to the pubertal stage [235]. More specifically, 
IHC studies in rats and mice have documented an increase in the number of Kp-IR 
neurons in the AVPV during pubertal maturation, although this increase was higher in 
females than in males [204, 236]. The functional relevance of such rise of kisspeptin 
tone in the AVPV for the timing of puberty is supported by the simultaneous increase 
of Kp-IR projections originating from AVPV to GnRH neurons [236]. Nonetheless, 
studies conducted in the ARC have demonstrated a rise in Kiss1 mRNA levels during 
the pubertal transition [204, 226], although with a magnitude more modest compared 
with the reported in the AVPV, especially in female [204].  
In addition to changes in the ligand, studies to evaluate potential modifications 
in Gpr54 signaling showed an increase in Gpr54 mRNA expression during puberty at 
the hypothalamus of rats and monkeys [212, 235]. Moreover, ISH analyses and 
electrophysiological recordings suggested that this phenomenon was not primarily 
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caused by an increase in the expression levels of Gpr54 mRNA per cell, but a gradual 
increase of GnRH neurons expressing Gpr54, as well as, an enhancement in the 
efficiency of this receptor to couple with its effector systems during the pubertal 
transition [213].  
The above data suggest a rise of the kisspeptinergic tone during puberty, 
supported by the observation in monkeys of an increase in the pulsatile release of Kp-
54 in the ME during this stage, which is coincident with the elevation of GnRH pulse 
frequency seen at puberty [237]. In support of the essential role of kisspeptins in the 
acquisition of reproductive function, pharmacological studies have demonstrated that 
central repeated administration of Kp-10 in prepubertal female rats induced 
precocious VO and earlier activation of the HPG axis, with the consequent 
gonadotropins response [151]. In fact, it has been demonstrated that Kp-10 
administration in immature rats was followed by an increase on LH circulating levels 
[207]. 
The functional relevance of kisspeptin signaling in the pubertal maturation has 
been recently confirmed by the observation of the delayed puberty in pubertal female 
rats after the central infusion of an effective kisspeptins antagonist, peptide 234 [238]. 
However, recent data suggested that pubertal maturation in female mice can be 
attained even after congenital ablation of Kiss1- or Gpr54-expressing neurons. These 
observations could be indicative of the activation of compensatory mechanisms and/or 
the involvement of other neuronal populations with an important role in the activation 
of HPG axis during puberty [239]. 
1.5. METABOLIC CONTROL OF PUBERTY 
 The notion that reproduction requires of the amount of energy reserves dates 
back thousands of years. However, despite this intuitive knowledge, it was not until 
the 1960s and 70s when the works of Kennedy and Frisch formulated, on a scientific 
basis, the interactions between nutrition and reproduction. They established “the 
critical (fat) mass hypothesis” that proposes the need to have a critical body weight 
(BW) as a physiological requirement for menarche and maintaining of reproductive 
function in women [240-243]. Moreover, not only situations of energy insufficiency 
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induce serious alterations of reproductive function, conditions of severe energy excess, 
such as morbid obesity, are also coupled to reproductive disorders [244, 245]. 
Many signals, of both central and peripheral origin, are responsible to relay 
information about energy and metabolic state to the neural centers controlling 
reproductive function. In general, it is considered that signals of energy sufficiency 
inhibit food intake (anorexigenic signals) and stimulate reproductive function, while 
signals of insufficiency energy stimulate food intake (orexigenic signals) and inhibit the 
function of the HPG axis. 
1.5.1. PERIPHERAL SIGNALS INVOLVED IN THE INTEGRAL CONTROL OF 
ENERGY BALANCE AND REPRODUCTION 
 Several peripheral signals transmit the metabolic information to the neural 
centers involved in the control of reproduction. These signals are mainly originated 
from the adipose tissue, pancreas and gastrointestinal tract and are described in detail 
below. 
 Leptin 
 Leptin is considered an essential signal in the integrative control of BW, energy 
homeostasis and reproductive function. Leptin, also known as OB protein, is a 16 kDa 
peptide hormone encoded by the obese (ob) gene that was identified and cloned in 
1994 [246]. It is mainly produced by adipocytes and is present in serum, in both 
rodents and humans, at levels directly related with the amount of adipose tissue [247]. 
Leptin effects are mediated by its interaction with leptin receptors (Lep-R or Ob-R) 
which are expressed in several hypothalamic nuclei involved in the control of BW, 
energy homeostasis and reproduction. 
 Leptin has a key role in the control of energy balance as anorexigenic signal, 
suppressing appetite and increasing energy expenditure. Thus, the leptin-deficient 
(ob/ob) and leptin receptor-deficient (db/db) mice exhibit obesity due to hyperphagia, 
insulin resistance and infertility [248]. In addition, it has been demonstrated the 
peripheral and central administration of exogenous leptin to ob/ob mice reduces 
obesity and restores reproductive function [245]. Moreover, leptin exert a permissive 
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effect on puberty onset, as its lack or deficiency produces pubertal failure and HH 
[249-251]. 
 Although leptin acts centrally to promote puberty onset and to maintain 
fertility, the apparent lack of functional Ob-R in GnRH neurons suggests the existence 
of afferent pathways that would convey its action onto GnRH neurons [252]. In this 
sense, leptin could act via different neuronal populations involved in the metabolic 
control of reproduction, such as NPY neurons [253-256], POMC neurons [257], GALP 
neurons [258] and NO neurons [93, 97], the latter also intermediate of kisspeptin 
neurons [95]. These intermediate pathways whereby leptin indirectly modulates GnRH 
function will be detailed in the next sections.  
 Insulin  
 Insulin is a peptidergic hormone produced by β-cells of the pancreas. Insulin 
circulating levels increase after food intake, following the rise of the immediate 
principles in blood, mainly glucose. Insulin exerts an anorexigenic effect and is involved 
in the control of GnRH/LH secretion, thus participating in the metabolic control of the 
HPG axis. This argument is supported by the identification of insulin receptors (IR) in 
the hypothalamus of several species, specifically in neurons close to GnRH neurons in 
ME and ARC [259]. In addition, it has been demonstrated the presence of IR in cultured 
GnRH neurons [260]. Insulin administration to diabetic sheep model restored the 
pulsatile LH secretion, suggesting a central effect on GnRH secretion [261]. In line with 
above data, the neuronal-specific inactivation of IR in mice resulted in metabolic 
alterations and infertility associated with a decreased on GnRH levels [262], suggesting 
the critical role of insulin signaling in the brain for the metabolic control of the HPG 
axis. Besides the direct effects of insulin on GnRH secretion, it has been proposed also 
an indirect effect of insulin on GnRH/LH secretion mediated by NPY inhibition [256]. 
 Ghrelin  
 Ghrelin is a 28 aa peptide hormone secreted, mainly, by specific endocrine cells 
of the gastric mucosa, which was identified in 1999 as the endogenous ligand of the 
GH secretagogue receptor (GHS-R) [263]. Besides its stimulatory role on GH release, 
one of the most remarkable characteristics of ghrelin is its capacity to increase food 
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intake and to adjust reproductive function to the availability of energy reserves [264, 
265]. Due to its orexigenic effects, this hormone has been considered as a functional 
antagonist of leptin in the control of food intake [266]. Circulating ghrelin levels are 
inversely correlated with the body mass index; thus, it has been considered as a signal 
of energy insufficiency. In good agreement, it has been described that ghrelin operates 
as a negative modifier of gonadotropin secretion and, in rats, chronic central 
administration that this hormone produces a delay of puberty onset and a decrease on 
LH circulating levels [267]. 
 Peptide YY  
 Peptide YY (PYY) is a hormone consisting of 36 aa with structural homology to 
NPY. The two major forms, PYY1-36 and PYY3-36, are synthesized by L cells in the mucosa 
of the gastrointestinal tract. PYY3-36 binds to Y2 and Y5 receptors in the hypothalamus, 
mainly in the ARC, pituitary and intestine to control food intake, as signal of energy 
sufficiency. Additionally, PYY3-36 participates in the control of the HPG axis, stimulating 
LH and FSH releases by increase GnRH secretion and by acting at pituitary level [268].    
1.5.2. CENTRAL SIGNALS FOR THE INTEGRATIVE CONTROL OF ENERGY 
BALANCE AND REPRODUCTION 
 The central signals that participate in the control of energy balance modulate 
the activity of GnRH neurons directly or via hypothalamic interneurons which project 
to GnRH neurons. The main neurons involved in the metabolic control of reproduction 
are located in the ARC and express kisspeptins, NPY, orexins, NO, GALP and POMC and 
its peptides products (α-MSH and β-END). 
 Kiss1/Gpr54 system  
 The Kiss1/Gpr54 system has recently been proposed as a key integrative 
element that links energy homeostasis and reproductive function [269]. Several 
studies documented that pubertal rats and adult mice of both sexes subjected to 
fasting showed a decrease in the Kiss1 hypothalamic expression levels, which was 
associated with a decrease in circulating LH levels [270, 271]. Similarly, it has been 
demonstrated that central administration of Kp-10 to rats subjected to fasting revert 
Introduction 
 
 
41 
 
the reduction of gonadotropins induced by the state of negative energy balance. In 
addition, in female rats submitted to chronic subnutrition during the peripubertal 
period, repeated administration of Kp-10 rescued the negative effects on the puberty 
onset and LH secretion caused by chronic subnutrition [271].  
 Few years ago, it was demonstrated Kiss1 neurons in the ARC (and in the POA 
in ewes) express Ob-R. Since Ob-R are not present in GnRH neurons, it was proposed 
that leptin could act directly on Kiss1 neurons to mediate its effects on the puberty 
onset and maintaining of reproductive function [272, 273]. In good agreement, lower 
Kiss1 levels have been found in leptin-deficient mice that were recovered after 
administration of the hormone [272]. Moreover, rats subjected to food restriction 
during lactation displayed reduced hypothalamic expression of Kiss1 mRNA and Kp-IR 
in the ARC associated to hypoleptinemia [274, 275]. In addition, female rats subjected 
to postnatal overnutrition showed an advance in puberty onset associated with an 
increases in circulating leptin levels, Kiss1 mRNA levels and Kp-IR fibers in the AVPV 
[274]. However, against the putative role of Kiss1 neurons as direct mediators of leptin 
effects on HPG axis, it has been recently documented that the specific ablation of Ob-R 
on Kiss1 neurons does not prevent fertility, suggesting that leptin may act indirectly 
(and/or independly) on Kiss1 neurons to control the onset of puberty and reproductive 
function [276].  
 NPY/AgRP neurons 
 In rats, NPY neurons are located in different brain areas, including a large 
population of neurons in the ARC that coexpress AgRP (Agouti-Related Protein) and 
that has been postulated as key element in the metabolic control of the HPG axis.  
 NPY acts as an orexigenic neuropeptide and it has been demonstrated that the 
activation of ARC NPY/AgRP neurons stimulates feeding in mice [277]. With regard to 
the potential role of NPY in reproduction, since ARC NPY neurons project to GnRH 
perikarya and nerve terminals, it has been suggested that they participate in conveying 
information about energy insufficiency to the reproductive axis. In fact, it has been 
shown that food restriction increases NPY expression and reduces LH release [278]. 
Additionally, the infertile phenotype displayed by ob/ob mice has been associated with 
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high levels of NPY mRNA and indeed, deficiency of either NPY or its Y1 or Y4 receptors 
rescues fertility in these animals [279]. Moreover, given that GnRH neurons do not 
express Ob-R and IR, several studies suggested that NPY neurons can act as mediator 
for leptin and insulin actions on GnRH secretion [256].  
 POMC neurons 
 The neurons that coexpress POMC and CART (Cocaine and Amphetamine-
regulated transcript) in the ARC are also involved in the integrative control of 
metabolism and reproduction. Peptide products resulting from processing of the 
POMC precursor, such as α-MSH and β-END, exert different effects in food intake and 
gonadotropin release. Thus, while α-MSH, a signal of energy sufficiency, reduces food 
intake and stimulate LH release in adulthood [280], β-END, a signal of energy 
insufficiency, stimulates food intake and inhibits LH secretion [281]. The role of POMC 
and melanocortins as metabolic regulators of reproduction will be explained in more 
detail in the section 1.6.  
 RFRP/NPFF1R system 
 Recent data propose that the RFRP/NPFF1R system participates in the 
integrative control of energy homeostasis and reproduction. In addition to its role as 
inhibitor of the reproductive axis [125, 126] (see section 1.2.1.1.), pharmacological 
studies in birds, mice, ewes and non-human primates demonstrated that this system 
likely participates in the control of food intake, exerting an orexigenic effect [125, 282-
285]. Moreover, it has been documented that RFRP neurons project into NPY/AgRP 
and POMC/CART neurons in the ARC [286], suggesting that RFRP/NPFF1R system could 
be involved in the metabolic control of reproduction via these neurons. In this sense, 
recent data showed an inhibitory effect of GnIH on POMC neurons [153, 287].  
 Orexins 
 Orexins (A and B) belong to a family of neuropeptides mainly expressed in the 
LHA. Several studies have demonstrated that central administration of orexins 
increases food intake, in particular, orexin A showed the most potent orexigenic 
effects [288]. Surprisingly, although orexins are signals for energy insufficiency, several 
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lines of evidence suggest a putative role of orexins as stimulators of the HPG axis. 
Accordingly, it has been shown that hypothalamic levels of orexins change during the 
estrous cycle with the maximal levels at proestrous phase [289]. In addition, data 
obtained in different laboratories indicated that orexins stimulate LH secretion in OVX 
rats supplemented with E2 and P [290-292] and also, that central administration of 
orexins recovered the LH pre-ovulatory surge in rats subjected to fasting [293].  
 NO neurons 
As was mentioned above, in addition to its role in the neuroendocrine control 
of reproduction, neuronal NO signaling acts as intermediate pathway of leptin actions 
to GnRH neurons. Thus, it was demonstrated that the deletion of the gene encoding 
NOS or its pharmacological inhibition in the POA, prior to peripheral leptin 
administration, suppress the leptin-induced release of LH in mice and prevent the 
restoration of fertility in leptin-deficient female mice by leptin treatment. In addition, 
it was shown that the inhibition of nNOS activity abolished the ability of exogenous 
leptin to rescue fertility in fasting conditions [97]. These data show that part of the 
actions of leptin in the regulation of HPG axis are mediated by the activation of nNOS 
in the POA. 
 Despite progress made in the last few years in the identification of new central 
and peripheral signals involved in the integrative control of energy balance and 
reproduction, our knowledge in the area remains incomplete.  
1.6. THE MELANOCORTIN SYSTEM: ROLE IN THE HPG AXIS 
REGULATION 
 As discussed above, many factors are involved in the metabolic control of the 
reproductive axis. In this sense, a bidirectional interaction between GnRH neurons and 
key metabolic neuropeptides, such as α-MSH, has been recently proposed. In this 
section we will be described in detail the role of the central melanocortin system in the 
regulation of HPG axis and its interaction with leptin and GnRH neurons. 
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1.6.1. COMPONENTS OF THE MELANOCORTIN SYSTEM 
 The melanocortin system is a ligand/receptor system composed by four POMC-
derived peptides, five melanocortin receptors (MC1-R to MC5-R) and two endogenous 
antagonist, agouti and AgRP. 
 POMC-derived peptides include ACTH and α-, β- and γ-melanocyte stimulating 
hormone (α-, β- and γ-MSH), collectively known as melanocortins. All melanocortins 
are unified by the fact that they contain the aa sequence His-Phe-Arg-Trp, which is key 
for their biological activity [294]. Particularly α-MSH, of particular interest for this 
Thesis, is phylogenetically a remarkably well-conserved molecule and one of the first 
peptide hormones to be isolated [295, 296]. Besides the above mentioned peptides, 
cleavage of the POMC precursor also originates the corticotrophin-like intermediate 
peptide (CLIP), β- and γ-lipotropin, β-END and Met-enkephalin peptides (Figure 13).  
 
Figure 13. Processing pathway of pro-opiomelanocortin (POMC) in the hypothalamus and pituitary. 
 
 POMC-derived peptides are synthesized from a single gene, POMC, mainly 
expressed in the pituitary, CNS and peripheral tissues. In the pituitary, the POMC gene 
is expressed by two cell types: corticotropic and melanotropic cells, while in the CNS, 
the POMC gene is mainly expressed in the hypothalamus, and in peripheral tissues, it is 
abundantly expressed in the skin.  
 The melanocortins were primarily recognized for their role in the regulation of 
adrenal steroid production and skin pigmentation. However, it is now well-known that 
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melanocortins are also involved in other functions as the regulation of food intake, 
reproduction or inflammation. 
 The action of the melanocortin peptides is mediated by a family of five 
subtypes of the melanocortin receptors (MC-R) namely MC1-R to MC5-R. These are G 
protein-coupled receptors that, following ligand binding, induce an increase in cAMP in 
target cells. Additionally, MC-R signaling has also been associated with increases in 
intracellular Ca2+ concentration to activate PKC pathways. The MC1-R is mainly 
expressed by melanocytes, where it has a key role in determining skin and hair 
pigmentation. In addition, MC1-R is expressed in other cell types as keratinocytes or 
endothelial cells in the skin, and leukocytes, where it mediates the antiinflammatory 
and immunomodulatory actions of melanocortins. The MC2-R is expressed in the 
adrenal cortex where it mediates the effects of ACTH on steroid synthesis. This 
receptor is pharmacologically distinct from the other MC-R subtypes as it does not 
bind the MSH peptides but has high affinity for ACTH [297]. The MC5-R is primarily 
expressed in peripheral tissues, including the adrenal gland, adipocytes and leukocytes 
and it participates in exocrine function, particularly, in sebaceous gland secretion [298, 
299] (Table 1).  
 The MC3-R and MC4-R are involved in the central regulation of energy balance 
and reproduction and they are the most abundant MC-R in the brain. In detail, MC3-R 
is mostly confined to the hypothalamus, particularly high expression of MC3-R mRNA 
has been found in the ARC, where the main population of POMC neurons is also 
located. In addition, these receptors are also expressed in other areas of the CNS, 
including the cortex, hippocampus and thalamus, and in several peripheral human 
tissues, such as gastrointestinal tract and placenta [300]. Regarding MC4-R, it is only 
expressed in the CNS, where it is widely distributed, including the cortex, thalamus, 
brain stem and spinal cord and in the VMN and PVN in the medial hypothalamus [301]. 
Given the special interest in this Thesis to identify and analyze signals involved in the 
metabolic control of puberty, the role of MC3 and MC4 receptors in this function is 
described in detail in the section 1.6.2. 
Table 1. The main sites of expression, preferred endogenous agonist and antagonist, and the 
physiological roles for the five MC-R subtypes.   
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Subtype Expression sites 
Endogenous 
agonists 
Endogenous 
antagonists 
Physiological role 
MC1-R Skin α-MSH (ACTH) 
 
Agouti Pigmentation 
Inflammation 
MC2-R Adrenal gland ACTH  Steroid production and 
secretion 
MC3-R 
 
Brain α-MSH (γ-MSH) AgRP Energy balance 
MC4-R Brain α-MSH (β-MSH) AgRP (Agouti) Food intake and energy 
balance 
MC5-R 
 
Brain and a number 
of peripheral sites 
α-MSH  Exocrine gland secretion 
 
 One of the most interesting aspects of the melanocortin system is that it 
comprises also agouti and AgRP, two endogenous antagonists of the MC-Rs [302]. Both 
peptides show structural homology and they have selectivity MC-R subtype 
antagonism (see table 1). Pharmacologically, agouti shows a high-affinity to antagonize 
the effect of melanocortin peptides at MC1-R and MC4-R while AgRP is equipotent 
antagonist of MC3-R and MC4-R. Mice with mutations in the agouti gene show yellow 
fur, obesity, insulin resistance and increased somatic growth. AgRP is expressed 
primarily in the ARC of the hypothalamus and in the adrenal cortex. In the 
hypothalamus, AgRP acts as a potent orexigenic factor due to its ability to antagonize 
melanocortins at MC3-R and MC4-R. 
1.6.2. PHYSIOLOGICAL ROLES OF THE CENTRAL MELANOCORTIN SYSTEM  
 Given its importance in this Thesis, the physiological role of the central 
melanocortin system in energy homeostasis and regulation of the HPG axis is detailed 
below.  
1.6.2.1. POMC NEURONS IN THE CONTROL OF METABOLIC HOMEOSTASIS 
 POMC neurons act as key elements in the control of food intake and energy 
expenditure to keep BW.  
 In the brain, two different populations of POMC neurons have been identified. 
The main POMC neuronal population is located in the ARC. These neurons coexpress 
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neurotransmitters, including GABA and Glu (274, 275). In addition, these neurons 
express a wide variety of receptors such as Ob-R, IR and NPY Y1-R, that confer them 
the ability to sense different peripheral and central signals involved in the control of 
energy homeostasis. Additionally, a second small neuronal population has been 
located in the nucleus of solitary tract [274], whose which function is not yet well-
known. 
 A recent study has demonstrated that the selective ablation of ARC POMC 
neurons mimics the obese phenotype of the POMC-null mice, as consequence of an 
increase in food intake and a reduction on energy expenditure. In contrast, the 
selective ablation of NTS POMC neurons did not reproduce the obese phenotype, 
suggesting that POMC neurons in NTS may have a minor contribution in the control of 
energy homeostasis exerted by the POMC system [303]. 
1.6.2.2. ROLE OF POMC NEURONS IN THE CONTROL OF REPRODUCTIVE AXIS 
 In the last few years, several research groups tried to document whether GnRH 
neurons are direct targets for melanocortin actions. Recent data have demonstrated 
that GnRH neurons express MC3/MC4-R, supporting the direct effect of melanocortins 
in the control of GnRH secretion. In good agreement, IHC analyses showed that POMC 
neurons establish synaptic contacts with GnRH perikarya and nerve terminals, 
suggesting a direct effect of POMC-derived peptides on GnRH excitability [304] and, 
accordingly, electrophysiological recordings of GnRH neurons demonstrated that α-
MSH increases the cell firing in a majority of GnRH neurons through postsynaptic 
activation of both MC3-R and MC4-R [305]. 
 Pharmacological studies showed that the administration of α-MSH induces an 
increase of LH secretion in different mammalian species [306] and also stimulates 
sexual behavior in female rats. Moreover, it was demonstrated that melanotan II (MT 
II), a MC3-R and MC4-R agonist, increased GnRH release in goats [307]. Furthermore, 
subsequent data showed that, in addition to increased fat mass and reduced lean body 
mass, MC3-R KO female mice show a certain degree of subfertility [308]. In good 
agreement, it was demonstrated that mice with functional blockade of both MC3-R 
and MC4-R, by overexpression of AgRP, are infertile [309]. Finally, although data 
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demonstrated that MC4-R deficient male mice are fertile, females are poor breeders 
and exhibited reduced ovulation rates [310].  
1.6.2.3. ROLE OF POMC SYSTEM IN THE INTEGRATIVE CONTROL OF ENERGY 
BALANCE AND REPRODUCTION 
 Since, as mentioned above, GnRH neurons do not express either Ob-R or IR but 
they express MC3-R and MC4-R, it has been suggested that POMC neurons could 
transmit leptin and insulin metabolic information to GnRH neurons to modulate their 
secretory activity. 
 Although, initial studies documented that independent ablation of Ob-R or IR 
on POMC neurons did not disrupt fertility [304], more recently, analyses carried out in 
mice lacking both Ob-R and IR in POMC neurons, demonstrated that these animals 
display reproductive deficiencies that resulted in reduced fertility [311]. Moreover, 
ob/ob mice showed reduced POMC mRNA expression in the ARC and this expression 
was rescued after leptin administration [312]. Additionally, it was shown that Ob-R 
deletion from POMC neurons induces hyperleptinemia and disrupts BW homeostasis 
[313]. In this regard, it has been shown that leptin infusion in the POA and ME produces 
an increase in α-MSH secretion followed by GnRH/LH release [314]. Accordingly, the 
restoration of melanocortin indirect signaling in db/db mice recovers the normal 
timing of puberty onset and fertility, suggesting that in such extreme conditions of 
leptin signaling deficiency melanocortin actions can overcome the functional deficit of 
GnRH neurons [315].  
Despite all these evidence, the role of POMC neurons, and particularly α-MSH, 
in the regulation of puberty, as well as the existence of indirect intermediaries 
between POMC and GnRH neurons, remain unclear. For this reason, one of the main 
objectives of this Thesis was further to explore the role of α-MSH signaling on puberty 
onset as well as its role as mediator of the leptin effects in this maturational event. 
1.7. NEW SIGNALS INVOLVED IN THE CONTROL OF PUBERTY: 
MICRORNAs  
 As mentioned previously, puberty onset depends on complex neural networks 
whose concerted action determines the full activation of GnRH secretion from 
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hypothalamus. However, at the moment, the molecular events that precisely control 
GnRH neuronal activation at puberty remains poorly understood. Nonetheless, 
accumulating evidence suggests that the spatial and temporal control of gene 
expression can play a crucial role on the onset of puberty [316]. In this sense, miRNAs, 
which can modulate gene expression at multiple hierarchical levels, have been 
suggested as a potential regulatory system able to integrate the different networks 
involved in the control of puberty [162, 163].  
1.7.1. miRNAs 
 miRNAs are small non-coding RNA molecules of 18-24 nt in length first 
discovered in 1993 by Lee et al. in C. elegans [317]. In the larval stage of this 
nematode, these researchers found a 18-24 molecule partially complementary to a 
sequence in the 3´ untranslated region (3´UTR) of the lin-14 mRNA. The binding of this 
sequence at the 3´UTR region of lin-14 mRNA inhibited the production of LIN-14 
protein, as consequence, the correct transition from larvae into adult worm in the 
nematode was prevented [318, 319]. 
 After the identification in C. elegans of a second miRNA, namely lethal-7 (let-7) 
[318, 320], many groups of researchers began to seek, and actually found, other small 
non-coding RNAs. Presently, the primary miRNA sequence repository                                 
(http://www.mirbase.org/) contains more than 24000 miRNA loci present in unicellular 
eukaryotic organisms, some viruses, plants and numerous animal species [321]. 
Specifically in the human genome, currently more than 1000 miRNAs have been 
identified [321] and it has been recognized that, at least, one-third of all human genes 
is regulated by miRNAs.  
 From initial earliest work, miRNAs were grouped into 48 families. This 
classification is based on the similarities in 2-8 nt in the 5' end region. This region, 
known as the "seed sequence", is used to seek complementarity inside mRNA and 
predict possible miRNAs targets [322, 323]. 
 At first, it was thought that miRNAs only acting as negative regulators of gene 
expression and exerting their effects by binding to the 3´UTR region of their target 
mRNAs. However, recent data showed that the post-transcriptional control exerted by 
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miRNAs is much more complex and there is now consensus that miRNAs can not only 
decrease, but also increase gene expression binding to their target mRNAs both to the 
promoter and coding regions, as well as to 3´UTR region [324-326]. 
 It should be noted that miRNAs themselves can be regulated. This regulation 
can take place at transcriptional and processing level by autoregulatory feedback loops 
and, at least in mammals, by epigenetic mechanisms, including DNA methylation and 
histone modifications [324, 325]. As further some of complexity, computational and 
experimental approaches have revealed that a single miRNA can regulate entire 
networks of genes and also, each mRNA may be regulated by more than one miRNA 
[327].  
1.7.1.1. SYNTHESIS OF miRNAs 
 The synthesis of miRNAs is a complex process that involves two distinct steps, 
the first one takes place in the nucleus and the second one in the cytoplasm, where a 
mature single-stranded miRNA of about 18-24 nt is finally generated [328]. 
 The miRNA synthesis begins with the transcription of genes encoding miRNAs 
and requires the participation of RNA polymerase II (Pol II) and transcriptional factors 
such as c-Myc or p53. It is interesting to note that mammalian miRNA genes can be 
independent genes or portions of exons or introns of other genes. The initial 
transcriptional process generates molecules of about 100-1000 nt length called 
primary miRNAs (pri-miRNA). 
 Once the pri-miRNA is generated, a microprocessor complex, which consists of 
the RNase III endonuclease Drosha and its partner DGCR8 (DiGeorge syndrome 
chromosomal region 8), cleaves the pri-miRNA and reduces it into a molecule of about 
70 nt, namely the precursor miRNA (pre-miRNA). Then, this pre-miRNA is transported 
from the nucleus to the cytoplasm by the Exportin-5/Ran-GTP complex (Figure 14). 
 In the cytoplasm, the pre-miRNA is further processed by the RNase III Dicer, its 
cofactor TRBP (Tar RNA binding protein) and the argonaute protein (Ago), resulting in a 
miRNA/miRNA* duplex of about 22 nt.  
 Usually, only one strand of this duplex, the mature miRNA, is maintained and is 
integrated with the miRNA-induced silencing complex (miRISC). The passenger miRNA* 
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is subsequently degraded [329]. However, exceptionally, the miRNA* strand is also 
maintained and it can even be more functional relevant than the guiding strand. This 
fact has allowed suggesting a biological role for miRNA* [330].  
The mature miRNA after integration in the miRISC complex in cytoplasm, 
regulates its mRNA target by one of two mechanisms. When it binds its target with 
perfect complementarity, it leads to the target mRNA cleavage. Nevertheless, if it 
binds its target with imperfect complementarity, promotes mRNA degradation and 
translational suppression of the latter (Figure 14). 
 
Figure 14. Biogenesis de microARNs. Taken from [324] 
 
1.7.1.2. REGULATION OF miRNAs SYNTHESIS  
 The miRNAs synthesis is a regulated process at both transcriptional and post-
transcriptional level. Given the special interest of this Thesis, some of these regulators 
will be detailed in the following sections. In addition, to ease understanding of this 
phenomenon, some of the main regulators of this process are summarized in table 2. 
 Although at transcriptional level, Pol II provides the main point of control of 
biosynthesis of miRNAs, transcription can be also regulated by multiple other 
mechanisms. 
 Among the transcriptional factors involved in the regulation of miRNAs 
synthesis, it has been demonstrated that c-Myc, interacting miRNA promoters, 
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modifies the synthesis of several miRNAs including mir-15a, -29, -34 and members of 
let-7 family [331].  
 Regarding epigenetic control of miRNA biosynthesis, different studies have 
demonstrated that about 5-10% of miRNAs in mammals are regulated by epigenetic 
mechanisms such as DNA methylation and histone modifications. Accordingly, recent 
data showed that the major enzymes involved in the DNA methylation, DNMT1, 
DNMT3a and DNMT3b, can modify the expression of some miRNAs such as mir-148a, 
mir-34b, mir-9 and let-7a [332, 333]. In addition, expression of mir-127, among many 
other miRNAs, was altered after treatment with 5-Aza-Cdr, a potent DNA methylation 
inhibitor, and PBA, a histone deacetylase inhibitor [334]. As index of this complex 
regulation, it has been also published that, in mammals, the mir-34 family is regulated 
by both transcription factors, as c-Myc and p53 and epigenetic mechanisms. 
 Besides transcriptional regulation of miRNAs, their post-transcriptional 
regulation is also important. In this regard, the miRNA processing in the cytoplasm is 
regulated, either positively or negatively, by a number of factors interacting with 
Drosha [335], with miRNA precursors [336] and/or with Dicer [337] (Figure 15). 
 Among positive regulators that increase the mature miRNA production, several 
studies have been identified the heterogeneous nuclear ribonucleoprotein A1 
(hnRNPA1), the KH-type splicing regulatory protein (KSRP) and the p68/p72 helicases 
(see table 2). 
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Figure 15. Activators and repressors of microRNA processing. Taken from [338]. 
 
 With regard to negative regulators that decrease the production of mature 
miRNAs adenosine deaminase acting on RNA enzymes 1 and 2 (ADAR1 and 2) have 
been identified, since they can affect the accumulation of mature miRNAs. ADARs can 
change the adenosine by inosine residues in the double-stranded RNA-binding domain 
(dsRNA), resulting, for example, in the inhibition of the correct processing of pri-mir-
142 by Drosha [339]. Also, ADARs can affect the correct processing of some miRNAs by 
Dicer, inhibiting for example the complete maturation of mir-151 [340, 341]. 
 One of the best-studied negative regulator of the miRNAs is Lin28, which has 
important roles in regulating the levels of mature miRNAs of the let-7 family acting, at 
both at Drosha and Dicer levels. In view of the importance of Lin28 in this Thesis, its 
role in the regulation of miRNAs biogenesis will be described in detail in the section 
1.7.3. 
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Table 2. Main regulators of miRNAs biogenesis in animals. 
Regulator Regulation site Known Activity Mechanism Target miRNA 
c-Myc DNA binding 
(promoter site) 
Protooncogene Inhibiting tumor suppressor 
miRNAs 
mir-15a,-29,-34 
let-7 
p53 DNA binding 
(promoter site) 
Tumor 
suppressor 
Promoting Drosha cleavage 
Enhancing tumor suppressor 
miRNAs 
mir-16,-34-143  
ERα DNA binding Nuclear ER Inhibiting Drosha cleavage A subset  
p68/p72 Microprocessor 
complex 
Components of 
microprocessor 
Promoting Drosha cleavage 
 
A subset  
hnRNP A1 RRM, M9 Pre-mRNA 
splicing 
Chaperone for Drosha/DGCR8 
binding; Enhancing mature 
miRNA production 
mir-18a 
KSPR KH Pre-mRNA 
splicing 
Promoting Drosha and Dicer 
processing 
pre-mir-16,-20,-
21, pre-mir-26b, 
-106a,  pre-let-7  
Lin28 CCHC-type zinc 
finger 
Promoting 
pluripotency 
Inhibition 
Inhibition of Drosha and Dicer 
processing 
let-7 family 
ADARs dsRBD 
 
Adenosine-
Inosine RNA 
editing 
Inhibition of Drosha and Dicer 
processing 
Pri-mir-142, pri 
and pre-mir-151  
DGCR8  dsRBD Binding to 
Drosha 
Stabilizing Drosha Global  
Exportin-5 RanBP Binding to 
tRNAs and pre-
miRNAs 
Nuclear transport of pre-
miRNAs 
Global  
HuR RNA-binding 
protein 
Binding to 3’ 
UTR region of 
mRNA target 
Inhibiting miRNA inhibition mir-122  
Dnd1 RNA-binding 
protein 
Selective RISC 
complex-
competitive 
Inhibiting miRNA inhibition mir-430,  -221, -
1, mir-372, -206  
Importin 8 RNA-binding 
(P bodies) 
Components of 
RISC 
Enhancing RISC complex and 
argonaute activity 
Global  
Argonaute RNA-binding 
(P bodies) 
Components of 
RISC 
Stabilizing associated miRNAs Global  
ADARs, adenosine deaminase acting on RNA enzymes; dsRBD, double-stranded RNA-binding domain; 
DGCR8, DiGeorge syndrome critical region gene 8; ERa, estrogen receptor a; hnRNP A1, heterogeneous 
nuclear ribonucleoprotein A1; RRM, RNA recognition motifs; M9, nucleocytoplasmic shuttling signal 
sequence; KSRP, KH-type splicing regulatory protein; RanBP, ran-binding protein; Dnd1 (RNA-binding 
protein dead end homolog 1). 
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 Finally, there are several proteins that interfere with miRNA actions. For 
instance, it has been demonstrated that RNA-binding proteins, such as HuR [342] and 
Dnd1[343], block the capacity of some miRNAs to inhibit the expression of their mRNA 
targets and, in contrast, importin 8, an essential component of miRISC complex, 
facilitate the recruitment of Ago proteins and for this reason, the binding between 
miRNA and the 3’UTR region of mRNA targets [344] (see table 2).  
1.7.2. THE LET-7 FAMILY OF miRNAs 
 As mentioned previously, the let-7 gene was initially discovered as an essential 
developmental gene in C. elegans and, later, as a gene related with the synthesis of a 
family of miRNAs highly conserved across evolution, called the let-7 family [345-347].  
 Regulation of let-7 family of miRNAs in mammals is controlled, in part, at a 
post-transcriptional level. Recent studies have found that Lin28 is directly involved in 
this regulation. The role of Lin28 in mammals and the involvement of Lin28/let-7 
system in the control of puberty will be described in section 1.7.3.2.  
 Numerous members of the let-7 family have been identified in various species 
and different members are found in different species [348]. Thus, the multiple copies 
of let-7 miRNA variants in the genome are represented with a letter located after let-7 
to distinguish between multiple isoforms, which slightly differ in sequences, whereas a 
number at the end denotes that the same sequence is present in multiple genomic 
locations. At present, 10 mature subtypes of the let-7 family have been identified in 
humans, which are produced from 13 precursor sequences. Three separate precursors 
produce the mature let-7a sequence (let-7a-1, let-7a-2 and let-7a-3) and precursors 
from two different genomic locations produce the let-7f (let-7f-1 and let-7f-2) 
sequence [348]. 
 The let-7 family is involved in many biological functions including the regulation 
of stem cell differentiation in C. elegans [345], neuromusculature development and 
adult behaviors in flies [349], as well as limb development in chickens and mice [350, 
351]. In addition, let-7 family is involved in cell proliferation and differentiation in 
different species [352-354]. Accordingly, recent data demonstrated the increase in pri-
let-7a, pri-let-7e, let-7a, let-7c and let-7e during brain development in mice [335]. In 
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addition, many let-7-family members act as tumor suppressors in a diversity of cancers 
[348, 355]. 
1.7.3. LIN28 
 Lin28 is a RNA-binding protein which was first identified in C. elegans as a 
heterochronic gene which plays an essential role during development [356, 357]. In 
mammals, two Lin28-related genes, named Lin28 (also termed Lin28a) and Lin28b, 
have been described [358, 359]. Lin28 paralogs are highly conserved across evolution 
[360], therefore suggesting similar regulatory functions. These genes encode two 
different proteins, Lin28 and Lin28b, with two types of domains to bind to RNA targets, 
a cold shock domain in the N-terminal and pair of retroviral-type CCHC zinc finger 
motifs in the C-terminal.  
 In mammals, Lin28 is widely distributed during embryonic maturation, but its 
expression becomes restricted to specific tissues in adulthood [361, 362]. Lin28b is 
expressed in the testis, placenta, fetal liver and hepatocellular carcinoma [359]. Both 
Lin28 homologs are predominantly located in the cytoplasm and P bodies [363] and, 
consistent with this location, act to regulate mRNA translation or stability.  
 It is known that Lin28 has a putative role as a pluripotency factor and, together 
with OCT4, SOX2, and NANOG, was used for reprogramming adult human somatic cells 
into pluripotent stem (iPS) cells [364]. Accordingly, mutations in Lin28 gene alter the 
normal timing of maturational events in the nematode, resulting in the appearance of 
specificities of the larval period in adulthood or vice versa [319, 357]. However, its 
molecular function remains unclear.  
1.7.3.1. LIN28 AND LET-7 
 Years ago, several researchers found in mice that, at postnatal day 19 (PND-19), 
both embryonic stem cell (ESCs) and embryonic carcinoma cells, showed abundant 
expression primary-let-7g. However, in these undifferentiated cell types, mature let-7g 
expression was not detected whereas when these cells had differentiated, this let-7 
family member was abundantly expressed [365, 366]. This observation indicated that 
the processing of pri-let-7g was under post-transcriptional regulation [335, 367]. 
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 Later, four independents groups identified Lin28 and Lin28b as factors that 
prevent the let-7 processing in undifferentiated cells [365, 368-370]. In this regard, it 
has been demonstrated that Lin28 proteins bind to the terminal loops of precursors of 
the let-7 miRNAs, either pri- or pre-let-7 depending on the let-7 isoform, blocking their 
processing into mature miRNAs [365, 369]. This regulation is possible because Lin28 is 
known to transport between the nucleus and cytoplasm. Thus, in the nucleus, Lin28 
binds to the loop region of pri-let-7, blocking the interaction with Drosha, while into 
the cytoplasm, these proteins block Dicer processing by binding to the pre-let-7 [370].  
Accordingly, Heo  et al. suggested that Lin28 promote uridylation of pre-let-7 in C. 
elegans and mammalian cells by recruiting the terminal uridylyl transferase 4 (TUT4) 
enzyme, which adds multiple U residues to the 3′ end of pre-let-7, preventing Dicer 
processing and inducing precursor degradation  [368] (Figure 16).  
 
 
Figure 16. Lin28 selectively blocks let-7 biogenesis. Taken from [168]. 
 
 Besides the fact that Lin28/Lin28b represses the synthesis of mature let-7 
miRNAs, it has been demonstrated that let-7 miRNAs are able to suppress Lin28 levels, 
thereby creating a double-negative feedback loop (Figure 17).  
 To add further complexity in the relationship between Lin28/let-7, it has been 
observed that c-Myc transcriptionally activates both Lin28 and Lin28b expression and 
in turn, let-7a represses c-Myc expression in a Burkitt lymphoma cell line [371]. These 
data suggest a double-negative feedback loop in which c-Myc inhibits let-7 synthesis 
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via activation of Lin28 transcription, and let-7 negatively regulates c-Myc [168, 372, 
373] (Figure 17). In this way, deregulation of c-Myc/Lin28/let-7 network can explain in 
part the alteration of several miRNAs, included members of let-7 family, observed in 
many cancers [365, 374]. 
 In addition, numerous upstream regulators of the c-Myc/Lin28/let-7 have been 
identified recently. For example, it has been shown that mir-145 inhibits c-Myc 
expression at the post-transcriptional level [375]. Moreover, by the use of 
bioinformatic algorithms, mir-132 and mir-9 have been predicted as putative miRNA 
repressors of Lin28 our own data [376] (Figure 17).  
 
Figure 17. Squematic representation of the regulatory interactions between c-Myc/Lin28/let-7and 
upstream regulators. 
  
1.7.3.2. ROLE OF LIN28/LET-7 SYSTEM IN THE REGULATION OF POSTNATAL 
MATURATION AND PUBERTY 
 In the last few years, different GWAS have shown the putative link between 
variations in or around the Lin28b locus and changes in key developmental events in 
humans. Specifically, in 2008, Lettre et al. reported 12 loci, including Lin28b and 
several let-7 targets, that were strongly associated with variation around 2% in human 
height [377]. Independly, in 2009, four GWAS found an association of human growth,  
the age of menarche and other specific characteristics of the puberty with changes in 
or around the Lin28b locus [164-167]. These data, together with the observations in 
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nematodes regarding the essential role of Lin28 through development [356, 357], 
suggested that Lin28/let-7 system could play an important role in the normal 
development and the somatic cell reprogramming throughout the evolution, and 
alterations in this system could carried out to oncogenesis. 
 In 2010, Zhu et al explored the function of the Lin28/let-7 pathway in a model 
of Tg mice that overexpressed Lin28 [378]. Although, they observed that the WT and 
Lin28 Tg pups had the same size, Tg animals showed an increased growth rate and, in 
adulthood, were heavier and larger than control animals. Of note, the increased body 
size observed in Lin28 Tg mice was similar to phenotype previously described in 
humans associated with genetic variation in the Lin28b locus. Moreover, Lin28 Tg 
animals showed an increase in relative organ weight, suggesting a role for Lin28 in the 
regulation of organ size [377].  
 In relation with the putative role of Lin28 in the control of puberty and 
reproductive function, it has been documented that these Lin28 Tg female mice 
display delay in the age of VO and first estrous combined, with a decrease in ovarian 
and uterus weights (OW and UW). Additionally, those animals had a delay in the age 
date of their first litter.  
  Moreover, Lin28 expression has been found in reproductive tissues as testis. In 
this regard, Lin28 is differentially expressed in spermatogonia of mouse and primate, 
suggesting a role in the maintenance of spermatogonial stemness [379]. In fact, 
despite its wide expression during embryonic development, the testis is one of the few 
tissues where Lin28 is persistently detected in adulthood of several species, including 
the mouse, monkey, and human [379]. Recent works has been suggested a role for 
Lin28/let-7 system in fertility and spermatogenesis [380, 381] [382]. Thus, Chakraborty 
et al., using a conditional Lin28 KO in adult germ line stem cells, showed that the loss 
of Lin28 reduced testicular weight (TW), sperm number and impaired spermatogonial 
cell proliferation without compromising their differentiation capacity [382]. Nowadays 
relatively little is known about the role of the Lin28/let-7 system in the  male 
reproductive system.  
 In the work of Zhu et al, mentioned above, the potential involvement of 
metabolic mechanisms in the overgrowth of Lin28 Tg mice was also analyzed. In detail, 
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Zhu and coworkers observed that Lin28 Tg mice showed lower glucose levels than WT, 
both in fasting and normal fed conditions and also increased insulin sensitivity. They 
suggested that overexpression of Lin28 in muscle alters the metabolic state, increases 
glucose uptake and promotes glucose metabolism.  Additionally, the same group has 
reported both Lin28 and Lin28b Tg mice were resistant to obesity and showed 
increased insulin sensitivity and enhanced glucose tolerance. In contrast, muscle-
specific Lin28 KO and inducible let-7 Tg mice displayed glucose intolerance [383]. Thus, 
let-7 upregulation inhibited normal glucose metabolism, supporting the idea that Lin28 
and Lin28b exert their metabolic effects, at least in part, via let-7 suppression. Data 
showed by Zhu’s group reinforced the hypothesis that Lin28/let-7 system is a key 
regulator in modulating glucose metabolism in mammals.  
 Despite all these evidences, the potential involvement of miRNA regulatory 
pathways, and in particular of the Lin28/let-7 system, in the control of the central and 
peripheral developmental events that lead to puberty onset and metabolic 
homeostasis remains ill defined and warrant future analysis. 
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2. OBJECTIVES 
Puberty is defined by a sequence of events leading to full activation of 
reproductive axis and the acquisition of fertility. The regulatory signals controlling the 
HPG axis include, among others, peripheral factors that transmit nutritional 
information to CNS, where they interact with central regulators to control the onset of 
puberty [146]. As mentioned in the introduction of this Thesis, the key event required 
for puberty to occur is an increase in pulsatile GnRH release from GnRH neurons, the 
main hierarchical element in the neuroendocrine control of reproduction, which act as 
the final integrator of central and peripheral regulators of the HPG axis. 
In spite of the key role of GnRH neurons to integrate metabolic information to 
regulate the reproductive axis, different studies suggest that there is not a direct 
interaction between GnRH neurons and leptin. In this sense, recent evidence suggests 
that POMC neurons act as intermediary element to convey metabolic information to 
GnRH neurons [312, 314, 315]. Furthermore, a bidirectional interplay between α-MSH 
pathways and kisspeptins, indispensable signals in the control of puberty onset, has 
been suggested in adulthood [202, 273]. However, the role of α-MSH in the regulation 
of puberty, and its interaction with kisspeptins during this key maturational event, 
remain virtually unexplored. 
In addition, numerous studies have unveiled that the pubertal increase in GnRH 
secretion is controlled by a set of genes, hierarchically arranged, within functionally 
connected networks where GnRH is the final effector [159]. In this sense, recent 
evidence has indicated a role for epigenetic mechanisms, including miRNAs, in the 
control of the timing of female puberty [161]. In this context, previous data from 
GWAS demonstrated an association between early menarche and a sequence variation 
in or close to the LIN28B locus [164-167]. The major known role of Lin28b is the 
blocking of the processing of mature miRNAs of Let-7 family [365, 369]. However, 
despite the potential involvement of Lin28/let-7 system in the control of puberty [164-
167, 383], relatively little is known about the function of this system in pubertal 
maturation.  
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On the above basis, the GENERAL OBJECTIVE of this Thesis was to investigate 
the role of neuropeptidergic systems, particularly α-MSH and Kp, and novel regulatory 
mechanisms, specifically miRNAs, in the physiological control of puberty. To cover this 
general objective, the following SPECIFIC OBJECTIVES were addressed: 
1. To characterize the potential function of α-MSH signaling in the control of 
puberty onset and its potential interaction with leptin and kisspeptins. 
2. To define the profiles of expression of the Lin28/let-7 system, and several 
associated factors, during pubertal maturation and study the changes in their 
expression patterns in preclinical models of altered puberty at different sites of the 
HPG axis, including the hypothalamus and testis.  
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3. MATERIALS AND METHODS 
3.1. ANIMALS 
 Male and female Wistar rats bred in the vivarium of Faculty of Medicine at the 
University of Córdoba were used in this Thesis. After birth, the rat pups were cross-
fostered and reared in litter sizes of 10-12 pups, unless otherwise stated. 
Hypophysectomized (HPX) rats were purchased from Charles River (Barcelona, Spain). 
In addition, CB57B/6 mouse strain and genetically modified, Gpr54 null mice were 
used. Mice were bred and housed in the Animal Experimentation service Center of the 
University of Córdoba. 
 The day the animals were born was considered day 1 of age. Animals were 
housed under constant conditions of temperature (22°C) and light (14-hours from 
07.00 h), unless otherwise indicated. Animal were weaned at postnatal day (PND) 21 
and were provided with a free access to tap water and fed a standard soy-free diet. All 
experiments and animal protocols included in this Thesis were approved by Córdoba 
University Ethical Committee and were conducted in accordance with European Union 
normative for the use and care of experimental animals (Directive 2010/63/UE on 
September 2010).  
3.2. DRUGS 
 MT II (MCR-3/4 agonist), the selective MC4-R agonist (Cat. 043-31), SHU9119 
and Kisspeptin 110–119-NH2 (termed Kp-10) were purchased from Phoenix 
Pharmaceuticals Inc. (Burlingame, CA, USA). The selective MC3-R agonist (Ref. 56-0-13) 
was obtained from American Peptide Company Inc. (Sunnyvale, CA, USA). 
Recombinant rat leptin was obtained from ProSpec-Tany TechnoGene Ltd. (Ness Ziona, 
Israel). GnRH (Ref. L7134), estradiol benzoate (EB), testosterone propionate (TP) and 
17β-estradiol (E2) were obtained from Sigma Chemical Co. (St. Louis, MO, USA). FSH 
and human chorionic gonadotropin (hCG), a superagonist of LH, were purchased from 
Merck-Serono (Madrid, Spain). All drugs were dissolved in physiological saline (0,9% 
NaCl) with the exception of  EB, TP and E2 which were dissolved in olive oil.   
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3.3. GENERAL EXPERIMENTAL PROCEDURES 
3.3.1. CANNULATION AND ICV ADMINISTRATION  
 In order to allow the administration of different compounds in the lateral 
cerebral ventricle, rats and mice were cannulated 24 hours before the beginning of the 
different studies. Cannulae (INTRADEMIC polyethilene Tubing, Becton Dickinson, 
Sparks, MD, USA) were inserted to a depth of 2 mm beneath the surface of the skull, 
with an insert point at 1 mm posterior and 1.2 mm lateral to Bregma following 
standard procedures. Once the animals were cannulated, they were housed in 
individual cages until the end of the experiments. The doses of the different drugs 
were administrated in a final volume of 10 µl for rats and 5 µl for mice. 
3.3.2. GONADECTOMY AND HORMONAL SUPPLEMENTATION 
 To avoid the potential confounding factor of changes in circulating estrogen, in 
some experimental designs, female rats were subjected to bilateral OVX on PND-25 
and then, they received a subcutaneous implant of a SILASTIC brand silicone tubing 
(Dow Corning, Midland, MI) of 10 mm in length, 1.98 mm in inner diameter and 3.18 
mm outer diameter containing E2 (solution of 10 µg/ml in olive oil).  
3.4. GENERAL ANALYTICAL PROCEDURES 
3.4.1. REVERSE TRANSCRIPTION (RT) AND POLYMERASE CHAIN 
REACTION (PCR) FOR mRNA AND miRNA. 
3.4.1.1. TOTAL RNA EXTRACTION FROM TISSUES 
 Total RNA was extracted from different tissues using TRIsureTM reagent (Bioline, 
London, UK), in accordance with the conditions lay down by the manufacturer. RNA 
concentration of each sample was determined by measuring the absorbance at 260 
nm using a spectrophotometer (DU-530, Beckman). The quality samples were analyzed 
by electrophoresis in a 1% agarose gel to observe 28S, 18S and 5S ribosomal RNA 
bands. In those samples that did not meet the established quality criteria, the 
extraction was repeated. Up to this point, the steps to be followed for mRNAs and 
miRNAs analyses are the same. 
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3.4.1.2. REVERSE TRANSCRIPTION FOR mRNA QUANTIFICATION 
 To remove any traces of genomic DNA, RNA samples received a DNase 
treatment (Promega, WI, USA) prior to RT-PCR. RNA samples were treated with 2 units 
of RQ1 DNase and were incubated at 37°C for 30 min. Then, 1 µl of RQ1 DNase Stop 
solution was added and the samples were incubated at 65°C for 10 min to terminate 
the reaction. 
 RT reaction for the synthesis of cDNA from RNA molecules was carried out by 
the mix of following components: 
 2 µg of total RNA 
 6 μl of AMV RT 5X reaction buffer (250nM Tris-HCl, pH 8.3, 250 mM KCl, 
50 mM MgCl2, 50 nM DTT, 2.5 mM; Promega) 
 2 μl of dNTP mix 5 mM (Promega) 
 0.5 μl of Random Primers (Promega) 
 0.5 μl (20 units) of RNasin Ribonuclease Inhibitor (Promega) 
 7.5 units of AMV RT (Promega) 
 Nuclease-free water to final volume of 30 μl 
The reaction mixture was performed in a thermo-cycler (iCycler iQ®5; Bio-Rad, 
Hercules, CA, USA) which carried out the following cycles: 25°C for 5 min, 42°C for 60 
min and 85°C for 5 min. Once RT was over, the reaction volume was diluted with 
Nuclease-free water to final volume of 100 μl. The cDNA samples were stored at -20°C.  
3.4.1.3. QUALITATIVE FINAL TIME RT-PCR FOR mRNA  
 For the final time PCR were used 10 μl of the diluted cDNA samples following 
the protocol and conditions lay down by the manufacturer (Promega). They were 
amplified by the use of specific primers (Table 3) designed from the different 
sequences genes of study published in GenBank. The final volume of PCR reaction was 
50 μl. In addition to the cDNA samples, negative controls for genomic DNA, RT and PCR 
were included. The thermal cycling conditions for DNA polymerase-mediated PCR 
amplification were as follows: i) initial denaturation at 95°C for 5 min; ii) 25-36 cycles, 
depending of gene, at 95°C for 30 seconds (denaturation), 58-63°C, depending of the 
primer Melting Temperature (Tm), for 30 seconds (annealing) and 72°C for 10 seconds 
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(extension); and iii) final extension at 72°C for 5 min. Expression of ribosomal protein 
S11 (RP-S11) in rats and L19 (RP-L19) in mice were used as endogenous control genes 
(Table 3). PCR products were visualized by 2% agarose gel with ethidium bromide 
(1μg/ml) in 1X TBE (10X TBX: 10% Tris-HCl, 5% boric acid and 4% EDTA) electrophoresis 
buffer and their identity confirmed by direct sequencing in the Nucleic Acids Unit of 
the Research Support Services Center (SCAI) at the University of Córdoba. 
3.4.1.4. SEMIQUANTITATIVE REAL-TIME PCR FOR mRNA  
 The real time PCR (qPCR) is used to amplify and simultaneously detect and 
quantify the presence of nucleic acid sequences compared to standard PCR, where the 
product of the reaction is detected at its end. For the qPCR the detection system used 
was CFX96TM Real‐Time PCR (BIO‐RAD Laboratories, Hercules, CA). The PCR reaction 
included 5 μl of the diluted cDNA samples in duplicate. These samples were amplified 
by the use of specific primers for different genes (Table 3) and GoTaq® qPCR Master 
Mix (Promega). The final volume of PCR reaction was 15 μl. In addition to the cDNA 
samples, negative controls for genomic DNA, RT and PCR were included. Moreover, for 
data analysis, were included relative standard curves constructed from serial dilutions 
of one reference cDNA sample in the same plate. The thermal cycling conditions were 
as follows: i) one cycle of 10 min at 95°C; ii) 40 cycles of 15 seconds at 95°C, 35 seconds 
at 58-63°C (depending of the primer Tm) and 10 seconds at 72°C; and iii) one hold of 
72°C for 10 min. The dissociation (Melting) curve was used to assess the quality of the 
PCR. 
 The iCycleriQ qPCR system collects, with each amplification cycle, the increase 
in fluorescence intensity which is proportional to the increase in amplicon 
concentration. The cycle number at which an amplification plot crosses a threshold 
fluorescence level established is called the threshold cycle (Ct). The Ct values of the 
standard curve obtained were analyzed in logarithmic scale and then, the Ct value for 
each unknown target sample was directly correlated with the calibration curve 
obtained. To determine the relative concentration, the value of the target gene 
obtained was standardized to endogenous control genes, HPRT in rats and RP-L19 in 
mice (Table 3), with reference value at 100. 
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Table 3. Primers list used for PCR analysis of mRNA.  
Gene GenBank Primers 
Amplicon 
size 
Tm 
(°C) 
Lin28 
(rat) 
NM_001109269.1 
 
FW: 5’-CCCGGTGGACGTCTTTGTG-3’ 
RV: 5’-CACTGCCTCACCCTCCTTGA-3’ 
76 bp 60 
Lin28b 
(rat) 
XM_001069344.4  FW: 5’-GGATCAGATGTGGACTGTGAGAGA-3’ 
RV: 5’-GGAGGTAGACCGCATTCTTTAGC-3’ 
102 bp 
 
60 
Lin28 
(mouse) 
NM_145833.1 
 
FW: 5’-GTCTTTGTGCACCAGAGCAA-3’ 
RV: 5’-CTTTGGATCTTCGCTTCTGC-3’ 
194 bp 63 
Lin28b 
(mouse) 
NM_001031772.2 
 
FW: 5’-TGGTTCAACGTGCGCATGGGA-3’ 
RV: 5’-CCACTGGCTCTCCTTCTTTCAAGCT-3’ 
145 bp 63 
c-Myc 
(rat) 
NM_012603.2 
 
FW: 5’-AGCTCCTCGCGTTATTTGAAG-3’ 
RV: 5’-GAGTCGTAGTCGAGGTCATAGTTCCT-3’ 
117 bp 
 
60 
RP-S11 
(rat) 
NM_031110.1 FW: 5’-CATTCAGACGGAGCGTGCTTAC-3’ 
RV: 5’-TGCATCTTCATCTTCGTCAC-3’ 
240 bp 58 
HPRT 
(rat) 
NM_012583.2 FW: 5’-AGCCGACCGGTTCTGTCAT-3’ 
RV: 5’-GGTCATAACCTGGTTCATCATCAC-3’ 
72 bp 60 
RP-L19 
(mouse) 
NM_009078.2 
 
FW: 5’-GAAATCGCCAATGCCAACTC-3´ 
RV: 5’-ACCTTCAGGTACAGGCTGTG-3’ 
290 bp 55 
 
3.4.1.5. REVERSE TRANSCRIPTION FOR miRNA QUANTIFICATION 
 The most commonly used method to detect specific miRNAs is qPCR analysis. A 
miRNA real-time reaction starts with reverse transcribing RNA into cDNA. The limited 
length of the mature miRNA (about 22 nt), the lack of a common sequence feature like 
a poly(A) tail and the fact that the mature miRNA sequence is also present in the pri- 
and pre-miRNA transcript raise several problems for appropriate RT.  
 In our method, miRNAs were reverse transcribed individually by using stem–
loop–specific RT primers. They are designed to have a short single-stranded region that 
is complementary to the known sequence on the 3′ end of the miRNA, a double-
stranded part (the stem) and the loop that contains the universal primer-binding 
sequence (TaqMan MicroRNA RT; Applied Biosystems, Foster City, CA).  
 Each RT reaction combined: 5 µl of total RNA sample (2ng/µl), 3 µl of the 
TaqMan-specific RT primers (Applied Biosystems) and 7 µl of the RT master mix that 
contained the following reagents:  
 4.16 μl  of Nuclease-free water  
 1.5 μl of 10X RT Buffer (Applied Biosystems) 
 0.15 μl of dNTP mix (100mM total) (Applied Biosystems) 
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 0.19 μl of RNase Inhibitor (20 U/μl) (Applied Biosystems) 
 1 μl of MultiScribe™ RT enzyme (50 U/μl) (Applied Biosystems) 
The reaction mixture (15 μl) was performed in a thermo-cycler (iCycler iQ®5; 
Bio-Rad, Hercules, CA, USA) with the following conditions: 16°C for 40 min, 42°C for 40 
min and 85°C for 5 min. Once RT was over, the reaction volume was diluted with 
Nuclease-free water to final volume of 215 μl. The cDNA resulted was then used as a 
template for qPCR. 
3.4.1.6. REAL-TIME PCR FOR miRNA QUANTIFICATION 
 Each PCR reaction contained 1.33 µl of RT product (dilution 1:15) and the 
following reagents (Applied Biosystems):  
 1 μl  of TaqMan® Small RNA Assay 20X  
 10 μl of TaqMan® 2X Universal PCR Master Mix (No AmpErase®UNG) 
 7.67 μl  of Nuclease-free water  
 The final volume for PCR reaction was 20 μl.  The thermal cycling conditions 
were as follows: i) 2 min at 50°C; ii) 10 min at  95°C and iii) 40 cycles of 15 seconds at 
95°C and 1 min at 60°C. Data analyses were carried out in the same way than mRNA 
but, in this case, RNU6 (Applied Biosystems) was used as internal reference. The 
predesigned primers used were let-7a and let-7b, as two representative miRNAs of the 
let-7 family, miR-132, miR-145 and miR-9 (Applied Biosystems). 
3.4.2. ISH ASSAYS 
3.4.2.1. ISH TO DETECT mRNA 
 For the analysis of gene expression and neuroanatomical distribution of Kiss1 in 
hypothalamic tissues obtained from different experimental groups, ISH technique was 
performed. Five sets of coronal sections 20-μm-thick were generated and thaw 
mounted in SuperFrost Plus slides (VWR Scientific). The samples were stored at -80°C 
until their analyses. Standard procedures of tissue collection were applied, starting in a 
fixed coordenate in the rostral hypothalamic area up to the ARC, to encompass 
equivalent areas including anterior and medial portions of this nucleus, where Kiss1 
neurons are abundantly located (Paxinos and Franklin, 2001).  
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 For the ISH technique, a specific antisense riboprobe for Kiss1 rat mRNA (5’-
TGG TGA ACC CTG AAC CCAC A-3) located between 328-367 nt of the cDNA sequence 
(GenBank NM_181692.1) was used. This probe was generated using T7 RNA 
polymerase (Promega) and Kiss1 cDNA template containing T7 polymerase region. The 
radiolabeled RNA probe was synthesized by adding the following ingredients in a 
volume of 25μl: 250 Ci [33P]-UTP (Perkin Elmer, Massachusetts, USA), 1 μg of template 
product (0.5 mM rATP, rCTP and rGTP) and 40-U of T7 RNA polymerase. The residual 
DNA was digested with 4-U DNase (Bio-Rad) and the reaction was terminated by 
addition of 2 μl 0.5 M EDTA, pH 8.0. The labeled riboprobe was purified using 
IllustraTMProbeQuantTM G-50 MicroColums (GE Healthcare, UK). 
 A single set of sections was used for ISH (adjacent sections 100-μm apart). 
These tissue sections were: i) fixed in paraformaldehyde at 4% for 15 min; ii) stabilized 
with 0.1 M phosphate buffer (pH 7.4) at room temperature for 20 min; iii) treated with 
saline triethanolamine and acetic anhydride to prevent non-specific binding of probes; 
iv) dehydrated in increasing concentrations of ethanol; v) delipidated with chloroform 
and vi) air dried at room temperature for 1 h.  
 After these steps, the Kiss1 riboprobe hybridization was performed during 16 h 
at 55°C. The hybridization solution contained: 4X saline-sodium citrate (SCC) buffer, 
50% deionized formamide, 1X Denhardt’s solution, 50% dextran sulfate and 0.03 
pmol/ml of radiolabeled riboprobe along with yeast tRNA (10 mg/ml). 
 After hybridization, slides were: i) washed with 4X SSC for 30 min; ii) incubated 
in RNase-A buffer (Roche Biochemical) at 37°C (10mg/ml) for 1 h; iii) washed in 0.1X 
SSC for 1 h at 65°C; iv) dehydrated in increasing ethanol series and v) air dried at room 
temperature for 1 h.  
 Finally, slides were dipped in Kodak Autoradiography Emulsion type NTB 
(Eastman Kodak) and exposed for 1 week at 4°C in a dark room. After this period, the 
sections were developed and fixed following the manufacturer instructions (Kodak; 
Rochester, NY): 3 min in Kodak Dektol Developer; 10 second in distilled water; 5 min in 
Kodak Fixer and 5 min in distilled water. For the mounting, the sections were 
previously dehydrated and rinsed with citrasol (Sigma) and then, was used Permaslip 
(Sigma) as mounting medium. 
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 For the analysis, 50-60 sections from each animal (9-10 slides; 6 sections/ slide) 
were evaluated, with 5 animals per group. Slides from all of the animals were read 
under dark-field illumination with custom-designed software enabled to count the 
total number of cells (grain clusters). Cells were counted as Kiss1 mRNA positive when 
the number of silver grains in a cluster exceeded that of background. 
3.4.2.2. ISH TO DETECT miRNA 
 For detection and distribution of let-7b and miR-145 miRNAs in testicular 
tissues, ISH analysis was carried out. Testes from adult rats were obtained from 
different experimental groups and were formalin-fixed and paraffin-embedded in our 
laboratory. The ISH was performed in collaboration with Dr. Susana Sangiao-Alvarellos 
(University of Santiago de Compostela). The samples were sectioned at 10 μm 
thickness and placed on glass slides. For this analysis, double digoxigenin (DIG)-labeled 
miRCURY LNA™ let-7b, mir-145 and RNU6 detection probes (Exiqon, Denmark) were 
employed as was previously described [384]. 
3.4.3. IHC ASSAYS 
 IHC analyses carried out in this Thesis were conducted through two different 
IHC staining methods: immunoenzymological staining and immunofluorescence. 
3.4.3.1. IMMUNOENZYMOLOGICAL STAINING 
 Mice testes were removed immediately following the decapitation of animals 
and fixed in Bouin’s solution (formalin/picric acid) for 24 h. Then, tissues were 
embedded in paraffin and were cut to a thickness of 5 µm. The paraffin sections were 
processing to study by IHC assays the Lin28 and Lin28b protein distribution, using 
specific antibodies against each target. 
 Sections were deparaffinized, incubated in 2% hydrogen peroxide in methanol 
for 30 min to quench endogenous peroxidase, and after rehydration in graded ethanol, 
rinsed in PBS. In the case of Lin28 immunostaining, was necessary antigen retrieval by 
autoclaving at 1.5 atmospheres for 5 min in 0.1M citrate buffer (pH 7.6).  
 Thereafter, sections were incubated overnight at 4°C with primary antibodies: 
anti-Lin28, dilution 1:200 (Abcam, UK; ref. ab115698), and Lin28b-specific polyclonal 
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anti- body, dilution 1:25 (ProteinTech Group, Inc; Chicago, Illinois; ref. 16178-1-AP). 
Then, bound antibodies were revealed by the avidin-biotin-peroxidase complex 
method, as specified by the manufacturer. In both cases, sections were incubated for 
30 min using a VECTASTAIN ABC Kit, dilution 1:1000 (Rabbit IgG; Vector Laboratories, 
Burlingame, CA, USA). Finally, sections were stained with hematoxylin and eosin and 
examined under the microscope for their morphometric analysis. Tissue samples from 
different ages were run in the same assays to assess age-related changes in the 
intensity of immunostaining, using a semiquantitative scale. In addition, negative 
control sections were run in parallel by replacing primary antibodies by nonimmune 
serum or PBS.  
3.4.3.2. IMMUNOFLUORESCENCE 
 Perfused brains from pubertal female rats were removed and post-fixed in the 
4% PFA solution at 4°C for 24 h and then, were directly transferred into a PBS solution. 
Fixed brains were then impregnated with 30% sucrose in PBS at 4°C. When brains 
sunk, were cut coronally at 30 μm thicknesses and stored in cryoprotectant.  
 The immunofluorescence analyses were carried out in collaboration with Dr. 
Rafael Pineda (University of Edinburgh). The samples were mounted on SuperFrost 
Plus slides (VWR International, Cat. No.631-0108). After drying for 1 h at 37°C, sections 
were washed in PBS-T (0.1% Tween-20 - Sigma-P9416-) for 10 min at room 
temperature and then, heated in 10 mM sodium citrate (pH 6) (Sigma-S4641) for 10 
min at 90°C to induce the epitope retrieval. Afterwards, sections were cooled to room 
temperature and then washed 5 min in PBS. Sections were blocked in blocking buffer 
(3% Donkey Serum, Sigma-D9663; 0.4% Triton X-100, Sigma-T8787) in PBS for 45 min 
at room temperature. Next, sections were incubated with primary antibody against 
sheep Kp (approved by Professor Caraty), 1:10000 dilution, and with primary antibody 
against rabbit α-MSH (Peninsula Labs-T4434), in 1:1000 dilution, overnight at 4ºC. 
Then, sections were washed in PBS. Finally, sections were incubated with secondary 
antibodies Alexa Fluor® 488 Donkey Anti-Sheep IgG (H+L) (Invitrogen-A11015), 1:500 
dilution, and with Alexa Fluor® 555 Donkey Anti-Rabbit IgG (H+L) (Invitrogen-A31572), 
1:500 dilution, respectively, for 1 h at 37°C and later, washed in PBS. Slides were 
immersed for 30 seconds in double distilled water to remove salts and the coverslips 
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were mounted using PermaFluor Aqueous Mounting Medium (Thermo Scientific, TA-
030-FM). No signal was detected after applying secondary antibodies in absence of 
primary antibody. Immunoreactivity analyses were imaged on the Nikon A1R FLIM 
confocal system. Images were viewed and Z stacks condensed to 2D projections using 
NIS-Elements Viewer software.  
3.4.4. RADIOIMMUNOASSAY (RIA) 
 Serum LH levels in rat and mice were determined in a volume of 25-50 μl using 
a double antibody method and RIA kits supplied by the National Institute of Health, 
NIH (Dr. Parlow, National Institute of Diabetes and Digestive and Kidney Diseases 
National Hormone and Peptide Program, Bethesda, MD, USA). Hormonal 
determinations were performed in duplicate in the case of rats. Hormone provided by 
NIH (LH-I-10) was labeled with 125I using Iodo-gen® method (Pierce, Rockford, IL). The 
hormone concentrations were expressed using reference preparations of LH-RP-3. The 
sensitivity of the assay was 75 pg/ml. Intra- and inter-assay coefficients of variation 
(CV) were lower than 8%. The reliability of the hormone determinations was confirmed 
by measurement of rat serum samples with known concentrations of hormone of 
interest.  
3.5. EXPERIMENTAL DESIGNS  
3.5.1. CHARACTERIZATION OF THE ROLE OF MC3/4-R SIGNALING IN THE 
CONTROL OF THE GONADOTROPIC AXIS AT PUBERTY AND ITS POTENTIAL 
INTERACTION WITH LEPTIN AND KISSPEPTIN 
 As was mentioned in the introduction of this Thesis, recent evidence suggest 
that POMC neurons, known particularly for their key role in the control of energy 
homeostasis, could act as intermediary element to convey metabolic information to 
GnRH neurons. In addition, bidirectional interplay between MC3/4-R and kisspeptin 
neurons has been suggested. Nevertheless, most of data in the literature about the 
effect of α-MSH in the reproductive axis have been carried out in adults animals, thus 
the role of α-MSH in the regulation of puberty remains virtually unexplored. 
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 In order to analyse the putative function of central melanocortin signaling in 
the control of puberty onset and to explore its potential interaction with leptin and 
kisspeptins, three sets of experimental designs were carried out.   
3.5.1.1. ANALYSIS OF EFFECTS OF ACUTE CENTRAL ADMINISTRATION OF MT II 
ON LH SECRETION 
 In the first set of experiments, the acute effects of central administration of MT 
II (a MC3/4-R agonist) on LH secretion were monitored. 
 In experiment 1, peripubertal male (PND-43) and female (PND-29) rats (n=10-
12 animals/group) fed ad libitum or fasted for 48h, were icv injected with vehicle (0.9% 
NaCl) or MT II (1 nmol/rat). Animals were underwent with light ether anesthesia and 
blood samples were obtained by jugular puncture at before (0), 15- , 30- and 60-min 
(only male rats) after injection (Figure 19).  
 
 
Figure 19. Schematic representation of the experimental protocol used in experiment 1. 
 In addition, in experiment 2, infantile male and female rats (PND-15; group 
size: n=10-12) were icv injected with vehicle (0.9% NaCl) or MT II (1 nmol/rat). Animals 
were killed by decapitation 15 min after the injection and blood samples were recorder 
(Figure 20).  
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Figure 20. Schematic representation of the experimental protocol used in experiment 2. 
 
  Since MT II bind both MC3-R and MC4-R, in order to know which receptor 
mediated the effect of MT II on LH secretion, in experiment 3, peripubertal male (PND-
43) rats (n=9-11 animals/group) were icv injected with vehicle (0.9% NaCl) or a 
selective MC3-R or MC4-R agonist (0.2-, 1- or 5-nmol/rat). Blood samples were 
obtained by jugular venipuncture after light ether anesthesia, before (0) and 15-, 30- 
and 60- min after injections (Figure 21). 
 
Figure 21. Schematic representation of the experimental protocol used in experiment 3. 
 
3.5.1.2. ANALYSIS OF THE EFFECTS OF CHRONIC BLOCKADE OF MC3/4-R 
DURING PUBERTAL TRANSITION   
 In a second set of studies, the effects of chronic blockade of MC3/4-R during 
the pubertal transition were explored. To this end, in experiment 4, female rats (n=10-
11) received two daily icv injections of vehicle (0.9% NaCl) or SHU9119 (1nmol/rat), a 
MC3/4-R antagonist, between PND-28 to -35. Since treatment with SHU9119 increases 
daily food intake, in order to avoid the possible influence of BW on puberty onset, 
SHU9119-treated animals were fed with the same amount of food eaten the vehicle-
treated animals (pair-feeding). BW and VO were daily monitored during treatment. 
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Animals were killed by decapitation 60 min after the last injection and blood samples, 
ovaries and uterus were collected (Figure 22). 
 
Figure 22. Schematic representation of the experimental protocol used in experiment 4. 
 
 In order to explore the putative role of MC3/4-R signaling on the permissive 
effect of leptin on puberty onset, in experiment 5, peripubertal female rats were 
submitted to a 20% restriction in daily food intake from PND-23 (UN) received two 
daily icv injections of vehicle (0.9% NaCl), leptin (3.1 µg/12 h/rat) alone or in 
combination with SHU9119 (1 nmol/12 h/rat) between PND-29 to -35 (n=9-12). A 
groups of animals fed ad libitum (NN) that received two daily icv injections of vehicle 
served at controls. BW and VO were daily monitored. On PND-35, animals were killed 
by decapitation 60 min after the last injection and trunk blood, ovaries and uterus 
were collected (Figure 23). 
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Figure 23. Schematic representation of experimental protocol used in experiment 5. 
3.5.1.3. CHARACTERIZATION OF THE POTENTIAL MC3/4-R AND KISSPEPTIN 
INTERACTIONS IN THE CONTROL OF PUBERTY ONSET 
 To study the potential MC3/4-R and kisspeptin interactions in the metabolic 
control of puberty, the third set of studies was carried out in two ways. Firstly, in 
experiment 6, it was studied the possible role of MC3/4-R as mediators of kisspeptins 
effects on LH secretion. Then, in experiment 7 and 8 was explored the possible 
kisspeptidergic mediation of the effects of MC3/4-R on LH secretion. 
 In experiment 6, the effect of Kp-10 on LH secretion after the blockage of 
MC3/4-R signaling was analyzed. To this end, two groups of peripubertal male rats 
(groups size: n=30) were icv injected with vehicle (0.9% NaCl) or SHU9119 (1 nmol/rat) 
at -120 min and -60 min before administration of a third bolus with vehicle or SHU9119 
alone or combined with Kp-10 (100 pmol/rat) or MT II (1nmol/rat). Blood samples 
were obtained before (0) and 15- and 60-min after last injection (Figure 24).  
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Figure 24. Schematic representation of the experimental protocol used in experiment 6. 
 
 In experiment 7, the effect of MT II on LH secretion in the absence of 
kisspeptidergic signaling was studied using a Gpr54 null mouse model. The Gpr54 KO 
mouse is a model of congenital hypogonadism of central origin as a result of the lack of 
kisspeptin signaling. Detailed description of the generation and phenotypic 
characteristics of the Gpr54 KO mouse line has been recently described by our group 
[65]. Adult male mice (>2-month-old) of both genotypes (Gpr54−/−, Gpr54+/+) were 
used. To exclude the possibility that defective gonadotropin responses to the stimuli 
can be derived from insufficient pituitary responsiveness to GnRH due to their low 
endogenous tone, Gpr54 KO mice were subjected to a protocol of GnRH priming 
during two days before the test. The priming protocol consisted of five successive ip 
boluses of a low dose of GnRH (0.15 μg/mouse), with the following schedule: at 10.00 
h, 17.00 h, and 00.00 h on day 1; and at 08.00 h and 16.00 h on day 2. Gpr54+/+ mice 
were submitted to a similar protocol but with vehicle injections served as controls. On 
day 3, Gpr54+/+ (n=12) and Gpr54−/− (n=7) male mice received a single icv injection of 
vehicle (0.9% NaCl) or MT II (1nmol) and blood samples were collected 15 min after 
injection (Figure 25).  
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Figure 25. Schematic representation of the experimental protocol used in experiment 7. 
 
 In experiment 8, hypothalamic Kiss1 mRNA levels were assayed after blockade 
of MC3/4-R. To avoid the potential confounding factor of changes in circulating 
estrogens, 25 day-old female rats were subjected to bilateral OVX and supplemented 
with E2, following standard protocol (see section 3.3.2.). This dose of replacement was 
selected to achieve moderate levels of circulating E2. Animals received two daily icv 
injections of vehicle (0.9% NaCl) or SHU9119 (1nmol/rat) between PND-28 to -32. 
SHU9119-treated animals were pair fed to vehicle-treated rats, as was described in 
experiment 4. BW was daily monitored and, at the end of the experiment, animals 
were euthanized by decapitation and brains removed, frozen on dry ice and stored at -
80°C for ISH analyses (Figure 26).  
 
Figure 26. Schematic representation of the experimental protocol used in experiment 8. 
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 In order to analyze the localization of POMC fibers and Kiss neurons, in 
experiment 9, pubertal female rats were injected with an effective dose of anaesthetic 
(pentobarbital) and intracardially perfused with saline solution (0.9% NaCl) followed by 
4% PFA in PBS (pH 7.4). Brains were removed and post-fixed for immunofluorescence 
analyses (see section 3.4.3.2.).  
3.5.2. CHARACTERIZATION OF THE PUTATIVE ROLES OF miRNAs IN THE 
CONTROL OF PUBERTY ONSET 
 Previous data from GWAS and functional genomic studies suggest the potential 
involvement of miRNA regulatory pathways in general and of Lin28/let-7 system in 
particular, in the central control of developmental events that lead to pubertal 
activation. However, in spite of these recent studies, relatively little is known about the 
function of Lin28/let-7 system in the pubertal maturation. In order to extend our 
knowledge about the participation of Lin28/let-7 system in the control of puberty, a 
series of experimental designs were carried out. The let-7a and let-7b were analysed as 
two representative miRNAs of the let-7 family belonging to different clusters [348]. In 
addition, c-Myc, miR-145 [375, 385, 386], as well as miR-9 and miR-132, miRNAs 
predicted as potential regulators of the Lin28/let-7 system by the use of bioinformatic 
algorithms in this Thesis, were also studied.  
3.5.2.1. CHARACTERIZATION OF THE TISSUE DISTRIBUTION AND DIFFERENTIAL 
EXPRESSION OF LIN28 AND LIN28B GENES  
  In experiment 10, the expression profiles of Lin28 and Lin28b mRNAs was 
explored in a broad panel of tissues from adult rats (>75-days-old, n=3) and mice (>2-
month-old, n=3). Different tissues were collected immediately after decapitation of 
animals. On the basis of the expression results of this experiment, the following studies 
were conducted in the hypothalamus and testes of rats and testes of mice. 
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3.5.2.2. CHARACTERIZATION OF THE PROFILE OF EXPRESSION OF LIN28/LET-7 
SYSTEM AND RELATED miRNAs IN HYPOTHALAMUS AND TESTES IN RATS 
3.5.2.2.1. ANALYSIS OF THE PROFILES OF HYPOTHALAMIC AND TESTICULAR 
EXPRESSION OF LIN28/LET-7 AND RELATED miRNAs DURING POSTNATAL 
MATURATION 
In experiment 11, the expression profiles of Lin28, Lin28b and c-Myc mRNAs, as 
well as let-7a, let-7b, mir-145, mir-132, and mir-9 miRNAs were determined in testes 
and hypothalamus, both males and females, in rats at different age during postnatal 
maturation (n=7-9/group of age). The ages of studies were selected according to the 
classification proposed by Ojeda et al. [387]: neonatal (PND-1), late neonatal (PND-7), 
infantile (PND-15), juvenile (PND-24 in females; PND-30 in males), early pubertal (PND-
30 in females; PND-38 in males), pubertal (PND-35 in females; PND-45 in males), and 
adult (>PND-75) ages.  Pubertal ages were determined by the observation of external 
index of puberty onset, VO in females and balano-preputial separation (BPS) in males.  
In experiment 12, neonatal (PND-1) and pubertal male (PND-45) and female 
(PND-35) rats were killed by decapitation and cortex and hypothalamus were 
collected. In these samples, Lin28b expression was analyzed. 
In addition, in experiment 13 neonatal, infantile, juvenile and pubertal male 
and female rats (n=7-9) were euthanized by decapitation and hypothalami were 
obtained. Lin28, Lin28b, let-7a, and let-7b expression were analyzed in two main areas 
related with reproductive function, in the POA region and in the MBH. 
3.5.2.2.2. ANALYSIS OF CHANGES IN THE PROFILES OF HYPOTHALAMIC AND 
TESTICULAR EXPRESSION OF LIN28/LET-7 AND RELATED miRNAs IN MODELS OF 
PERTURBED PUBERTY  
 In order to provide further evidence for the putative role of Lin28/let-7 system 
in the maturational program leading to puberty, the next set of experiments were 
carried out in various preclinical models of disturbed puberty.   
 It is known that alterations of the sex steroid milieu during the critical neonatal 
period of sexual differentiation disrupt pubertal maturation and gonadotropic function 
later in the life [388]. In this line, in experiment 14, male and female rats (n=10 per 
group) received at PND-1 subcutaneous (sc) injection of EB (100 µg/rat in females; 500 
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µg/rat in males) or vehicle (olive oil). An additional group of females (n=10) was sc 
injected on PND-1 with TP (1.25 mg/rat) (Figure 27). In order to verify the perturbed 
pubertal maturation in these animals, hormonal and phenotypic indices of puberty 
were studied. Trunk blood samples, testes and hypothalamus, both male and female, 
were obtained from peripubertal (PND-45 in males; PND-35 in females) animals. Tissue 
samples were stored at -80°C until further processing. 
 
 
Figure 27. Schematic representation of the experimental protocol used in experiment 14. 
 
 On the basis of previous evidence showing that either changes in melatonin 
levels or photoperiod/day length modify the normal timing of puberty [389, 390], in 
experiment 15, photoperiodic manipulation was used as another model of perturbed 
puberty. In this respect, male and female rats were submitted to constant darkness 
(CD), between PND-10 to -15. , Male and female rats (n=8–12) were euthanized and 
testes and hypothalamus, were collected at PND-15 (immediately after completion of 
CD) and at puberty (PND-35 in females; PND-45 in males) (Figure 28). Pubertal 
maturation was monitored by detecting VO in females and BPS in males. Groups of 
rats reared in standard photoperiod conditions (14-h light/10-h dark) served as 
controls. 
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Figure 28. Schematic representation of the experimental protocol used in experiment 15. 
 
 In experiment 16, the impact of undernourishing during lactation on 
hypothalamic and testicular expression of the Lin28/let-7 system was explored in male 
and female rats bred in large litters (20 pups/litter; UN) [274]. This model has been 
proposed to mimic subnutrition conditions during the last trimester of human 
gestation [391]. After weaning, rats were fed ad libitum. Subsets of rats were killed at 
representative ages of postnatal maturation, PND-5, -15, and -35 (in females) or -45 (in 
males) and hypothalamic and testicular samples were collected (Figure 29). Animals 
bred in normal litters (12 pups/litter) were used as model of normonutrition (NN). 
Phenotypic parameters such as BW, testicular weight (TW), BPS and VO were studied. 
 
Figure 29. Schematic representation of experimental protocol used in experiment 16. 
 
 In experiment 17, another form of metabolic distress, involving persistent 
caloric restriction after weaning was used in order to discriminate between early (large 
PND-15 PND-35 or -45
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•Trunk blood samples
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• Tissues disection
PND-1
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litter model) and late metabolic insults. Male and female rats were submitted to a 30% 
reduction in their daily food intake from PND-23 to puberty. Females and males were 
euthanized at about the time of puberty (PND-35 and PND- 45, respectively) and the 
hypothalami was removed (Figure 30). Rats fed ad libitum were used as control group. 
 
Figure 30. Schematic representation of experimental protocol used in experiment 17. 
 
3.5.2.2.3. ANALYSIS OF CHANGES IN TESTICULAR EXPRESSION OF LIN28/LET-7 
SYSTEM AND RELATED miRNAs IN MODELS OF DISTURBED NEUROENDOCRINE 
AXIS  
 In experiment 18, regulation by gonadotropins of testicular Lin28 and let-7 
expression were explored using HPX male rats as experimental model. Groups of long-
term HPX adult rats (4 weeks after HPX) received for 7 days a daily ip injection of 
vehicle (0,9% NaCl), hCG (50 IU/24 h, n=8), FSH (12.5 IU/24 h, n=7) or a combination of 
both (n=8) (Figure 31). At the end of the treatments, animals were killed by 
decapitation and testes were removed. Groups of intact animals injected with vehicle 
(100 µl) served as controls. After the surgery, rats HPX were provided with a bottle of 
isotonic saline (0.9%). 
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Figure 31. Schematic representation of the experimental protocol used in experiment 18. 
 
3.5.2.3. CHARACTERIZATION OF THE TESTICULAR EXPRESSION OF LIN28/LET-7 
SYSTEM IN MICE 
 Based on the abundant mRNA expression of both Lin28 and Lin28b in the testis 
(see experiment 10), the following mice studies were conducted in this tissue. Firstly, 
in addition to RNA data, in experiment 19, the expression of Lin28 and Lin28b peptides 
in testes from adult mice was studied. Testes form adult (2-month-old) mice from the 
C57B/6 strain (n=4) were dissected and fixed overnight in Bouin solution for IHC 
analyses. The results obtained lead to analyze the expression pattern of Lin28/let-7 
system in testes during postnatal maturation and in a mouse model of hypogonadism. 
3.5.2.3.1. ANALYSIS OF THE EXPRESSION OF LIN28/LET-7 SYSTEM DURING 
POSTNATAL TESTICULAR DEVELOPMENT 
 In experiment 20 the expression profiles of Lin28, Lin28b as well as let-7a and 
let-7b miRNAs were determined in testicular samples from mice at three 
representative ages of postnatal testicular maturation: neonatal (PND-1), infantile 
(PND-15), and pubertal/early adult (PND-45) stages (n=6–7 animals per age-point). 
Testes were obtained following decapitation of animals and stored at -80°C until use 
for RNA/miRNA analyses. 
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3.5.2.3.2. ANALYSIS OF TESTICULAR EXPRESSION OF LIN28 AND LIN28B IN A 
MOUSE MODEL OF HYPOGONADOTROPIC HYPOGONADISM 
 In experiment 21, the testicular expression of Lin28/let-7 system was analyzed 
in Gpr54 KO mice, a model of congenital hypogonadism (see experiment 7). This 
mouse line displays markedly decreased circulating LH and FSH levels, as well as 
severely reduced testis weights in adulthood [65]. WT animals, harboring two alleles 
for Gpr54, served as controls. Adult (>2-month-old) WT and Gpr54KO mice were 
sacrificed and testicular samples were removed for IHC and mRNA studies of Lin28 and 
Lin28b. In addition, the relative levels of let-7a and let-7b miRNAs were also analyzed.  
 In order to provide an insight into the hormonal regulation of the testicular 
expression patterns of Lin28 and Lin28b in Gpr54 null mice, in experiment 22, adult 
Gpr54 KO mice were subjected or not to standard protocols of gonadotropin priming. 
Groups of Gpr54 KO mice (n=4) received a daily ip injection of recombinant hCG (5 
IU/100 µl) or FSH (3.75 IU/100 µl) for 7 days (Figure 32). Animals injected with vehicle 
served as controls. Testicular samples were removed and fixed overnight in Bouin 
solution for IHC analyses.  
 
Figure 32. Schematic representation of the experimental protocol used in experiment 22. 
 
3.6. BIOINFORMATIC ANALYSIS 
 Bioinformatic analyses used to search the potential regulatory miRNAs of Lin28 
and Lin28b were carried out in collaboration with Dr. Susana Sangiao-Alvarellos 
(University of Santiago de Compostela) and were used four different algorithms: 
TargetScan [392]: http://www.targetscan.org/; miRanda [393]: http://www. 
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microrna.org/microrna/home.do; PicTar [394]: http://pictar.mdc-berlin.de/; and  
Diana Lab [395]: http://diana.cslab.ece.ntua.gr/microT/.  
3.7. STATISTICAL ANALYSIS 
 Data of BW, absolute and relative organ weight, ISH and hormonal levels are 
expressed as the mean ± SEM (standard error of the mean). Both time-course data and 
integral LH levels of different experimental groups relative to the control groups were 
estimated as area under the curve (AUC) by the trapezoidal rule. Expression data were 
expressed as percentage of the control group in each experiment and presented as 
mean ± SEM. Hormonal determinations were conducted with a minimal total number 
of 7-12 determinations per group. RNA analyses were performed in duplicate from at 
least 6 independent samples per group. ISH assays were conducted with 5 animals per 
group. Results were analyzed using Student t test and ANOVA followed by Student-
Newman-Keuls multiple range tests or post hoc Tukey test (Prism GraphPad 5.0 
software; GraphPad Software Inc., La Jolla, CA). Significance level was set at P ≤ 0.05 
and different letters or asterisks indicate statistical significance. 
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4. RESULTS 
4.1. CHARACTERIZATION OF THE ROLE OF CENTRAL MELANOCORTIN 
SIGNALING IN THE CONTROL OF THE GONADOTROPIC AXIS AT 
PUBERTY AND ITS POTENTIAL INTERACTION WITH LEPTIN AND 
KISSPEPTIN 
 With the aim to analyze the putative function of MC3/4-R signaling in the 
control of puberty onset and to explore their potential interaction with leptin and 
kisspeptins, three sets of experimental studies were performed.   
4.1.1. EFFECTS OF CENTRAL ACTIVATION OF MC3/4-R SIGNALING ON LH 
SECRETION 
 In the first set of experiments, we studied the effect of acute activation of MC3-
R and MC4-R on LH secretion, as surrogate marker of GnRH function. 
Firstly, we examined the effect of central administration of an effective dose of 
MT II (1 nmol/rat), a MC3/4-R agonist, on peripubertal male (PND-43) and female 
(PND-29) rats fed ad libitum or fasted for 48h. We observed that in males fed ad 
libitum, MT II evoked a significant increase in LH secretion at 15 min with persistently 
elevated LH levels at least up to 30 min after injection. In animals subjected to fasting 
for 48h basal LH levels were significantly decreased. In fasted males, MT II induced a 
significant increase in serum LH levels only at 30 min (Figure 33, upper panels). In the 
case of females, we found that a single bolus of MT II elicited a rapid and robust 
response in terms of LH secretion that extended for at least 30 min, despite the 
unfavorable metabolic conditions (Figure 33, lower panels). 
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Figure 33. Serum LH levels (ng/ml) after central MC3/4-R activation. Time course for the effects of 
vehicle (0,9% NaCl solution, Veh) or MT II (1nmol/rat) icv administration to peripubertal male (upper 
panels) and female (lower panels) rats fed ad libitum or fasted for 48 h are shown. LH levels were 
assayed before (0 min) and at 15-, 30- and 60-min (only in males) after the icv injection. Group sizes: 
n=8-10. Data are presented as mean ± SEM. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001 vs. corresponding 
vehicle-injected group, followed by Student t test.  
 
We also examined the LH response after same doses of MT II in infantile (PND-
15) male and female rats. Our data indicated that, MC3/4-R activation failed to induce 
a significant increase in LH secretion 15 min after injection of MT II, either in males and 
females (Table 4).  
 
Males Females  
Vehicle 0,39 ± 0,07 0,69 ± 0,08 
MT II 0,50 ± 0,10 0,85 ± 0,09 
 
Table 4. Effects of acute administration of vehicle (0,9% NaCl solution) or MT II (1nmol/rat) on LH 
secretion (ng/ml) in 15 day-old male and female rats at 15 min after icv injection are shown. Group 
sizes: n=10. Data are presented as mean ± SEM, followed by Student t test. 
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Finally, we further examined whether the effects of MT II on LH secretion are 
mediated through MC3-R and/or MC4-R. To this end, peripubertal male rats received a 
single bolus of different doses (0.2-, 1- or 5-nmol) of a selective MC3-R or MC4-R 
agonists. We found that activation of both MC3-R and MC4-R produces significant 
changes in LH release in a dose-dependent manner. Thus, we detected that 0.2- and 1-
nmol doses of the MC3-R agonist evoked a significant increase LH levels, at 15 min 
after the icv injection, while a high doses caused a significant decrease LH secretion at 
60 min (Figure 34A). In contrast, while doses of 0.2- and 1-mnol of the MC4-R agonist 
did not cause changes on LH secretion, animals injected with 5 nmol displayed a 
significant increase in LH levels at 15 min after the icv injection, which remained 
elevated for at least 60 min (Figure 34B). Interestingly, the profile of LH increase was 
similar to that found after MT II administration (see Figure 33A).  
 
Figure 34. Secretory profiles of LH responses (ng/ml) to different doses of selective MC3-R or MC4-R 
agonists in peripubertal male rats. Animals were icv injected with vehicle (0,9% NaCl solution) or a single 
dose of 0,2-, 1- or 5-nmol of MC3-R (A) or MC4-R (B) agonists. LH levels were assayed before (0 min) and 
at 15-, 30- and 60-min after the icv injection. Both time-course data and integral LH levels, estimated as 
area under the curve (AUC) over the 60 min after injection by the trapezoidal rule, are shown. Group 
sizes: n=8-10. Data are presented as mean ± SEM. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001 vs. 
corresponding vehicle-injected group; ANOVA followed by Student-Newman-Keuls multiple range test.  
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4.1.2. EFFECTS OF CENTRAL INACTIVATION OF MC3/4-R SIGNALING 
DURING THE PUBERTAL TRANSITION   
 In the second set of experiments, we evaluated in female rats the effects of 
central chronic blockade of MC3/4-R during pubertal transition through administration 
of SHU9119 (1 nmol/rat). Initial experiments evidenced that repeated icv 
administration of SHU9119 caused an increase in daily food intake. Thus, in order to 
avoid the possible influence of changes in BW on puberty onset, SHU9119-treated 
animals were pair fed to control animals. As we expected, no differences in BW 
between both groups were observed at PND-35 (Figure 35, left upper panel). However, 
repeated injections of SHU9119 between PND-28 to PND-35 caused a marked delay on 
puberty onset. In fact, at PND-35 less than 13% of SHU9119-treated group showed 
complete VO versus 75% of vehicle-treated group (Figure 35, right upper panel). This 
effect was associated to a reduction in relative UW and OW at the end of experiment 
(Figure 35, left and middle lower panels). At this time, in the SHU9119 group, LH levels 
tended to be lower than in the vehicle-treated group. However, these differences were 
not statistically significant (Figure 35, right lower panel). 
 
Figure 35. Effects of central inactivation of MC3/4-R signaling between PND-28 to -35 in female rats.  
BW (g), VO (%), relative UW and OW (mg%gBW) and serum LH levels (ng/ml) are presented from 
animals subjected to repeated icv administration of vehicle (0,9% NaCl solution) or SHU9119 (1 
nmol/rat) for 7 days. Group sizes: n=9-11. Data are presented as mean ± SEM. *, P ≤ 0.05 vs. vehicle-
injected group, followed by Student t test. 
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Based on the above data, we further evaluated whether the permissive effect 
of leptin on puberty onset depends on proper MC3/4-R signaling, using female rats 
subjected to moderate food restriction (20%) from PND-23 (UN) as model. To this end, 
food restricted animals were subjected to repeated central injection of vehicle or, 
leptin alone or in combination with SHU9119 from PND-29 to -35. Females fed ad 
libitum (NN) and chronically treated with vehicle served as controls. As we expected, 
chronic subnutrition produced a significant reduction on BW, relative UW, delayed 
puberty onset and a decrease in relative OW and LH circulating levels (Figure 36). 
Repeated administration of leptin to UN animals was able to partially rescue the 
negative effect of the subnutrition on the age of puberty onset and completely 
reversed the decrease in relative UW (Figure 36). Interestingly, concomitant blockade 
of central MC3/4-R signaling prevented the rescue effect of leptin on the timing of VO 
without affect its on UW. Moreover, no significant differences in terminal serum LH 
levels were detected among any of the groups subjected to food restriction (Figure 
36). 
 
Figure 36. Central inactivation of MC3/4-R signaling prevents the permissive effect of leptin on puberty 
onset in female rats.  BW, VO, relative UW, relative OW and terminal LH levels are presented from 
animals under moderate restriction (20%) in daily food intake (UN) and submitted to repeated icv 
administration of vehicle (0,9% NaCl solution) or leptin (3,1 µg/rat) alone or in combination with 
SHU9119 (1 nmol/rat). UN females group, as well as NN female rats, chronically treated with vehicle 
served as controls. Group sizes: n=9-11. Data are presented as mean ± SEM. Groups with different 
superscript letters are statistically different, P ≤ 0.05; ANOVA followed by Student-Newman-Keuls 
multiple range tests. 
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4.1.3. CHARACTERIZATION OF THE POTENTIAL MC3/4-R AND KISSPEPTIN 
INTERACTIONS IN THE CONTROL OF PUBERTY ONSET 
In the third set of studies, we evaluated whether MC3/4-R signaling is required 
for kisspeptin effects in the control of puberty onset or  vice versa. 
Firstly, we examined the effect of Kp-10 on LH release after blockade of central 
MC3/4-R signaling by SHU9119. Interestingly, we observed that central administration 
of two boluses of SHU9119 (1 nmol/rat), at 120- and 60-min before the analysis, 
caused a significant decrease of LH levels (Figure 37A). As we expected, SHU9119 
administration completely blocked the effect of MT II on LH secretion at 15 min (Figure 
37B). In contrast, melanocortin blockade by SHU9119 did not affect LH response to Kp-
10 at 15- and 60-min post-injection (Figure 37C). 
 
Figure 37. Secretory profiles of LH in response to MT II and Kp-10 after blockade of MC3/4-R in 
peripubertal male rats. (A) LH levels after the pretreatment, at 120- and 60-min before, with vehicle 
(0,9% NaCl solution) or SHU9119 (1 nmol/rat) are presented. Group sizes: n=26-30. Data are presented 
as mean ± SEM. ***, P ≤ 0.001 vs. corresponding veh-treated group, followed by Student t test. LH levels 
immediately before (0 min) and at 15- and 60-min after the last icv injection with Veh- or SHU-alone or 
co-administered with MT II (B) or Kp-10 (C) are shown. Group sizes: n=8-10. Data are presented as mean 
± SEM. ***, P ≤ 0.001 vs. corresponding veh-injected group with the same pre-treatment; ANOVA 
followed by Student-Newman-Keuls multiple range test. 
 
 Secondly, we also evaluated the effect of MT II on LH secretion in the absence 
of kisspeptin signaling using a Gpr54 KO mice model, which had been subjected to a 
protocol to GnRH priming previously. As we expected, WT animals showed a significant 
increase on LH secretion 15 min after icv administration of a single bolus of MT II (1 
nmol/mouse). However, LH response to MT II was markedly attenuated, although not 
totally eliminated, in Gpr54-deficient mice (Figure 38). 
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Figure 38. Effects on LH secretion of central activation of MC3/4-R signaling in the absence of kisspeptin 
signaling. Adult WT and Gpr54 KO male mice were treated with vehicle (0,9% NaCl solution) or MT II 
(1nmol/mouse) and LH levels (ng/ml) were assayed at 15 min after the icv injection. Group sizes: n=6-9. 
Data are presented as mean ± SEM. *, P ≤ 0.05 vs. corresponding vehicle-injected group; a, P ≤ 0.01 vs. 
corresponding WT values, followed by Student t test. 
 
 In the next experiment, we studied in female rat the effect of the chronic 
blockade of endogenous MC3/4-R signaling between PND-28 to -32 on hypothalamic 
Kiss 1 mRNA expression. To avoid the potential confounding factor of changes in 
circulating estrogen on Kiss1 expression, female rats were subjected to bilateral OVX 
and supplemented with moderate doses of E2 to mimic physiological levels. In 
addition, in order to avoid the possible influence of changes of BW on puberty onset, 
SHU9119-treated animals were pair fed to control animals. In keeping with previous 
studies, two main hypothalamic populations of Kiss1-expressing neurons were located 
in the ARC and AVPV. Our ISH analyses detected that chronic administration of 
SHU9119 induced a significant suppression (45%) of Kiss1 mRNA levels in the ARC of 
peripubertal females, whereas Kiss1 expression in AVPV was not affected by SHU9119 
treatment (Figure 39).  
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Figure 39. Hypothalamic expression of Kiss1 after central MC3/4-R blockade. In the upper panels, 
representative in situ hybridization photomicrographs showing Kiss1 mRNA expressing-neurons in the 
AVPV and ARC of peripubertal OVX+E2 female rats after repeated icv administration of vehicle (0,9% 
NaCl solution) or SHU9119 (1nmol/rat) between PND-28 to -32. In the lower panel, the total number of 
Kiss1-expressing cells (defined as grain in clusters) in the AVPV and ARC subjected to analysis are 
presented. Group sizes: n=5. *, P ≤ 0.05 vs. corresponding vehicle-injected group followed by Student t 
test.  
 
Finally, we further evaluated the possible physical contacts between POMC and 
kisspeptin neurons in the ARC of pubertal female rats by neuroanatomical studies. We 
found that α-MSH-IR fibers were located in close apposition to kisspeptin cell bodies in 
the ARC. 
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Figure 40. Illustration of localization of α-MSH-IR fibers and kisspeptin cell bodies in the ARC of pubertal 
female rats. Immunofluorescence using antibodies against Kp (green) and α-MSH (magenta) is 
presented. 
 
4.2. CHARACTERIZATION OF THE PATTERNS OF EXPRESSION OF 
LIN28/LET-7 SYSTEM AND RELATED FACTORS DURING PUBERTAL 
MATURATION 
In order to analyse the putative role of Lin28/let-7 system in the control of 
puberty, a series of expression analyses were carried out. The let-7a and let-7b, as two 
representative members of the let-7 family, c-Myc, mir-145, as well as mir-9 and mir-
132, miRNAs predicted as potential regulators of the Lin28/let-7 system by the use of 
bioinformatic algorithms, were studied (see Figure 17). 
4.2.1. TISSUE DISTRIBUTION AND DIFFERENTIAL EXPRESSION OF LIN28 
AND LIN28b GENES  
 In a first approach, we explored the expression profiles of Lin28 and Lin28b 
mRNAs in different tissues from adult rats and mice (Figure 41).  
 In the case of adult male and female rats, our analyses showed that Lin28 
mRNA is prominently expressed in placenta, testes, ovary and pituitary, with modest 
expression in the hypothalamus and weak expression in adipose tissue, heart, lung, 
liver and stomach. No expression was detected in kidney, spleen and skeletal muscle 
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(Figure 41A). Likewise, we detected that Lin28b mRNA is abundantly expressed in 
testes and placenta. In addition, remarkable expression was observed in the 
hypothalamus and modest but detectable levels of Lin28b mRNA were found in 
skeletal and cardiac muscle. The pituitary, pancreas and stomach showed very low or 
undetectable Lin28b mRNA levels (Figure 41A). 
Screening of adult male and female mouse tissues for expression of Lin28 and 
Lin28b genes revealed that Lin28 is only prominently expressed in the testis, whereas 
weak to null expression was detected in a panel of tissues including the pituitary, ovary 
(both with low but detectable mRNA levels), skeletal muscle, liver, brown adipose 
tissue, lung, spleen, heart and hypothalamus (data not shown). Similarly, we observed 
that Lin28b transcript was abundantly expressed in adult mouse testes and 
hypothalamus, whereas modest expression was observed at the pituitary and skeletal 
muscle and weak expression in the ovary. No expression of Lin28b was detected in 
liver, brown adipose tissue, lung, spleen and heart (data not shown). Figure 41B shows 
the expression patterns of Lin28 and Lin28b transcripts in selected tissues, including 
testis, hypothalamus, liver and muscle.  
Based on these expression analyses, showing the lack of expression of Lin28b in 
rat ovary and the weak expression of Lin28 and Lin28b in mouse ovary, we carried out 
our studies in the hypothalamus and the testis of rats and testis of mice. 
 
Figure 41. Representative PCR amplification patterns of expression of Lin28 and Lin28b genes in 
different tissues from adult, male and female, rats (A) and mice (B). 
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4.2.2. BIOINFORMATIC ANALYSES 
It is well established that the Lin28/let-7 system is subjected to a dual negative 
feedback regulatory loop. Lin28 and Lin28b repress the synthesis of mature let-7 
miRNAs, which in turn post-transcriptionally suppress Lin28/Lin28b expression. Besides 
the known regulators of this system, c-Myc (transcriptional activator of Lin28) and mir-
145 (suppressor of c-Myc), we searched for additional miRNAs and genes that may be 
involved in Lin28/let-7 modulation, using the four bioinformatic algorithms 
enumerated in Materials and Methods. A summary of the most relevant results 
obtained from these analyses are shown in Table 5.  
miRNA/GENE 
CONSERVED SITES POORLY CONSERVED SITES 
Total 8mer 7mer-m8 7mer-1A Total 8mer 7mer-m8 7mer-1A 
POSSIBLE REGULATORS OF LIN28B 
let-7 4 1 3 0 0 0 0 0 
mir-208 0 0 0 0 3 0 1 2 
mir-144 0 0 0 0 4 1 2 1 
mir-9 2 0 2 0 1 0 1 0 
mir-499 1 1 0 0 1 0 0 1 
mir-132 1 0 0 0 0 0 0 0 
POSSIBLE TARGET GENES OF LET-7 FAMILY 
HMGA2 6 1 3 2 1 0 0 1 
LIN28B 4 1 3 0 1 0 0 1 
IGF2BP1 3 3 0 0 1 0 1 0 
LIN28 2 2 0 0 0 0 0 0 
MAP3K1 1 1 0 0 0 0 0 0 
ZNF512B 3 0 3 0 0 0 0 0 
 
Table 5. Potential miRNA regulators of Lin28b (using TargetScan) and target genes of let-7 family in rats. 
Only the targets identified simultaneously by at least three of the four bioinformatics algorithms, 
TargetScan, miRanda, PicTar and Diana Lab, used in this Thesis are shown.  HMGA2: high mobility group 
AT-hook 2; IGF2BP1: insulin-like growth factor 2 mRNA binding protein 1; MAP3K1: mitogen-activated 
protein kinase kinase kinase 1; ZNF512B: zinc finger protein 512B. 
 
Considering the biological profiles of these potential candidates to regulate 
Lin28b, we included mir-132 in our testicular analyses and both mir-9 and mir-132 in 
our hypothalamic analyses. This selection was further supported by the fact that both 
are highly conserved across most vertebrates and are highly expressed in the rat 
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hypothalamus, as compared with other miRNAs, such as mir-208, mir-144 and mir-499 
which are not expressed or at low levels expressed in this tissue. In addition, we also 
used bioinformatic tools to identify potential target genes of the let-7 family (Table 5). 
4.2.3. CHARACTERIZATION OF HYPOTHALAMIC EXPRESSION PROFILES OF 
THE c-MYC/LIN28/LET-7 SYSTEM AND RELATED miRNAs IN RATS 
4.2.3.1. ANALYSIS OF EXPRESSION OF c-MYC/LIN28/LET-7 AND RELATED 
miRNAs IN THE HYPOTHALAMUS DURING POSTNATAL MATURATION 
 First, the expression profiles of c-Myc/Lin28/let-7 were analyzed in male and 
female rats during postnatal maturation in the hypothalamus, cortex and specific 
hypothalamic areas related with reproductive function, POA and MBH.  
 In the hypothalamus of both sexes, we observed that Lin28 and Lin28b mRNA 
showed similar profiles. Thus, both genes displayed very high expression levels during 
the neonatal period. In the case of Lin28, expression levels declined precipitously 
thereafter, remaining at low, almost imperceptible, values from infantile period until 
adulthood (Figure 42 and 43, upper panels). Regarding Lin28b mRNA, its abundance 
declined less pronouncedly, by about 50% during the infantile period, remaining at 
these values until early puberty. At puberty, the values declined further remaining low 
in adulthood (Figure 42 and 43, upper panels). In addition, it was detected that 
expression levels of c-Myc mRNA in rat hypothalamus paralleled those of Lin28b in 
both male and female rats (Figure 42 and 43).  
In clear contrast, let-7a and let-7b, mir-132, and mir-145 miRNA levels displayed 
opposite profiles, with minimal neonatal expression levels and progressive increase 
along postnatal maturation in both male and female rats. However, these trends were 
not detected for mir-9, whose hypothalamic levels showed the highest expression 
during the neonatal (in males) and late neonatal (in female) periods and declined 
gradually during postnatal maturation (Figure 42 and 43). 
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Figure 42. Expression profiles of the components of the Lin28/let-7 system and related factors in the 
whole hypothalamus of male rats during postnatal maturation. Expression analyses of Lin28, Lin28b and 
c-Myc mRNAs, as well as let-7a, let-7b, mir-132, mir-145 and mir-9 miRNAs. Group sizes: n=8-10. Data 
are presented as mean ± SEM. Different superscript letters above bars indicate statistical differences, P 
≤ 0.05; ANOVA followed by post hoc Tukey test. NEO: neonatal; INF: infantile; JUV: juvenile; EP: early 
puberty; PUB: pubertal; AD: adult. 
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Figure 43. Expression profiles of the components of the Lin28/let-7 system and related factors in the 
whole hypothalamus of female rats during postnatal maturation. Expression analyses of Lin28, Lin28b 
and c-Myc mRNAs, as well as let-7a, let-7b, mir-132, mir-145 and mir-9 miRNAs. Group sizes: n=8-10. 
Data are presented as mean ± SEM. Different superscript letters above bars indicate statistical 
differences, P ≤ 0.05; ANOVA followed by post hoc Tukey test. NEO: neonatal; LN: late neonatal; INF: 
infantile; JUV: juvenile; EP: early puberty; PUB: pubertal; AD: adult. 
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When Lin28b expression was analyzed in frontal cortex and hypothalamus from 
male and female rats during postnatal maturation, opposite patterns were found in 
both sexes between these two localizations. Thus in male rats, we detected a 
significant increase of Lin28b expression levels between the neonatal and pubertal 
periods in the frontal cortex, whereas a decrease of expression was observed in the 
hypothalamus (Figure 44A). This trend was observed also in females, but the increase 
of Lin28b expression levels in frontal cortex was not significant (Figure 44B). 
 
Figure 44. Lin28b expression in the frontal cortex and hypothalamus from neonatal and pubertal male 
(A) and female (B) rats. Group sizes: n=4-5. Data are presented as mean ± SEM. *, P ≤ 0.05 vs. 
corresponding neonatal-group, followed by Student t test. NEO: neonatal; PUB: pubertal. 
 
Expression analyses of Lin28/let-7 system during postnatal development in POA 
region and MBH of male and female rats showed broadly similar trends to those 
shown in Figure 42 and 43. Thus, we detected high expression of Lin28 and Lin28b in 
the POA and MBH in both sexes and markedly declined thereafter, with virtually 
negligible levels of Lin28 and moderate but detectable levels of Lin28b at later stages 
(infantile, juvenile and pubertal) of postnatal development (Figure 45 and 46).  
In clear contrast, let-7a and let-7b expression levels were low in neonatal 
samples from the POA and MBH, in both male and female rats and progressively 
increased thereafter, with subtle differences being detected between let-7a and let-7b 
profiles depending on the sex and hypothalamic region. Thus, in male rats, we 
observed that the expression levels of let-7a and let-7b progressively rose during 
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postnatal maturation in both the POA and MBH, with a trend for higher expression 
levels of both targets (at least at some age-points) in the MBH (Figure 45).  
 
Figure 45. Expression profiles of the components of the Lin28/let-7 axis in POA and MBH regions from 
male rats at different stages of postnatal maturation. Group sizes: n=7-9. Data are presented as mean ± 
SEM. *, P ≤ 0.05 vs. neonatal in each region; a, P ≤ 0.05 vs MBH for each age; b, P ≤ 0.05 vs. infantile in 
each region; c, P ≤ 0.05 vs. juvenile in each region. Two-way ANOVA followed by post hoc Tukey test. 
NEO, neonatal; INF, infantile; JUV, juvenile; PUB, pubertal. 
 
In females, we detected that let-7a and let-7b expression levels were notably 
higher in the MBH along postnatal maturation, with clear increases during 
developmental progression. In contrast, in the POA, the rise of expression of let-7 
miRNAs was more modest and only statistically significant for let-7a (Figure 46).  
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Figure 46. Expression profiles of the components of the Lin28/let-7 axis in POA and MBH regions from 
female rats at different stages of postnatal maturation. Group sizes: n=7-9. Data are presented as mean 
± SEM. *, P ≤ 0.05 vs. neonatal in each region; a, P ≤ 0.05 vs MBH for each age; b, P ≤ 0.05 vs. infantile in 
each region; c, P ≤ 0.05 vs. juvenile in each region. Two-way ANOVA followed by post hoc Tukey test. 
NEO, neonatal; INF, infantile; JUV, juvenile; PUB, pubertal. 
4.2.3.2. ANALYSIS OF CHANGES IN THE PROFILE OF HYPOTHALAMIC 
EXPRESSION OF c-MYC/LIN28/LET-7 AND RELATED miRNAs IN MODELS OF 
PERTURBED PUBERTY 
In order to provide further evidence for the putative roles of c-Myc/Lin28/let-7 
system in the maturational program leading to puberty onset, we analyzed in the 
hypothalamus the expression patterns of this system, as well as of related miRNAs, in 
different preclinical models of disturbed puberty.   
In the first study, we analyzed in male and female rats the effect of the 
disruption of pubertal maturation through the alterations of the sex steroid milieu 
during the critical neonatal period. In agreement with previous data, we observed that 
male rats treated neonatally with EB showed at PND-45 decreased serum levels of 
both gonadotropins, absent BPS, diminished TW (data not shown). In these animals, 
we detected significantly increased hypothalamic Lin28b and c-Myc mRNA expression 
levels. A similar profile was detected for Lin28 expression levels although this increase 
did not reach statistical significance. In contrast, hypothalamic let-7a, mir-132 and mir-
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9 miRNA levels were significantly lower than in control animals. In addition, our data 
demonstrated that in EB-treated male rats the hypothalamic let-7b and mir-145 
expression remained unchanged (Figure 47).  
 
Figure 47. Expression profiles of the components of the Lin28/let-7 axis and related factors in the 
hypothalamus of pubertal male rats following neonatal estrogenization. Expression analyses were 
conducted in whole hypothalamic fragments from PND-45 male rats subjected to a standard protocol of 
neonatal estrogenization (estradiol benzoate, EB) or androgenization (testosterone propionate, TP). 
Animals injected with vehicle (olive oil, Veh) served as controls. Group sizes: n=7-9. Data are presented 
as mean ± SEM. *, P ≤ 0.05 vs. vehicle-injected group, followed by Student t test.  
 
Similarly, sex steroid milieu manipulation during the neonatal period in female 
rats, by the injection on PND-1 of EB or TP, resulted in hormonal and phenotypic 
indices of disrupted puberty at PND-35 as evidenced by perturbed gonadotropin levels 
and altered timing of VO (data not shown). These alterations were associated with 
detectable changes in the expression patters of the c-Myc/Lin28/let-7 system in the 
hypothalamus at the expected time of puberty (PND-35). Thus, as in EB-treated males, 
expression levels of Lin28b and c-Myc mRNA were significantly increased in neonatally 
EB- and TP-treated female rats (Figure 48). In turn, neonatal treatments with EB or TP 
decreased the hypothalamic expression levels of let-7b and mir-145, while there was a 
trend for a drop of let-7a miRNA levels, especially in EB-treated females, which did not 
reach statistical significance. Hypothalamic expression of mir-9 and mir-132 did not 
change with neonatal EB or TP treatments, except for a modest increase in mir-132 
levels that was observed in androgenized female rats (Figure 48). 
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Figure 48. Expression profiles of the components of the Lin28/let-7 axis and related factors in the 
hypothalamus of pubertal female rats following neonatal estrogenization or androgenization. Expression 
analyses were conducted in whole hypothalamic fragments from PND-35 female rats subjected to a 
standard protocol of neonatal estrogenization (estradiol benzoate, EB) or androgenization (testosterone 
propionate, TP). Animals injected with vehicle (olive oil, Veh) served as controls. Group sizes: n=7-9. 
Data are presented as mean ± SEM. *, P ≤ 0.05 vs. vehicle-injected group, followed by Student t test. 
 
In the second set of experiments, we analyzed in male and female rats the 
effect of photoperiodic manipulation during postnatal maturation. In the case of 
males, the phenotypic indices of disrupted puberty were confirmed by the observation 
of a delay in the age of BPS in males submitted to constant darkness (CD) between 
PND-10 and -15. Thus, at PND- 45, only 27.3% of CD males showed complete BPS, as 
compared with 91.7% of control animals, reared under standard photoperiod 
conditions (data not shown). At this age, no differences were observed in terms of 
pubertal BW and TW between control and CD animals. At the end of darkness period 
(PND-15), the analysis of CD males revealed a significant increase in hypothalamic 
Lin28b and c-Myc mRNA levels. In contrast, these animals exhibited a consistent 
decline in let-7a, let-7b, mir-132 and mir-145 miRNA expression, while mir-9 remained 
unchanged (Figure 49). Surprisingly, these changes were transient as similar 
modifications in the hypothalamic expression of the above targets were not detected 
in CD males when studied at PND-45, i.e., the expected time of puberty (data not 
shown). 
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Figure 49. Expression profiles of the components of the Lin28/let-7 axis and related factors in the 
hypothalamus of 15 days-old male rats following photoperiod manipulation (CD, constant darkness 
between PND-10 and -15). Animals reared under standard photoperiod conditions served as controls. 
Group sizes: n=7-9. Data are presented as mean ± SEM. *, P ≤ 0.05 vs. control group, followed by 
Student t test.  
 
With respect to females, we detected that at PND-35 only 12.5% of CD females 
had VO as compared with 90% of control females (data not shown). Yet, no differences 
were observed at PND-35 on pubertal BW, OW and UW between control and CD 
animals. Our data indicated that at the end of darkness period (PND-15) animals 
showed increased expression levels of Lin28b and c-Myc mRNA levels, decreased 
expression levels of mir-145 and no changes in the other targets studied. At PND-35, 
CD females displayed increased hypothalamic Lin28b expression levels, significantly 
lower levels of let-7a, let-7b, mir-132 and mir-145 miRNA levels and no changes in mir-
9 (Figure 50). 
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Figure 50. Expression profiles of the components of the Lin28/let-7 axis and related factors in the 
hypothalamus of 15- and 35-days-old female rats following photoperiod manipulation (CD, constant 
darkness between PND-10 and -15). Animals reared under standard photoperiod conditions served as 
controls. Group sizes: n=7-9. Data are presented as mean ± SEM. *, P ≤ 0.05 vs. PND-15 group for each 
photoperiodic regimen; a, P ≤ 0.05 vs control group for each age. Two-way ANOVA followed by post hoc 
Tukey test. 
 
In order to analyze the impact of the disruption of pubertal maturation due to 
metabolic distress by undernutrition upon the expression profile of Lin28/let-7 system, 
two different animal models were generated.  
In the first model, male and female rats were submitted to a protocol of 
subnutrition during lactation, generated by breeding in large litters (20 pups/litter). 
This manipulation induced a delay in the timing of puberty onset in both sexes. Thus, 
at PND-45, only 22% of males reared in large litters had BPS as compared with 92.6% 
of control males, and at PND-35, only 37.5% of females from large litters had complete 
VO in comparison with 90% of control females (data not show).  
Data obtained in this model showed that postnatal underfeeding of males and 
females resulted in increased Lin28b and c-Myc mRNA levels during the neonatal (PND-
5) and infantile (PND-15) periods (Figure 51, A and B). Regarding other miRNAs 
analyzed, changes in hypothalamic expression induced by postnatal subnutrition were 
less evident and displayed some degree of sexual dimorphism. Thus, while in males 
and females let-7b miRNA levels remained unchanged, let-7a modestly decreased in 
underfed males during the neonatal period, but increased in infantile females. 
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Hypothalamic levels of mir-132 tended to diminish in pubertal females subjected to 
postnatal undernutrition, but did not significantly change in underfed males. Finally, 
hypothalamic mir-145 miRNA showed opposite profiles. Thus, males subjected to 
postnatal underfeeding showed lower levels during neonatal and infantile periods, 
while significantly increased expression in underfed infantile females was detected 
(Figure 51,A and B). 
 
 
Figure 51. Expression profiles of the components of the Lin28/let-7 axis and related factors in the 
hypothalamus of male and female rats following postnatal undernourishment. Expression analyses were 
conducted in hypothalamic samples obtained at PND-5, -15 and -45 or -35 from male (A) and female (B) 
rats, respectively. Group sizes: n=6-8. Data are presented as mean ± SEM. *, P ≤ 0.05 vs. corresponding 
PND-5 pups litter group; a, P ≤ 0.05 vs. corresponding 12 pups/litter for each age; b, P ≤ 0.05 vs. 
corresponding PND-15 pups litter group. Two-way ANOVA followed by post hoc Tukey test.  
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Finally, we analyzed in male and female rats, the impact upon the expression 
profile of Lin28/let-7 system of the disruption of pubertal maturation due to persistent 
caloric restriction (CR) by reduction of 30% daily food intake from weaning to puberty. 
Our data indicated that CR induces a delay in the timing of puberty onset, especially in 
females (data not shown). This protocol of late CR caused a modest reduction in 
hypothalamic expression of Lin28b and let-7b in males and females at the time of 
puberty, which was associated with a small reduction in c-Myc mRNA levels selectively 
in females (Figure 52,A and B). 
 
 
Figure 52. Expression profiles of the elements of the Lin28/let-7 axis and related factors in the 
hypothalamus of male (A) and female (B) rats subjected to prepubertal caloric restriction (CR). Studies 
were conducted at PND-45 in males) and PND-35 in females. Group sizes: n=6-8. Data are presented as 
mean ± SEM. *, P ≤ 0.05 vs. control group, followed by Student t test. 
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4.2.4. CHARACTERIZATION OF THE PROFILE OF TESTICULAR EXPRESSION 
OF LIN28/LET-7 SYSTEM AND RELATED miRNAs IN RATS AND MICE 
Our initial analyses showed that Lin28 and Lin28b mRNA are prominently 
expressed in the testis of rats and mice (see Figure 41). Based on these results, we also 
analyzed the expression profile of key components of the Lin28/let-7 system in the 
testis of these species during postnatal maturation, as a means to complement our 
central studies on the roles of this system in the control of pubertal maturation. In 
addition, the potential changes in their expression patterns in various models of 
altered puberty and the involvement of different hormonal axes in its regulation were 
analyzed.  
4.2.4.1. ANALYSIS OF TESTICULAR EXPRESSION OF LIN28/LET-7 AND RELATED 
miRNAs DURING POSTNATAL TESTICULAR DEVELOPMENT  
In rats, data obtained by RT-PCR indicated that Lin28 and Lin28b mRNAs 
displayed low testicular expression during the neonatal period, increasing markedly 
during infantile period. However, Lin28 mRNA levels showed a subsequent decreased 
to adulthood, when levels were similar to those of the day of birth, while Lin28b mRNA 
levels remained high from the infantile period to adulthood. Let-7a, let-7b, mir-132 
and mir-145, showed opposite expression profiles to Lin-28b but with minor 
differences (Figure 53). All miRNAs, with the exception of let-7b, declined after the 
neonatal period, but let-7a levels gradually decreased until puberty whereas mir-145 
levels remained elevated during the infantile period and dropped during the juvenile 
transition. Levels of mir-132 decreased during the infantile period and remained low 
until puberty, increasing again during adulthood, but with levels lower than neonatal 
period. Let-7b levels increased slightly during the infantile period and then decreased 
to adulthood (Figure 53). 
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Figure 53. Expression profiles of the components of the Lin28/let-7 axis and related factors in rat testis 
at different stages of postnatal development. Expression analyses of Lin28 and Lin28b mRNAs, as well as 
let-7a, let-7b, mir-132 and mir-145 miRNAs were conducted in testis fragments from rats at different 
stages of postnatal development. Group sizes: n=8-10. Data are presented as mean ± SEM. Different 
letters above bars indicate statistical differences, P ≤ 0.05; ANOVA followed by post hoc Tukey test. 
NEO: neonatal; INF: infantile; JUV: juvenile; EP: early puberty; PUB: pubertal; AD: adult. 
 
In good agreement with results obtained in rats, we also detected expression of 
Lin28 and Lin28b mRNA in mouse testes at all stages of postnatal maturation selected, 
corresponding to neonatal (PND-1), infantile (PND-15) and pubertal/early adult (PND-
45) ages. In addition, these profiles of expression across the different ages were also 
different for both signals. Thus, Lin28 mRNA levels abruptly increased (more than 14-
fold increase) between PND-1 and PND-15 and markedly declined (about 60% 
reduction) between PND-15 and PND-45, whereas Lin28b mRNA expression increased 
between the neonatal and infantile periods (about 7-fold rise) but remained elevated 
during the pubertal transition, with similar mRNA levels at PND-15 and -45 (Figure 54). 
In clear contrast, relative levels of both let-7a and let-7b miRNAs were maximal during 
neonatal period and declined thereafter. During postnatal development, we found 
differences between both let-7 miRNAs. Thus, whereas let-7a levels gradually declined, 
with 50% reduction between the PND-1 and PND-15 and further decreased at PND-45, 
Results 
 
 
118 
 
testicular let-7b expression remained elevated at the infantile period and dropped by 
about 60% during the pubertal transition (Figure 54). 
 
Figure 54. Expression profiles of Lin28/let-7 system in the testis of mouse during postnatal maturation.. 
Group sizes: n=4-7. Data are presented as mean ± SEM. Different superscript letters above bars indicate 
statistical differences, P ≤ 0.05; ANOVA followed by Student-Newman-Keuls multiple range test. 
 
4.2.4.2. HISTOLOGICAL CHARACTERIZATION OF THE TESTICULAR EXPRESSION 
OF LIN28/LET-7 AND RELATED miRNAs  
In order to further study the testicular expression of Lin28/let-7 system, we 
analyzed the distribution patterns of this system and related miRNAs in mice and rats. 
Because our initial validation tests in rats were not successful (none of the 
antibodies tested worked adequately), IHC analyses to study the cellular location of 
Lin28 and Lin28b was carried out mainly in mice. Such studies confirmed the presence 
of both Lin28 and Lin28b peptides in testis from adult (>2-month-old) mice from the 
C57B/6 strain. These assays revealed quite different cellular locations for Lin28 and 
Lin28b proteins within the testicular tissue. Thus, Lin28-IR was restricted to the 
seminiferous tubules where the signal was confined to cells at the basal zone of the 
seminiferous epithelium, in particular corresponding to spermatogonia (Figure 55, A 
and C). However, interstitial Leydig cells were negative (Figure 55C). In clear contrast, 
Lin28b-IR was detected in both spermatids in the seminiferous tubules and Leydig cells 
in the interstitial compartment (Figure 55,B and D), whereas other interstitial cells and 
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blood vessels were negative. These results set the basis for additional expression 
analyses during postnatal maturation and in a mouse model of impuberism and 
hypogonadism. 
 
Figure 55. Representative photograph of Lin28 and Lin28b protein distribution in testis of adult mice. A 
and C, Immunostaining for Lin28; C, At higher magnification of Lin28-IR cells in the seminiferous tubules 
(ST) correspond to spermatogonia (Sg), whereas interstitial Leydig cells (LC) were negative. B, D, 
Immunoreactivity for Lin28b; D, At higher magnification of Lin28b-IR cells correspond to spermatids (Sd) 
in the tubules and to Leydig cells in the interstitium (I).  
 
As a way to complete our initial rat studies of testicular expression of miRNAs 
linked to the Lin28/let-7 system, detailed ISH assays of the patterns of expression of 
let-7b and the related miRNA, mir-145, were conducted in adult male rats. We 
observed that let-7b miRNA expression in adult testis was restricted to germ cells in 
the seminiferous tubules in a stage-dependent pattern and it was absent in the 
interstitial areas (Figure 56A). The hybridization signal was strong in pachytene 
spermatocytes (Figures 56, A-C), weaker in round spermatids from stage I to stage VII 
and disappeared in elongating spermatids from stage VIII onwards (Figures 56, B and 
C). The same expression pattern was observed for mir-145, with the exception that it 
was strongly expressed in smooth muscle cells in the interstitial blood vessels (Figure 
56D).  
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Figure 56. Representative in situ hybridization of testicular distribution of let-7b and mir-145 in adult 
rats. ISH signal (purple color) of let-7b (A-C) and mir-145 (D) are presented. E, Positive control 
(hybridized for the ubiquitous microRNA U6); F, Negative control (hybridized with sense probes). ST, 
seminiferous tubules; I, interstitium; P, pachytene spermatocytes; RS, round spermatids; ES, elongating 
spermatids; BV, interstitial blood vessels.  
 
4.2.4.3. ANALYSIS OF CHANGES OF TESTICULAR EXPRESSION OF LIN28/LET-7 
AND RELATED miRNAs IN MODELS OF PERTURBED PUBERTY  
With the aim to further characterize changes of the expression of the elements 
of the Lin28/let-7 system, we analyzed the testicular expression patterns of this system 
in different preclinical models of disturbed puberty in both rats and mice.  
 First, we studied the effect of the disruption of pubertal maturation after 
neonatal administration of EB to male rats. The hormonal and phenotypic indices of 
disrupted puberty were mentioned previously (see Figure 47). Neonatal 
estrogenization resulted in evident changes in the Lin28/let-7 axis at the expected time 
of puberty (PND-45). Thus, neonatally estrogenized males displayed decreased Lin28 
and Lin28b mRNA levels. In contrast, let-7a, let-7b and mir-145 miRNA levels were 
significantly higher than in control animals, while mir-132 expression did not show 
significant changes (Figure 57).  
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Figure 57. Expression profiles of the components of the Lin28/let-7 axis and related factors in pubertal 
rat testis from animals neonatally treated with vehicle or estradiol benzoate (EB). Group sizes: n=7-9. 
Data are presented as mean ± SEM. *, P ≤ 0.05 vs. vehicle-injected group, followed by Student t test.  
 
As previously indicated, male rats submitted to constant darkness (CD) 
between PND-10 to -15 displayed a delay in the normal timing of puberty onset (see 
details in Figure 49). Testicular analysis at PND-15 and -45 did not show changes in 
testicular Lin28 and Lin28b mRNAs or let-7a miRNA levels, except for Lin28b whose 
expression levels were decreased on PND-45. On the other hand, these animals 
exhibited a decrease in let-7b, mir-132 and mir-145 miRNA at PND-15, but these 
changes in miRNA levels were transient and were not detected at PND-45 (Figure 58).  
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Figure 58. Expression profiles of the components of the Lin28/let-7 axis and related factors in rat testis 
following photoperiod manipulation (CD, constant darkness between PND-10 and -15). Animals reared 
under standard photoperiod conditions served as controls. Expression analyses were conducted at PND-
15 and -45. Group sizes: n=7-9. Data are presented as mean ± SEM. *, P ≤ 0.05 vs. PND-15 group for 
each photoperiodic regimen; a, P ≤ 0.05 vs. control group for each age. Two-way ANOVA followed by 
post hoc Tukey test.  
 
In addition, we analyzed the patterns of testicular expression of the Lin28/let-7 
system in models of perturbed puberty due to metabolic distress associated to 
subnutrition during lactation in rats.  As mentioned above, males bred in large litters 
(20 pups/litter) presented a delay in the timing of puberty (see details in Figure 51A). 
With regard to Lin28 and Lin28b expression levels, we observed that early postnatal 
subnutrition resulted in increased expression of both mRNAs at PND-5 and PND-15 
(Figure 59). However, at PND-45, Lin28b mRNA levels showed lower expression 
compared with male rats bred in normal litters, while Lin28 mRNA levels remained 
increased. Changes in testicular miRNA expression were less consistent; thus, while let-
7b miRNA levels remained unchanged along postnatal maturation, let-7a decreased 
during the neonatal period compared with the control group. Levels of mir-132 and 
mir-145 tended to decrease only at PND-15 in animals from large litters (20 
pups/dam)(Figure 59). 
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Figure 59. Expression profiles of the components of the Lin28/let-7 axis and related factors in rat testis 
following postnatal undernourishment. Expression analyses were conducted at PND-5, -15, and -45. 
Group sizes: n=6-8. Data are presented as mean ± SEM. *, P ≤ 0.05 vs. corresponding PND-5 pups litter 
group; a, P ≤ 0.05 vs. corresponding 12 pups/litter for each age; b, P ≤ 0.05 vs. corresponding PND-15 
pups litter group. Two-way ANOVA followed by post hoc Tukey test.   
 
 In order to further analyze gonadotropin regulation of testicular Lin28/let-7 
system, we used HPX male rats with or withput gonadotropin replacement as 
experimental model. It was observed that long-term HPX resulted in the decrease of 
testicular Lin28b mRNA to virtually negligible levels, a response that was not reverted 
by the replacement with hCG, FSH or a combination of both (Figure 60). Anyhow, 
relative Lin28b levels were partially increased by FSH, either alone or in combination 
with hCG. In contrast, Lin28 mRNA expression increased after HPX and was reversed by 
treatments with hCG or FSH. The administration of both hormones provoked lower 
Lin28 levels than those observed in intact rats (Figure 60). With regard to miRNAs, HPX 
did not cause alterations in let-7a, let-7b and mir-145 miRNA levels. However, both 
hCG and FSH treatments provoked an increase in their expression compared with HPX 
or intact rats. This increase was more marked when both hormones were administered 
together (Figure 60). On the other hand, levels of mir-132 miRNA diminished after HXP 
and significantly increased after treatment with hCG or FSH with higher values than 
control rats. The combined administration of both hormones caused cumulative 
effects on mir-132 miRNA expression (Figure 60). 
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Figure 60. Effects of HPX and gonadotropin replacement on testicular expression of Lin28/let-7 axis and 
related factors in adult male rats. Group sizes: n=5-6. Data are presented as mean ± SEM. Different 
letters above bars indicate statistical differences, P ≤ 0.05; ANOVA followed by post hoc Tukey test.  
 
 Finally, we conducted protein and RNAs analyses of the Lin28/Lin28b system 
using a genetic model of impuberism and hypogonadotropic hypogonadism, as a result 
of inactivation of Gpr54. As was mentioned previously, Gpr54 KO mice displayed 
decreased circulating LH and FSH levels, as well as severe reduction in TW in 
adulthood. WT animals, harboring two alleles for Gpr54, were used as controls.  
On one hand, we carried out complementary RNA analyses to identify changes 
in testicular Lin28/let-7 levels between WT and Gpr54 KO mice in adult animals. We 
detected that Gpr54 null mice displayed increased relative levels of Lin28 mRNA, but 
not Lin28b mRNA in the testis, with about 3-fold increase over WT values (Figure 61). 
In addition, Gpr54 null mice showed enhanced relative levels of let-7a (about 2.5-fold 
increase) and let7-b (about 6-fold increase) miRNAs compared with values detected in 
WT animals. Considering that TW of Gpr54 KO mice was severely decreased compared 
with WT values (about 14-fold decrease), in addition to relative expression, total 
expression levels of the above targets per testis were calculated, as estimated by the 
product of the expression of the specific transcript by the TW. This analysis revealed 
that total testicular expression of Lin28 and let-7 transcripts was markedly reduced in 
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Gpr54 KO mice, although the degree of suppression varied among the different 
targets. Thus, total expression levels were 25% for Lin28; about 8% for Lin28b; 17% for 
let-7a; and 43% for let-b of corresponding values in WT testes. Note that this method 
of calculation of total testicular expression of RNA allows an easy estimation of the 
absolute expression of a given target per testis and has been previously used by our 
group to complement relative expression data in models, such as HPX, characterized 
by dramatic changes in weight and/or cellular composition of the testis. 
 
Figure 61. Expression profiles of Lin28/let-7 system in the testis of adult WT and Gpr54 KO mice. Lin28 
and Expression analyses of Lin28 and Lin28b mRNAs, as well as let-7a and let-7b miRNAs were 
conducted in WT and Gpr54 KO mie. Group sizes: n=4-6. Data are presented as mean ± SEM. *, P ≤ 0.05 
vs. vehicle-injected group, followed by Student t test.  
 
Finally, we carried out morphometric analyses in adult WT and Gpr54 KO mice. 
The results obtained from WT mice showed normal seminiferous tubules with 
complete spermatogenesis and prominent eosinophilic Leydig cells in the interstitial 
areas (Figure 62A). In contrast, adult Gpr54 KO mice showed small seminiferous 
tubules with arrested spermatogenesis; the most advanced germ cells corresponded to 
leptotene (or occasional pachytene) spermatocytes (Figure 62C). Analyses of testicular 
sections, stained with hematoxylin and eosin, from WT and Gpr54 null mice, 
documented the important alterations of testicular histology present in this model of 
impuberism. Regarding the characterization of Lin28 and Lin28b, we observed that 
Lin28-IR was detected at the base of the seminiferous epithelium (Figure 62B), 
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confirming our previous results (see Figure 55). In Gpr54 KO mice, Lin28-IR was also 
present in analogous spermatogonial populations, but irregular distribution access 
testicular sections was observed (Figure 62D). With respect to Lin28b, IHC analyses in 
Gpr54 KO mouse testes failed to detect any specific signal (data not shown). 
 
Figure 62. Ultrastructural features and cellular distribution of Lin28 in the testis of adult WT and Gpr54 
KO mice. A and C, Representative testicular sections stained with hematoxylin and eosin (H&E) from WT 
and Gpr54 null mice are shown. B and D, Representative IHC analyses of Lin28 in WT and Gpr54 null 
mice are presented. 
 
In order to further understand the hormonal regulation of the testicular 
expression patterns of Lin28 and Lin28b, IHC analyses were also implemented in Gpr54 
null mice subjected, or not, to protocols of gonadotropin replacement with 
recombinant hCG or FSH, as previously described. Our analyses indicated that 
treatment with hCG for 7 days resulted in a marked increase in the seminiferous 
tubule diameter with progression of spermatogenesis up to elongating spermatids and 
enlargement of interstitial Leydig cells (Figure 63C). In turn, FSH administration 
resulted in a detectable, although less prominent, increase in tubular diameter and 
progression of spermatogenesis up to the round spermatid stage, without any 
discernible effect on the morphology of Leydig cells (Figure 63D). 
Considering that Lin28-IR was persistently detectable in testes of Gpr54 KO 
mice, but Lin28b was absent, and that testicular Lin28-IR did not change substantially 
after gonadotropin treatment of Gpr54 null mice (data not shown), only the analyses 
of changes in the expression profiles of the Lin28b following effective gonadotropin 
stimulation are present below. 
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In agreement with our initial analyses in C57B/6 adult mice (see Figure 55), we 
detected intensive Lin28b-IR in both Leydig cells in the interstitial areas and elongating 
spermatids within the seminiferous tubules in WT mice (Figure 63A). In contrast, 
Gpr54 null mice did not show detectable Lin28b immunostaining because of the lack of 
elongating spermatids and fully differentiated Leydig cells (Figure 63B). It was 
observed that gonadotropin administration rescued Lin28b expression with different 
effects between hCG and FSH treatments. Thus, hCG administration induced very 
intense Lin28b-IR in Leydig cells and elongating spermatids (Figure 63C), whereas FSH 
treatment caused more modest effects, with Lin28b-IR detected in round spermatids, 
but not in Leydig cells (Figure 63D).  
 
Figure 63. Representative testicular section of Lin28b-IR of WT and Gpr54 KO mice after gonadotropin 
treatment. IHC analyses of Lin28b in the testis of adult WT (A) and Gpr54 KO mice treated with vehicle 
(B) or an effective doses of recombinant hCG (C) or FSH (D) are presented. 
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5. DISCUSSION 
Puberty is defined as the transitional period from the juvenile stage to 
adulthood during which the reproductive capacity is acquired. From a neurobiological 
perspective, the onset of puberty and so, the full activation of reproductive axis, 
requires an increase in the pulsatile neurosecretion of GnRH [12]; this induces full 
gonadotropin stimulation at the pituitary, which subsequently increases gonadal 
hormone secretion and funtion.  
During the last years, substantial efforts have been made to identify the 
ultimately mechanisms responsible for the control of puberty onset. In this sense, it is 
know that the components of the HPG axis are controlled, among others, by peripheral 
factors that relay the nutritional information to the CNS, where they interact with 
central regulators involved in the control of the onset of puberty [396, 397]. GnRH 
neurons are considered the main hierarchical element in the neuroendocrine control 
of reproductive function and act as the final integrator of central and peripheral 
regulators of the HPG axis. However, several lines of evidence have demonstrated that 
these neurons may not be targeted directly by metabolic signals, such as leptin [252], a 
key factor involved in the integral control of energy balance and reproduction. Despite 
the progress made during the last few years in the identification of the potential 
candidate afferents responsible for transmitting metabolic information to GnRH 
neurons, our knowledge about this area remains incomplete. 
Additionally, different studies have described that, rather than the result of a 
single trigger, the pubertal increase in GnRH secretion depends on the coordinate 
changes of neuronal excitatory and inhibitory inputs to GnRH neurons [149], in 
conjunction with signals from non-neuronal cells, such as glia cells [147, 148, 154]. In 
this context, it has been proposed the hypothesis that puberty is controlled by a set of 
genes hierarchically arranged within functionally connected networks where GnRH is 
the final effector [159]. Several studies suggested that miRNAs could modulate gene 
expression at multiple hierarchical levels [162, 163]; hence, miRNA pathways are well 
suited to act as dynamic regulatory elements able to integrate the different networks 
involved in the control of puberty. Indeed, recent GWAS have demonstrated an 
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association of early menarche with a sequence variation in Lin28b [164-167], which is 
involved in the blockade of the processing into mature miRNAs of the let-7 family of 
miRNAs [168]. However, the actual roles of miRNAs in general, and of the Lin28/let-7 
system in particular, in the control of the events that lead to the puberty onset 
remained unexplored until recently.  
Based on the above, and in order to advance in our current knowledge about 
the systmes involved in the control of the pubertal activation of the HPG axis, this 
Thesis had the following main objectives: I) to characterize the potential function of 
central α-MSH signaling in the control of puberty onset and its putative interaction 
with leptin and kisspeptin signaling; and II) to define the profiles of expression of the 
Lin28/let-7 system, and several associated factors, during pubertal maturation, and 
study the changes in their expression patterns in preclinical models of altered puberty 
at different sites of the HPG axis, including the hypothalamus and testis. These 
expression studies would pave the way for future studies addressing the functional 
dissection of the regulatory roles, molecular targets and neuronal pathways involved in 
such miRNA modulation of puberty onset.  
In order to facilitate the discussion of the results, this section has been divided 
in two major subsections corresponding to each of the two major objectives listed 
above. 
5.1. MELANOCORTIN SIGNALING AND PUBERTY: INTERACTIONS WITH 
LEPTIN AND KISSPEPTIN 
 As indicated in previous sections of this Thesis, the fine tuning of the tempo of 
puberty depends on the delicate balance between peripheral and central regulators, 
which interplay to ultimately modulate the GnRH output from the hypothalamus to 
drive full activation of the downstream elements of HPG axis at puberty. Among the 
central transmitters involved in such function, kisspeptins have received considerable 
attention in recent years, given their prominent roles in the direct (and possibily 
indirect) regulation of GnRH neurons and the overt phenotype of humans and rodents 
harboring inactivating mutations in the elements of this system (see Section 1.4.). In 
this context, specific analyses have addressed whether Kiss1 neurons participate in 
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conveying the regulatory actions of different peripheral metabolic signals, such as  
leptin, insulin and ghrelin, with prominent roles in the control of puberty[175]. 
Likewise, the putative interplay between kisspeptins and other central neuropeptide 
pathways with relevant roles in energy and body weight homeostasis has been 
explored[175]; yet, these analyses have been fragmentary and our knowledge in this 
area remains incomplete. 
 In this work, we aimed to provide further insight into this phenomenon by 
exploring the specific roles of central melanocortin signaling, mediated by MC3 and 
MC4 receptors, in the regulation of puberty, and its interplay with key peripheral (i.e., 
leptin) and central (i.e., kisspeptins) modulators of puberty. The interest in -MSH 
signaling derives from its prominent role in the central control of energy homeostasis, 
and the proposed functional interplay between Kiss1 and POMC neurons; the latter, 
however, was suggested solely on the basis of electrophysiological studies in adult 
mice, and the physiological relavence of this phenomenon remains unexplored. In fact, 
some experimental studies had pharmacologically addressed the roles of -MSH in the 
control of gonadotropin secretion in adulthood, with predominant stimulatory actions, 
and more recently the potential interplay between melanocortin and kisspeptin 
pathways had been studied, mainly in the sheep (also in adulthood). Also recently, 
direct effects of -MSH on GnRH neurons, as measured by electrical responses, have 
been characterized in adult mice [305]. Despite this compelling evidence, the actual 
role of melanocortin signaling in the regulation of puberty remained largely 
unexplored. 
 To assess the putative role of central -MSH signaling in the control of puberty, 
we implemented a series of studies addressing three major aspects of such role. First, 
we studied gonadotropic responses to central melanocortin receptor activation during 
the infantile-pubertal transition and assessed the effects of central blockade of 
melanocortin signaling on the timing of puberty. Second, we explored the role of 
melanocortin signaling in mediating the permissive effects of leptin, as major 
metabolic regulator, on puberty onset. Finally, we studied the putative bidirectional 
interplay between -MSH and kisspeptin signaling in the control of the HPG axis at 
puberty. Altogether, our studies have surfaced a prominent physiological role of -
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MSH signaling in the fine control of puberty onset, by playing an essential role as 
transmitter of leptin effects and modulator of the hypothalamic Kiss1 system.  
Using LH responses as surrogate marker of GnRH activation, the present data 
are, to our knowledge, the first to document the precise program of developmental 
acquisition of the stimulatory actions of melanocortin (MC3/MC4) receptor signaling 
on the GnRH/gonadotropic axis, which takes place during the infantile-juvenile 
transition in female rats, as documented by the unambiguous LH responses to the 
MC3/MC4 agonist, MT-II, in juvenile, but not in infatile rats. The physiological 
relevance of melanocorting signaling in the control of gonadotropin secretion at this 
age is further supported by the finding that acute bloackade of MC3/MC4 receptors 
resulted in a significant lowering of basal LH levels. Likewise, chronic inhition of central 
melanocortin signaling during the pubertal transition resulted in a dramatic suppression/ 
delay of puberty onset, as monitored by a combination of external and internal indices 
of pubertal maturation, such as delayed vaginal opening, reduced uterus and ovarian 
weight, and a clear trend for a decrease in circulating LH levels. Altogether, our 
pharmacological gain- and loss-of-function experiments are clearly indicative of a 
stimulatory role of -MSH signaling in the regulation of puberty in rats.   
The lack of stimulatory effects of the agonist MT-II in infantile rats is in clear 
contrast with the potent gonadotropin-releasing effects of kisspeptin-10 detected in 
male and female rats at the same age [207]. Assuming that kisspeptins might operate 
as downstream effectors of -MSH (see below), one tempting possibility is that, while 
the capacity of kisspeptins to activate GnRH neurons is achieved at very early 
developmental stages (e.g., the neonatal/infantile period), upstream activators of 
endogenous kisspeptin pathways, which become operational at alter maturational 
periods, at are needed to actually set in motion afferent kisspeptin signals responsible 
for the full activation of GnRH neurons at puberty. Interestingly, the switch between 
null (at PND-15) and detectable (at PND-25) LH responses to MT-II coincides with the 
pattern of developmental maturation of Kiss1 neurons reported in mice and rats 
during postnatal maturation. This observation indirectly supports the hypothesis that 
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Kiss1 neurons might actually mediate the GnRH/gonadotropin releasing effects of -
MSH. 
Our pharmacological studies also revelaed that robust stimulatory responses, in 
terms of LH secretion, were only observed after central administration of high doses of 
the selective MC4-R agonist, while the MC3-R agonist was ineffective at such high 
dose. However, moderate, but significant LH-releasing effects of the MC3-R agonist 
were detected at low doses. These observations, together with the fact that responses 
to MT-II were similar in magnitude to those evoked by the MC4-R agonist, suggest that 
this melanocortin receptor subtype is responsible for mediating the major stimulatory 
actions of -MSH on the GnRH/gonadotropic axis. It must be noted, however, that 
maximal responses to the MC4-R agonist were obtained at doses 5-times higher than 
those of MT-II; this might be explained by the fact that MT-II activates also MC3-R and, 
as mentioned above, the agonist of this receptor was also capable to induce modest 
stimulatory responses in the low dose range. Also notably, our data unveil that the 
stimulatory effect of melanocortin signaling on the GnRH/goadotropic axis persists 
even in face of severe conditions of negative energy balance that significantly lower 
basal gonadotropin levels. Again, this is reminiscent of the situation with the Kiss1 
system, as kisspeptins can also revert the potent inhibitory effects of conditions of 
energy deficit on gonadotropin secretion, therefore suggesting the convergence of -
MSH and kisspeptin signaling in the central control of the HPG axis.  
The fact that central melanocortin (MC3/MC4) receptor activation could bypass 
the suppression of basal LH levels in pubertal animals is compatible a role -MSH as 
transmitter for the reproductive effects of peripheral metabolic regulators of the HPG 
axis, such as leptin, whose levels are suppressed in conditions of negative energy 
balance linked to inhibition of the reproductive system. Indeed, this was further 
confirmed by our physiological experiments in female rats that revealed that the 
permissive effects of leptin on puberty onset, as monitored by the standard 
phenotypic index (namely, vaginal opening), could be prevented by the concomitant 
blockade of central -MSH signaling. Of note, assessment of the effects of leptin on 
puberty onset, and its interplay with melanocorting signaling, was conducted in a 
model of chronic subnutrition, in which moderate caloric restriction during the 
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pubertal transition induces the lowering of endogenous leptin levels and prevents 
normal pubertal maturation. This model has been previously used by our group in 
experimental studies on the metabolic control of puberty, as this background permits 
to uncover the permissive/stimulatory effects of leptin. Of note, our previous studies 
have revelaed that the permissive effects of leptin on puberty onset are also blocked 
after inhibition of central mTOR signaling [398]. While the magnitude of the reported 
effects of the mTOR inhibitor on the HPG axis probably exceeds that of the 
melanocortin receptor antagonist used in the present study, the fact that blockade of 
these two signaling systems equally prevents the permissive action of leptin is strongly 
suggestive of some degree of convergence. In fact, previous studies have revealed that 
mTOR signaling is controlled by energy status and leptin in specific regions of the 
hypothalamus and colocalizes with POMC neurons in the ARC, thereby playing a major 
role in body weight homeostasis. Altogether, our previous and current data are 
compatible with a leptin-mTOR-MSH pathway, coverging on POMC neurons, as key 
element for the metabolic regulation of puberty onset.          
 Our study also surfaces a relevant -MSHkisspeptin regulatory pathway with 
a putativelty prominent role in the regulation of puberty. Considering previous 
electrophysiological and expression data in adulthood, which fragmentarily pointed 
out a potential bidirectional interplay between these two systems, hormonal and 
expression studies were implemented in this Thesis to test the feasibility and 
physiological relevance of such bidirectional interaction. Our data strongly suggest that 
kisspeptins are very unlikely to operate, at least for their LH-releasing effects, via 
modulation of the -MSH output to GnRH (or other intermediary) neurons, as 
illustrated by the fact that the potent LH responses to (even) submaximal doses of 
kisspeptin-10 were fully preserved in spite of effective blockade of MC3/MC4 
receptors. These results are not compatible with the previous proposal of a major 
regulatory role of kisspeptins on POMC neurons; yet, it must be stressed that such 
hypothesis was solely based on electrophysiological recordins in adult mice. Hence, 
our current experiments cast doubts on a physiological translation of such electrical 
responses into GnRH regulation in vivo. This is in good agreement with unpublished 
data from our group showing that LH responses to kisspeptin-10 are fully preserved in 
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mice engineered to lack Gpr54 selectively in POMC neurons. Admittedly, however, it is 
possible that direct effects on POMC neurons might serve additional functions of 
kisspeptins, as their proposed anorectic effects, although the physiological relevance 
of such feeding-suppressing actions of kisspeptins is yet to be demonstrated.  
In contrast, Kiss1 neurons appear to play a central role in transmitting the 
stimulatory effects of melanocortin signaling onto the reproductive centers. This is 
nicely documented by (i) the severe attenuation of LH responses to MT-II in mice with 
congenital inactivation of the kisspeptin receptor, Gpr54; and (ii) the significant 
suppression of Kiss1 mRNA expression in the ARC of pubertal females subjected to 
chronic blockade of MC3/MC4 receptors; i.e., a protocol that was previously shown to 
inhibit/delay puberty onset.  
 Of note, blunted, but detectable responses to the MC3/MC4 receptor agonist 
were observed in Gpr54 null mice. This finding suggests that part of the stimulatory 
effects of -MSH on GnRH secretion is independent on kisspeptin signaling. Indeed, as 
mentioned earlier in this Thesis, direct electrical responses to -MSH and MT-II have 
been recorded in GnRH neurons [305]; our findings do not refute and are fully 
compatible with such direct effects, as part of the stimulatory actions of -MSH on the 
gonadotropic axis. Yet, our data clearly illustrate the striking impact of the lack of 
kisspeptin signaling upon GnRH/gonadotropin responses to -MSH activation. In the 
same vein, our ISH results illustrate a rather dramatic drop of Kiss1 mRNA expression 
in the ARC following inhibition of central -MSH signaling. Previous studies in the 
sheep had illustrated divergent, nucleus-specific Kiss1 expression responses to 
activation with MT-II. Intriguingly, however, those studies suggested that while 
melanocortins stimulate Kiss1 expression in the preoptic area, they actually down-
regulated Kiss1 mRNA levels in the ARC; the latter response to the agonist is at odds 
with the decrease in ARC Kiss1 expression following antagonist administration, as 
reported here. It must be stressed, though, that previous studies were conducted in 
the adult sheep and involved the pharmacological activation of MC3/MC4 with an 
exogenous compound, rather than the blockade of the endogenous receptors. Thus, 
we are persuaded that, beyond obvious differences in experimental conditions, our 
present results are endowed with a notable physiological interest and, together with 
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our hormonal data, are strongly suggestive of an unidirectional ARC -MSHKiss1/ 
kisspeptin pathway, which might integrate upstream signals (e.g., leptin) and would 
play a central role in the metabolic regulation of puberty onset.  
 As discussed earlier in this Thesis (see Section 1.6), mice with genetic 
inactivation of MR3 and MC4 receptors, while not being infertile, display a variable 
degree of fertility problems. Thus, MC3-R KO female mice are subfertile, while MC4-R 
null mice, although fertile, are poor breeders and show decreased ovulatory rates 
[310]. Altogether, these observations in mouse models of congenital deficiency of MC3 
or MC4 receptors suggest that although -MSH signaling might not be indispesanble to 
achieve reproductive competence, this system actually plays a discernible role in the 
control of some functional aspects of the HPG axis. In any event, it must be stressed 
that in the above null mouse lines detailed characterization of puberty was not 
conducted, and it must be remembered that congential KO models may suffer some  
developmental compensation of the nullified pathway; a possibility that is specially 
tenable in partially redundant systems, such as MC receptors, when only one element 
of the family (MC3-R or MC4-R) is congenitally ablated. Notably, mice with functional 
blockade of both MC3-R and MC4-R, by overexpression of the endogenous antagonist, 
AgRP, have been shown to be infertile [309], whereas ablation of AgRP rescues fertility 
in leptin receptor deficient, db/db mice [315]. As a whole, the above data are 
suggestive of a relevant role of melanocortin signaling in the control of the adult HPG 
axis. Our data expands these previous observations and documents for the first time 
the physiological relevance of a leptin-MSHKiss1 pathway for the metabolic 
control of puberty.   
5.2. CHARACTERIZATION OF PATTERNS OF EXPRESSION OF miRNAs 
AND RELATED FACTORS DURING PUBERTAL MATURATION 
 As mentioned above, it seems clear that the increase in secretion of GnRH, 
required for the initiation of puberty, is driven by the coordinated changes of neuronal 
inputs to GnRH neurons of excitatory and inhibitory nature, in conjunction with glial 
stimulatory signals [149]. Recent studies have led to the hypothesis that puberty is 
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brought about by the concerted activation of central (hypothalamic) gene networks, in 
which central regulatory hubs and many subordinate genes interplay for the fine 
control of puberty onset [159]. According to this concept, these coordinated changes 
in network activity would ensure proper timing of the pubertal process [399, 400]. The 
existence of regulatory systems capable to integrate at different levels the functional 
output of such networks appears mandatory for the precise control of puberty, but 
these systems remain to be identified.  
In this context, miRNAs might be especially a good candidate to exert these 
functions, because of their ability to modulate gene expression at multiple hierarchical 
levels [162, 163]. In this Thesis, we tried to address this question by providing an initial 
characterization of the potential roles that miRNAs may have in the central control of 
puberty. Considering recent GWAS and functional genomic data [164-167, 401], we 
focused our work on the Lin28/let-7 system and, in addition, included in our analyses 
additional related factors of this regulatory pathway, such as c-Myc, mir-145, mir-9 and 
mir-132; the latter two were identified in our group as putative regulators of the hub 
using several bioformatic algorithms (see Figure 17).  
 Consistent with a role of the Lin28/let-7 system as one of the factors involved in 
the control of puberty, Lin28 and Lin28b expression was detected in key reproductive 
tissues in both rat and mouse. Our data showed that Lin28 mRNA is prominently 
expressed only in placenta, testis, ovary and pituitary of adult rats, with modest 
expression in the hypothalamus. Likewise, Lin28b mRNA is also expressed in adult rat 
testis and placenta, however, contrasting with Lin28, substantial hypothalamic Lin28b 
mRNA levels were observed in adult rats, whereas no expression was detected in the 
ovary. Our data in adult mouse showed that Lin28 is also prominently expressed in the 
testis and weak expression was detected in pituitary and ovary. Similarly, Lin28b mRNA 
was abundantly expressed in adult mouse testes and hypothalamus, whereas modest 
expression was observed at the pituitary and weak expression in the ovary. Taking into 
account the putative relationship, as predicted by different GWAS, between Lin28b 
and the age at menarche [164-167] and recent works suggested a role for Lin28/let-7 
axis in fertility and spermatogenesis [380, 381], along with the lack of expression of 
Lin28b in rat ovary and the weak expression of Lin28 and Lin28b in mouse ovary, we 
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focused our expression analyses on the hypothalamus and the testis of rats and testis 
of mice.  
5.2.1. HYPOTHALAMIC STUDIES 
Our study documented for the first time that Lin28 and Lin28b, as well as c-
Myc, mRNAs are abundant in the rat hypothalamus of both sexes during the neonatal 
period, declining strikingly during the infantile-to-juvenile transition. The fact that a 
similar trend was not observed in other brain areas, such as the cortex, where Lin28b 
mRNA levels increased between the neonatal and the pubertal period, suggests that 
postnatal loss of Lin28b expression is specific to the hypothalamus. Recently, it has 
been demonstrated that hypothalamic Lin28b mRNA levels show a similar profile in 
female rhesus monkeys during postnatal development [376], suggesting that this 
maturational change is evolutionary conserved.  
In contrast to the decline observed in the hypothalamic expression of 
Lin28/Lin28b, let-7 (mainly, let-7b), mir-132 and mir-145 miRNAs levels displayed 
opposite profiles, with minimal neonatal expression levels and progressive increase 
along postnatal maturation in both male and female rats. These results are coherent 
with previous studies showing that mir-145 suppresses c-Myc expression [375], 
resulting in reduced Lin28/Lin28b transcription and derepression of let-7 family 
maturation. Moreover, a recent study showed that seven of the eight miRNAs of the 
let-7 family are highly expressed in ARC and PVN of adult rats [402]. The above 
developmental profile is reminiscent of that found in C. elegans, in which high levels of 
Lin28 at the beginning of first larval stage (L1) are followed by an abrupt drop at the 
end of the L1 phase to allow progression to late larval stage, while let-7 levels increase 
progressively to reach maximum values at the adult stage [347]. Moreover, 
overexpression of let-7 at early stages of worm development causes premature 
adoption of adult fates, while let-7 underexpression results in failure to terminally 
differentiate at the larval to adult transition. Altogether, these data suggest that the 
level and timing of mature let-7 miRNA expression, in a reciprocal equilibrium with 
Lin28, plays a vital role in defining key aspects of development in C. elegans [347]. An 
inverse relationship between the expression levels of Lin28 and let-7 had been also 
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reported in mammals, suggesting that Lin28 is an important regulator of let-7 
biogenesis across species [348, 365, 369, 370, 403]. 
We also analyzed the changes in hypothalamic levels of mir-132 and mir-9 
miRNAs, two putative negative regulators of Lin28b. We observed that mir-132 levels 
increased gradually during postnatal/prepubertal maturation, in keeping with a 
potential role of this miRNA in the negative regulation of Lin28b. In contrast, mir-9 
miRNA levels were the highest during the neonatal period, declining gradually 
thereafter. This expression pattern suggests that mir-9 does not play a major role in 
repressing hypothalamic Lin28/Lin28b expression during postnatal maturation. 
Instead, mir-9 may be involved in the regulation of neurogenesis and maturational 
events at earlier fetal stages of brain development [404, 405]. 
In order to provide further evidence for a role of the Lin28/let-7 system in the 
development of the hypothalamic systems leading to the initiation of puberty, we 
conducted a series of expression analyses using different preclinical models of 
disturbed puberty.   
 As first model, we used rats in which sexual differentiation of the brain had 
been altered by neonatal exposure to high doses of estrogen or androgens. Consistent 
with previous studies [388], these treatments induced persistently decreased LH and 
FSH levels and prevented normal puberty onset. We observed that hypothalamic levels 
of c-Myc and Lin28b mRNAs were enhanced in these animals, while let-7 and mir-145 
miRNA levels were decreased at the expected time of puberty, similar to the high Lin28 
and low let-7 levels detected in the hypothalamus of immature animals. The 
association between enhanced Lin28 expression and delayed puberty observed in rats 
exposed to high sex steroid levels during neonatal period is in agreement with the 
delay of puberty onset reported in Lin28a Tg mice [27], thus supporting the idea that 
decreasing hypothalamic Lin28 expression is permissive for the correct timing of 
puberty. A discordant finding is the sex difference in mir-9 and mir-132 miRNA levels 
after neonatal estrogenization. Whereas in males both mir-9 and mir-132 miRNA levels 
diminished with estrogenization, no such changes occurred in females rats treated 
with EB. In fact, mir-132 levels increased in females treated with TP. The physiological 
importance of these differences remains to be established. 
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 We also observed a trend for an increased ratio of Lin28/let-7 expression in 
male and female rats with delayed puberty caused by early manipulation of the 
photoperiodic conditions. Thus, animals subjected to CD during between PND-10 and -
15 not only displayed delayed puberty onset, but also disturbed expression levels of 
Lin28 transcripts and several miRNAs in the hypothalamus at different stages of 
postnatal development. Like the immature rats and neonatally estrogenized/ 
androgenized animals, Lin28b and c-Myc mRNA levels were significantly increased in 
the hypothalamus of CD male and female rats, whereas let-7a and let-7b miRNA levels 
were decreased. However, a sex dimorphism was detected for the time course of 
these changes, so that altered Lin28/let-7 ratios were detected in infantile, but not 
peripubertal males, whereas in females such alteration was only detectable around the 
time of puberty. As observed in rats exposed to high doses of sex steroids during 
neonatal period, mir-132 and mir-145 miRNA levels, but not those of mir-9, were 
decreased in male and female rats exposed to CD. These data suggesting that delayed 
puberty caused by either altering neonatal sex differentiation of the brain or disrupting 
photoperiod signals during infantile development is associated with alterations of the 
Lin28/let-7 regulatory system, a finding that indirectly supports a tentative inhibitory 
role of this system on the timing of puberty. The functional relevance of these 
changes, and of their temporal differences, for the alteration of puberty observed after 
photoperiodic manipulation requires further investigation. 
 In clear contrast, altered puberty due to manipulation of the metabolic/feeding 
status did not cause comparable changes. Thus, let-7a levels decreased in males during 
the neonatal period, but increased in infantile females reared in large litters, whereas 
hypothalamic let-7b miRNA levels remained unchanged in male and female rats 
subjected to early subnutrition. Likewise, while mir-132 levels were lower in pubertal 
female rats subjected to postweaning undernutrition, mir-145 miRNA levels in the 
hypothalamus displayed opposite profiles between males and females subjected to 
postweaning underfeeding. Therefore, neither early subnutrition, through rearing 
large litters, nor a condition of negative energy balance around puberty, which had 
caused delayed puberty onset, altered the hypothalamic Lin28/let-7 system as did 
early androgenization, estrogenization and CD conditions. However, these 
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observations strongly suggest that, in spite of conditions of early metabolic stress 
causing pubertal alterations can perturb the expression of some of the elements of the 
Lin28/let-7 system in the hypothalamus, the underlying mechanisms and cellular 
substrate for such alterations are likely different from those caused by early 
manipulations of brain sex differentiation or photoperiod. 
 System biology approaches have allowed identification of a putative gene 
network operating within the female hypothalamus to control the initiation of puberty. 
Among the elements of this network, a set of tumor suppressor genes [406], including 
enhanced at puberty protein1 (EAP1) [399, 407], the POU gene, octamer transcription 
factor 2 (OCT2) [400], was shown to play a major role in the timing of puberty. 
Hypothalamic TSG networks are hierarchically controlled by specific regulatory 
centers. One of the predicted main hubs is p53, whose expression has been shown to 
increase in the hypothalamus during the pubertal transition in female rhesus monkeys 
[159]. Importantly, p53 is a tumor suppressor that negatively regulates c-Myc, while it 
induces the transcription of mir-145, which in turn represses a number of oncogenes, 
including c-Myc itself [375, 385]. Given the positive regulatory loop between c-Myc 
and Lin28/Lin28b expression [372, 373], it is possible that the decline in c-Myc/Lin28 
expression along postnatal maturation observed in our analyses can be caused by the 
increase in p53 and hence, mir- 145, that takes place during postnatal development. In 
turn, decreased levels of Lin28 might cause the observed increase in let-7 miRNA 
levels. Because bioinformatic analysis predicts that let-7 or related miRNAs regulate 
OCT-2 and EAP1, the latter only is regulated by let-7e and not by several members of 
the let-7 family, these genes might serve as portals conveying the regulatory actions of 
the Lin28/let-7 system to the neuroendocrine complex that controls the timing of 
puberty. Since let-7 and other miRNAs are considered to be tumor suppressors, it is 
tempting to assume that they represent an additional component of the regulatory 
TSG network postulated to be involved in the physiological regulation of puberty. 
5.2.2. TESTICULAR STUDIES 
In mammals, the spermatogenesis is a complex event involving numerous cell 
types and a large range of specific regulatory factors, which act at the transcriptional 
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or posttranscriptional levels and are essential for the adequate control of male 
gametogenesis. Among these factors, miRNAs, which mainly exert post-transcriptional 
control the stability or translation of their target messenger RNAs [162], have emerged 
with force in last years [408].  
Recent studies have reported the expression of let-7 family in rodent testis 
[409, 410] and have suggested a role for lin28/let-7 system in fertility and 
spermatogenesis. Thus, it has been demonstrated that Lin28 KO mice compromises the 
size of the germ cell pool in mice both males and females by affecting primordial germ 
cell proliferation during embryogenesis leading to reduced fertility in adults [381]. 
Moreover, Lin28 KO males have altered levels of FSH and testosterone [381]. In the 
same line, the embryonic overexpression of let-7 provoked a reduction of the germ cell 
pool [381] and Lin28 transgenic mice showed delayed puberty [378]. Moreover, it has 
been reported that conditional knockout models of Lin28 in adult germline stem cells 
showed reduced testis weight, sperm number and impaired spermatogonial cell 
proliferation without compromising their differentiation capacity [382]. 
At the initiation of this Thesis, little was known on the testicular roles of the 
Lin28/let-7 system as it relates to pubertal maturation and no studies existed about 
Lin28/Lin28b and let-7 distribution in rodent testis. Our results demonstrate that Lin28 
and Lin28b mRNAs are abundant in the rat and mouse testis and their profiles of 
expression along male gonadal maturation are roughly similar in both species. Thus, 
Lin28 and Lin28b mRNAs displayed low testicular expression during the neonatal 
period, and both markedly increased from the birth to the infantile period. However, 
while Lin28 mRNA levels showed a subsequent decreased from the infantile period to 
adulthood where levels were similar to the newborn, Lin28b mRNA levels remained 
high from infantile to adulthood. 
In order to extend our previous observations, IHC analyses to determine 
protein distribution of Lin28 and Lin28b in adult mouse testis were carried out. Our 
data demonstrated that Lin28 and Lin28b proteins, as evaluated by IHC in mouse 
testes, display totally different distribution expression protein patterns. Thus, they did 
not show overlapping in terms of tissue compartments (germ cells vs. interstitial cells), 
stages and cell types within the seminiferous epithelium (spermatogonia vs 
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spermatids), and even preferential intracellular location (cytoplasmic vs nuclear). 
Notably, regarding Lin28, our analyses detected this factor in all type-A spermatogonia, 
which is in partial contrast with previous findings that suggested that Lin28 is restricted 
to undifferentiated (As-Aal) spermatogonia and absent in differentiating (with the 
exeption of A1) spermatogonia [379]. 
Overall, our findings reinforce the view that Lin28 and Lin28b are likely to 
conduct different  roles in the regulation of male gametogenesis and gonadal function 
during postnatal maturation in rodents. Admittedly, due to technical limitations with 
the available antibodies, our IHC data are restricted to the mouse testes. Nonetheless, 
considering that Lin28 and Lin28b mRNA expression profile along postnatal maturation 
in rats and mice is identical, we consider tenable that Lin28 and Lin28b protein 
distribution in the rat testis is the same that in mouse. Hence, in adult rat testis Lin28 
protein would be expressed in undifferentiated and type-A spermatogonia, whereas 
Lin28b protein would be expressed in spermatids and Leydig cells. 
 
Figure 64. Schematic representation comparing the expression of Lin28b protein in mouse germ cells 
[410] and let-7b and miR-145 microRNAs in rat germ cells. 
 
In addition to IHC studies in mouse, we analysed by ISH analyses the expression 
patterns of one member of let-7 miRNA family, let-7b, and mir-145 in adult rat testis. 
Our data showed that the expression of let-7b was strong in pachytene spermatocytes 
and weaker in round spermatids from stage I to stage VII, whereas it disappeared in 
elongating spermatids. In addition,  let-7b was absent in the interstitial areas. The 
same expression pattern was detected for mir-145, with the exception that it was 
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strongly expressed also in smooth muscle cells in the interstitial blood vessels, in 
accordance with previous works [411, 412]. 
  As was mentioned in the introduction of this Thesis, numerous studies have 
demonstrated that Lin28/Lin28b represses the synthesis of mature let-7 miRNAs, 
which in turn are able to suppress Lin28 levels, therefore creating a double-negative 
feedback loop (see Figure 17). Taking into account the patterns of cellular distribution 
of let-7b observed and, if we assume that the cellular distribution of Lin28/Lin28b in 
testis is the same in the rat and mouse, the differences in this distribution could 
explain the partial lack of inverse correlation between some of the elements of this 
system studied in this Thesis. Nonetheless, it is significant that during neonatal period, 
when Lin28/Lin28b mRNA expression showed minimal levels, let-7, mir-132 and mir-
145 miRNAs expression was maximum, decreasing progressively thereafter. These 
results are coherent with previous studies showing that mir-145 suppresses c-Myc 
expression, resulting in reduced Lin28/Lin28b transcription and derepression of let-7 
family maturation. Moreover, in germ cells of the adult rat testis we could expect that 
expression of Lin28 is restricted to spermatogonias, where Lin28b and let-7b and mir-
145 expression is absent. When Lin28 expression disappears in spermatocytes, strong 
expression of both let-7b and mir-145 was detected. Thus, both signals showed weak 
expression in round spermatids from stage I to stage VII and no expression was 
detected in elongating spermatids from stage VIII onwards when Lin28b expression 
appear. 
In order to provide further evidence for a role of the Lin28/let-7 system in the 
testis development and sexual maturation, we conducted a series of expression 
analyses using various models of perturbed puberty in rats and mice.  
Neonatally estrogenized rats, in which their puberty was altered, showed 
decreased testicular Lin28 and Lin28b mRNA levels, while let-7a, let-7b and mir-145 
miRNAs expression levels were enhanced. It is known that these rats present 
alterations in cellular composition of testes, i.e. spermatogenic arrest with 
degenerating germ cells and delayed maturation of Sertoli and Leydig cells. Based on 
this, we can suggest that the latter expression changes could be attributable, at least 
partially, to impaired development of testicular cell types expressing these genes after 
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neonatal estrogenization. Likewise the decrease observed in Lin28b mRNA expression 
levels in rats with delayed puberty caused by early undernutrition and manipulation of 
the photoperiodic conditions, also would be a consequence of alterations in cellular 
composition, probably by a decrease in the number of spermatides.  
In order to further analyse gonadotropin regulation of testicular Lin28/let-7 
system, HPX rats with or without gonadotropin replacement were used. Our data 
showed that deprivation of pituitary hormones enhanced Lin28 mRNA expression 
levels but replacement with human hCG or FSH, completely restored the Lin28 mRNA 
expression and the combined use of FSH and hCG had synergic effects. However 
Lin28b mRNA expression levels diminished considerably by HPX but hormonal 
replacement did not restore this levels. Anyhow, a minor increase after treatment with 
FSH alone or in combination with hG was deteted. Regarding the differet miRNA 
expression levels, it was detected that let-7a, let-7b and mir-145 remained unchange 
by HPX. However, expression levels increased after the FSH and hCG replacement and, 
this increased was marked, after the combined use of both hormones. On the other 
hand, mir-132 miRNA levels diminished in animals HXP compared with intact rats, and 
their expression levels increased significantly, with higher values to those of control 
rats, after treatment with FSH or hCG. The combined administration of both hormones 
caused additive effects on mir-132 miRNA expression.   
In the normal adult rat testis there is a complex interaction between Leydig 
Sertoli and germ cells. Leydig cells drive spermatogenesis since LH stimulates the 
Leydig cells to secrete testosterone, which acts on the Sertoli cells to produce an 
environment which enables normal growth and division of the testicular germinal cells. 
In turn, FSH stimulates Sertoli cells; without this stimulation, the conversion of the 
spermatids to sperm would not occur. In rats, long-term HPX provokes atrophy of all 
testicular compartments [413, 414]. The alterations in Leydig cells and germ cells 
together with the partial recovery of these cells after treatment with hCG and/or FSH, 
as well as the differential pattern of cellular expression of Lin28, Lin28b and miRNAs 
studied would explain the results observed for Lin28/let-7 system in HPX rats.  
Our analyses in Gpr54 KO mice, as model of impuberism and hypogonadotropic 
hypogonadism, due to the lack of kisspeptin signaling and, hence, low gonadotropin 
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levels, further supported our findings in control mouse testes. In line with the obvious 
hypogonadotropism of Gpr54 null mice, these animals failed to show the prototypical 
increase in tubular diameter during pubertal maturation, suffered spermatogenic 
arrest and lacked mature Leydig cells in the testicular interstitium, as was previously 
described by our group [65]. 
Regarding Lin28 mRNA and protein expression, it was clearly detectable in the 
testes of Gpr54 KO mice, where Lin28-IR was observed in undifferentiated and type A 
spermatogonia, whose appearance and maintenance seem to be independent of 
gonadotropic stimulation. This latter was further supported by the fact that the 
pattern of cellular expression of Lin28 in Gpr54 KO testes did not change substantially 
after the FSH or hCG replacement for one week. In clear contrast, Lin28b-IR was 
undetectable, and its absolute mRNA levels dropped markedly in Gpr54 KO mouse 
testes, likely reflecting the lack of mature Leydig cells and spermatids in this model, 
hence suggesting that testicular expression of Lin28b is gonadotropin-dependent. In 
fact, gonadotropin administration to Gpr54 null mice rescued such defective 
expression. Thus, hCG treatment induced the appearance of strong Lin28b 
immunostaining, coincident with the appearance of hyperthropic Leydig cells and 
elongating spermatids, whereas the effects of FSH replacement were less robust, with 
Lin28b-IR being detected only in round spermatids. 
The comparison between the testicular expression profiles of Lin28 and let-7 
transcripts in WT and Gpr54 KO (see Figure 61) reveals clear similarities with changes 
associated to the maturational transition between the infantile and young adult 
periods (see Figure 54), as both Gpr54 KO and immature testes displayed markedly 
elevated Lin28, let-7b and, to a lesser extent, let-7a levels than control adult values, 
whereas the relative Lin28b mRNA levels were not significantly different. These 
observations provide a molecular mark for the state of testicular immaturity of Gpr54 
null mice and help to dissect out the gonadotropin-dependent vs independent 
regulation of Lin28 and let-7 expression in the testis.  
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 6. CONCLUSIONS 
In the present Thesis we set out: 1) to investigate the role α-MSH signaling in 
the control of puberty onset, as well as to characterize its potential interaction with 
leptin and kisspeptin pathway; and 2) to characterize the hypothalamic and testicular 
profiles of expression of the Lin28/let-7 system during pubertal maturation and to 
study the changes in their expression patterns in preclinical models of altered puberty. 
The main conclusions of our studies are the following: 
 Central activation of α-MSH signaling stimulates LH responses (as surrogate 
marker of GnRH secretion) in peripubertal, but not in infantile rats; this 
stimulatory action is conducted preferently via MC4-R. 
 Central inactivation of melanocortin signaling during the pubertal transition 
disrupts the normal timing of puberty, suppresses Kiss1 expression in the ARC 
and blocks the permissive effects of leptin on puberty onset.  
 The stimulatory actions of α-MSH on LH secretion at puberty are, to a large 
extent, dependent on preserved kisspeptin signaling, while kisspeptin effects 
on LH are independent of central melanocortin signaling. These findings, 
together with the expression and pharmacological data summarized above, are 
suggestive of a leptin-MSHKiss1 pathway with a relevant role in the 
(metabolic) control of puberty 
 During prepubertal maturation, there is marked decline in hypothalamic c-
Myc/Lin28/Lin28b expression coupled to significant increases in let-7, mir-145 
and mir-132 miRNA levels; these changes do not occur at other brain sites, such 
as the cortex. The above trends in hypothalamic expression are perturbed in 
situations of delayed/disrupted puberty, due to either neonatal exposure to sex 
steroids or infantile exposure to constant darkness, suggesting that the inverse 
changes in hypothalamic expression of the above elements of the Lin28/let-7 
system may be permissive for and/or drive the onset of puberty. 
 Lin28 and Lin28b display clearly distinct patterns of RNA expression and cellular 
distribution in rodent testes, suggesting specific, non-redundant functions of 
each Lin28 RNA-binding protein in the control of testicular development and/or 
function.  
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 Inverse changes in Lin28b and let-7a/let7-b expression are detected in rodent 
testes along postnatal maturation, but these are opposite to those observed in 
the hypothalamus, with increases in Lin28b mRNA and decreases in let-7a/let7-
b miRNA levels. The testicular expression levels of these (and related) targets 
are perturbed in rat and mouse models of altered puberty and under the 
regulation of pituitary gonadotropins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REFERENCES 
 
 
  
 
 
 
 
 
 
 
  
 
References 
 
 
 
155 
 
7. REFERENCES 
1. Carel, J.C., et al., Consensus statement on the use of gonadotropin-releasing 
hormone analogs in children. Pediatrics, 2009. 123(4): p. e752-62. 
2. A Guyton, H.J., M. R., Tratado de Fisiología Médica. Duodécima Ed McGraw-HIll, 
Interamericana de España, Madrid, 2010. 
3. FInk, G., Neuroendocrinology in Physiology and Medicine. Humana Press, 
Totowa, New Jersey: p. 107-134. 
4. Tena-Sempere, M.a.H., I., Gonadotropins and gonadotropin receptors. In 
Fauser, BCJM, editor Reproductive medicine: molecular, cellular and genetic 
fundamentals New York: , 2003. Parthenon Publishing: p. 225–244. 
5. Schwartz, N.B., Neuroendocrinology in physiology and medicine. Humana Press, 
2000. Ch. 8 ( eds Conn, P. M. & Freeman, M. E): p. 135–146. 
6. Amat-Munóz., P., Anatomía Humana Funcional y Aplicativa. 1991, Espaxs S.A.: 
Barcelona. p. 1448-1474. 
7. Everitt BJ, H.T., Neuroendocrine anatomy of the hypothalamus. In 
Neuroendocrinology. Oxford, 1986. 
8. Hoffman GE, P.C., Khachaturian H, Sladek JR., Neuroendocrine projections to the 
median eminence. In Morphology of hypothalamus and its connections. New 
York, Springer Verlag, 1981. 
9. Liposits, Z., et al., Synaptic communication between somatostatinergic axons 
and growth hormone-releasing factor (GRF) synthesizing neurons in the arcuate 
nucleus of the rat. Histochemistry, 1988. 89(3): p. 247-52. 
10. Schally, A.V., et al., Gonadotropin-releasing hormone: one polypeptide 
regulates secretion of luteinizing and follicle-stimulating hormones. Science, 
1971. 173(4001): p. 1036-8. 
11. Burgus, R., et al., Primary structure of the ovine hypothalamic luteinizing 
hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-
mass spectrometry-decapeptide-Edman degradation). Proc Natl Acad Sci U S A, 
1972. 69(1): p. 278-82. 
12. Millar, R.P., et al., Gonadotropin-releasing hormone receptors. Endocr Rev, 
2004. 25(2): p. 235-75. 
13. Okubo, K. and Y. Nagahama, Structural and functional evolution of 
gonadotropin-releasing hormone in vertebrates. Acta Physiol (Oxf), 2008. 
193(1): p. 3-15. 
14. Kauffman, A.S. and E.F. Rissman, A critical role for the evolutionarily conserved 
gonadotropin-releasing hormone II: mediation of energy status and female 
sexual behavior. Endocrinology, 2004. 145(8): p. 3639-46. 
15. Gonzalez-Martinez, D., et al., Immunohistochemical localization of three 
different prepro-GnRHs in the brain and pituitary of the European sea bass 
(Dicentrarchus labrax) using antibodies to the corresponding GnRH-associated 
peptides. J Comp Neurol, 2002. 446(2): p. 95-113. 
16. Witkin, J.W., Access of luteinizing hormone-releasing hormone neurons to the 
vasculature in the rat. Neuroscience, 1990. 37(2): p. 501-6. 
References 
156 
 
17. Smith, J.T., et al., Variation in kisspeptin and RFamide-related peptide (RFRP) 
expression and terminal connections to gonadotropin-releasing hormone 
neurons in the brain: a novel medium for seasonal breeding in the sheep. 
Endocrinology, 2008. 149(11): p. 5770-82. 
18. Seeburg, P.H., et al., The mammalian GnRH gene and its pivotal role in 
reproduction. Recent Prog Horm Res, 1987. 43: p. 69-98. 
19. Chan, Y.F., et al., Interpreter services in emergency medicine. J Emerg Med, 
2010. 38(2): p. 133-9. 
20. Karten, M.J. and J.E. Rivier, Gonadotropin-releasing hormone analog design. 
Structure-function studies toward the development of agonists and antagonists: 
rationale and perspective. Endocr Rev, 1986. 7(1): p. 44-66. 
21. Dutlow, C.M., et al., Prepubertal increases in gonadotropin-releasing hormone 
mRNA, gonadotropin-releasing hormone precursor, and subsequent maturation 
of precursor processing in male rats. J Clin Invest, 1992. 90(6): p. 2496-501. 
22. Millar, R.P., et al., Diversity of actions of GnRHs mediated by ligand-induced 
selective signaling. Front Neuroendocrinol, 2008. 29(1): p. 17-35. 
23. Millar, R.P., GnRHs and GnRH receptors. Anim Reprod Sci, 2005. 88(1-2): p. 5-
28. 
24. Childs, G., Functional ultraestructure of gonadotropes: a review. Morphology of 
hypothalamus and its connections, 1981: p. 47-97. 
25. Bonini, J.A., et al., Identification and characterization of two G protein-coupled 
receptors for neuropeptide FF. J Biol Chem, 2000. 275(50): p. 39324-31. 
26. Themmen, A.P.N. and I.T. Huhtaniemi, Mutations of gonadotropins and 
gonadotropin receptors: elucidating the physiology and pathophysiology of 
pituitary-gonadal function. Endocr Rev, 2000. 21(5): p. 551-83. 
27. Buzdar, A., et al., Phase III randomized trial of droloxifene and tamoxifen as 
first-line endocrine treatment of ER/PgR-positive advanced breast cancer. 
Breast Cancer Res Treat, 2002. 73(2): p. 161-75. 
28. Bo, M. and I. Boime, Identification of the transcriptionally active genes of the 
chorionic gonadotropin beta gene cluster in vivo. J Biol Chem, 1992. 267(5): p. 
3179-84. 
29. Ascoli, M., F. Fanelli, and D.L. Segaloff, The lutropin/choriogonadotropin 
receptor, a 2002 perspective. Endocr Rev, 2002. 23(2): p. 141-74. 
30. Szczypka, M.S., et al., Dopamine production in the caudate putamen restores 
feeding in dopamine-deficient mice. Neuron, 2001. 30(3): p. 819-28. 
31. Herrlich, A., et al., Involvement of Gs and Gi proteins in dual coupling of the 
luteinizing hormone receptor to adenylyl cyclase and phospholipase C. J Biol 
Chem, 1996. 271(28): p. 16764-72. 
32. Hsueh, A.J., M.L. Dufau, and K.J. Catt, Gonadotropin-induced regulation of 
luteinizing hormone receptors and desensitization of testicular 3':5'-cyclic AMP 
and testosterone responses. Proc Natl Acad Sci U S A, 1977. 74(2): p. 592-5. 
33. Bukovsky A, I.K., Fujiwara H, Cekanova M, Ayala ME, Dominguez R, Caudle MR, 
Wimalsena J, Elder RF, Copas P, Foster JS, Fernando RI, Henley DC, Upadhyaya 
NB, Multiple luteinizing hormone receptor (LHR) protein variants, interspecies 
reactivity of anti-LHR mAb clone 3B5, subcellular localization of LHR in human 
placenta, pelvic floor brain, and possible role for LHR in development of 
References 
 
 
 
157 
 
abnormal pregnancy, pelvic floor disorders and Alzheimer’s disease. Reprod. 
Biol. Endocrinology, 2003. 1: p. 46. 
34. Bowen RL, S.M., Harris PL, Kubat Z, Martins RN, Castellani RJ, Perry G, Atwood 
CS Elevated luteinizing hormone expression colocalizes with neurons vulnerable 
to Alzheimer's disease pathology. J Neurosci Res 
2002. 70: p. 514-‐518. 
35. Kerr, J.B., Functional cytology of the human testis. Baillieres Clin Endocrinol 
Metab, 1992. 6(2): p. 235-50. 
36. de Kretser, D.M. and J.B. Kerr, The cytology of the testis. In: Knobil E, Neil J 
editors. The Physiology of Reproduction. New York. p. p. 837-932. 
37. Morse, H.C., et al., Testosterone concentrations in testes of normal men: effects 
of testosterone propionate administration. J Clin Endocrinol Metab, 1973. 
37(6): p. 882-6. 
38. Hafez, E.S.E. and B. Hafez, Reproducción e Inseminación Artificial en animales. 
Séptima Edición.McGraw-Hill. 2000(Séptima Edición): p. p.40-44. 
39. Bardin, C.W., et al., The Sertoli cell. In: The Physiology of Reproduction. (E. 
Knobil, J. Neill et al., eds) Raven Press.New York. 1988: p. 933-974. 
40. Hansson, V., et al., Regulation of seminiferous tubular function by FSH and 
androgen. J Reprod Fertil, 1975. 44(2): p. 363-75. 
41. Fritz, I.B., Sites of action of androgens and folicle stimulating hormone on cells 
of the seminiferous tubule. En: Litwack G (ed) Biochemical Actions of 
Hormones. New York Academic Press, 1978: p. 249-271. 
42. Channing, C.P., T. Hillensjo, and F.W. Schaerf, Hormonal control of oocyte 
meiosis, ovulation and luteinization in mammals. Clin Endocrinol Metab, 1978. 
7(3): p. 601-24. 
43. McKinley and O'Loughlin, Human Anatomy, First Edition ed. McGraw-Hill 
Chapter 28: The Reproductive System. 2006. 
44. Sánchez-Criado, J.E., Fisiología del ovario. En: Fisiología Humana. Tresguerres 
JAF. (ed) Madrid, McGraw-Hilla/Interamericana, 1999: p. 1020-1032. 
45. Van Voorhis, B.J., Follicular development. En: Encyclopedia of Reproduction. 
Knobil E, Neil JD (eds) San Diego. Academic Press, 1998: p. 2:376-388. 
46. Tena-Sempere, M., E. Aguilar, and L. Pinilla, Fisiología del eje hipotálamo-
hipófiso-ovárico. En: Actualizaciones en Endocrinología. Gónadas. Diéguez C, 
Yturriaga R (eds) Madrid. McGraw-Hill/Interamericana, 2001: p. 21-42. 
47. Everett, J.W., C.H. Sawyer, and J.E. Markee, A neurogenic timing factor in 
control of the ovulatory discharge of luteinizing hormone in the cyclic rat. 
Endocrinology, 1949. 44(3): p. 234-50. 
48. Everett, J.W., Central Neural Control of Reproductive Functions of the 
Adenohypophysis. Physiol Rev, 1964. 44: p. 373-431. 
49. Curtis, H. and S.N. Barnes, Biología (6ª edición) Edit. Médica Panamericana. 
2000. 
50. Goldsmith, P.C. and K.K. Thind, Morphological basis for neuronal control of 
GnRH secretion in the monkey. En: Plant TM, Lee PA (eds) The Neurobiolgy of 
Puberty. Journal of Endocrinology Ltd, Bristol,UK, 1995: p. 73-85. 
References 
158 
 
51. Barnes, G.N. and J.T. Slevin, Ionotropic glutamate receptor biology: effect on 
synaptic connectivity and function in neurological disease. Curr Med Chem, 
2003. 10(20): p. 2059-72. 
52. Oswald, R.E., Ionotropic glutamate receptor recognition and activation. Adv 
Protein Chem, 2004. 68: p. 313-49. 
53. Iremonger, K.J., et al., Glutamate regulation of GnRH neuron excitability. Brain 
Res, 2010. 1364: p. 35-43. 
54. Kew, J.N. and J.A. Kemp, Ionotropic and metabotropic glutamate receptor 
structure and pharmacology. Psychopharmacology (Berl), 2005. 179(1): p. 4-29. 
55. Schoepp, D.D. and P.J. Conn, Metabotropic glutamate receptors. Pharmacol 
Biochem Behav, 2002. 74(1): p. 255-6. 
56. Brann, D.W. and V.B. Mahesh, Excitatory amino acids: evidence for a role in the 
control of reproduction and anterior pituitary hormone secretion. Endocr Rev, 
1997. 18(5): p. 678-700. 
57. Gore, A.C., Gonadotropin-releasing hormone neurons, NMDA receptors, and 
their regulation by steroid hormones across the reproductive life cycle. Brain 
Res Brain Res Rev, 2001. 37(1-3): p. 235-48. 
58. Ondo, J.G., K.A. Pass, and R. Baldwin, The effects of neurally active amino acids 
on pituitary gonadotropin secretion. Neuroendocrinology, 1976. 21(1): p. 79-87. 
59. Zanisi, M. and E. Messi, Sex steroids and the control of LHRH secretion. J Steroid 
Biochem Mol Biol, 1991. 40(1-3): p. 155-63. 
60. Ping, L., et al., Regulation of gonadotropin-releasing hormone and luteinizing 
hormone secretion by AMPA receptors. Evidence for a physiological role of 
AMPA receptors in the steroid-induced luteinizing hormone surge. 
Neuroendocrinology, 1997. 66(4): p. 246-53. 
61. Bourguignon, J.P., et al., Pulsatile release of gonadotropin-releasing hormone 
from hypothalamic explants is restrained by blockade of N-methyl-D,L-
aspartate receptors. Endocrinology, 1989. 125(2): p. 1090-6. 
62. Maffucci, J.A., et al., NMDA receptor subunit NR2b: effects on LH release and 
GnRH gene expression in young and middle-aged female rats, with modulation 
by estradiol. Neuroendocrinology, 2008. 87(3): p. 129-41. 
63. Iremonger KJ1, C.S., Liu X, Herbison AE., Glutamate regulation of GnRH neuron 
excitability. Brain research 2010. 10(1364): p. 35-43. 
64. Chakraborty, T.R., L. Ng, and A.C. Gore, Colocalization and hormone regulation 
of estrogen receptor alpha and N-methyl-D-aspartate receptor in the 
hypothalamus of female rats. Endocrinology, 2003. 144(1): p. 299-305. 
65. Garcia-Galiano, D., et al., Kisspeptin signaling is indispensable for neurokinin B, 
but not glutamate, stimulation of gonadotropin secretion in mice. 
Endocrinology, 2012. 153(1): p. 316-28. 
66. Wu, M., et al., Gonadotropin inhibitory hormone inhibits basal forebrain 
vGluT2-gonadotropin-releasing hormone neurons via a direct postsynaptic 
mechanism. J Physiol, 2009. 587(Pt 7): p. 1401-11. 
67. Page, N.M., New challenges in the study of the mammalian tachykinins. 
Peptides, 2005. 26(8): p. 1356-68. 
68. Sandoval-Guzman, T. and N.E. Rance, Central injection of senktide, an NK3 
receptor agonist, or neuropeptide Y inhibits LH secretion and induces different 
References 
 
 
 
159 
 
patterns of Fos expression in the rat hypothalamus. Brain Res, 2004. 1026(2): p. 
307-12. 
69. Goodman, R.L., et al., Kisspeptin neurons in the arcuate nucleus of the ewe 
express both dynorphin A and neurokinin B. Endocrinology, 2007. 148(12): p. 
5752-60. 
70. Navarro, V.M., et al., Regulation of gonadotropin-releasing hormone secretion 
by kisspeptin/dynorphin/neurokinin B neurons in the arcuate nucleus of the 
mouse. J Neurosci, 2009. 29(38): p. 11859-66. 
71. Krajewski, S.J., et al., Morphologic evidence that neurokinin B modulates 
gonadotropin-releasing hormone secretion via neurokinin 3 receptors in the rat 
median eminence. J Comp Neurol, 2005. 489(3): p. 372-86. 
72. Amstalden, M., et al., Neurokinin 3 receptor immunoreactivity in the septal 
region, preoptic area and hypothalamus of the female sheep: colocalisation in 
neurokinin B cells of the arcuate nucleus but not in gonadotrophin-releasing 
hormone neurones. J Neuroendocrinol, 2010. 22(1): p. 1-12. 
73. Corander, M.P., et al., The effects of neurokinin B upon gonadotrophin release 
in male rodents. J Neuroendocrinol, 2010. 22(3): p. 181-7. 
74. Topaloglu, A.K., et al., TAC3 and TACR3 mutations in familial hypogonadotropic 
hypogonadism reveal a key role for Neurokinin B in the central control of 
reproduction. Nat Genet, 2009. 41(3): p. 354-8. 
75. Yang, J.J., et al., Uncovering novel reproductive defects in neurokinin B receptor 
null mice: closing the gap between mice and men. Endocrinology, 2012. 153(3): 
p. 1498-508. 
76. Noritake, K., et al., Involvement of neurokinin receptors in the control of 
pulsatile luteinizing hormone secretion in rats. J Reprod Dev, 2011. 57(3): p. 
409-15. 
77. Wynick, D., et al., Galanin regulates prolactin release and lactotroph 
proliferation. Proc Natl Acad Sci U S A, 1998. 95(21): p. 12671-6. 
78. Branchek, T.A., et al., Galanin receptor subtypes. Trends Pharmacol Sci, 2000. 
21(3): p. 109-17. 
79. Sahu, A., et al., Effects of neuropeptide Y, NPY analog (norleucine4-NPY), 
galanin and neuropeptide K on LH release in ovariectomized (ovx) and ovx 
estrogen, progesterone-treated rats. Peptides, 1987. 8(5): p. 921-6. 
80. Lopez, F.J. and A. Negro-Vilar, Galanin stimulates luteinizing hormone-releasing 
hormone secretion from arcuate nucleus-median eminence fragments in vitro: 
involvement of an alpha-adrenergic mechanism. Endocrinology, 1990. 127(5): 
p. 2431-6. 
81. Mitchell, V., et al., Evidence for expression of galanin receptor Gal-R1 mRNA in 
certain gonadotropin releasing hormone neurones of the rostral preoptic area. J 
Neuroendocrinol, 1999. 11(10): p. 805-12. 
82. Dufourny, L. and D.C. Skinner, Distribution of galanin receptor 1-
immunoreactive neurons in the ovine hypothalamus: colocalization with GnRH. 
Brain Res, 2005. 1054(1): p. 73-81. 
83. Cunningham, M.J., Galanin-like peptide as a link between metabolism and 
reproduction. J Neuroendocrinol, 2004. 16(8): p. 717-23. 
References 
160 
 
84. Jureus, A., et al., Distribution and regulation of galanin-like peptide (GALP) in 
the hypothalamus of the mouse. Endocrinology, 2001. 142(12): p. 5140-4. 
85. Matsumoto, H., et al., Stimulation effect of galanin-like peptide (GALP) on 
luteinizing hormone-releasing hormone-mediated luteinizing hormone (LH) 
secretion in male rats. Endocrinology, 2001. 142(8): p. 3693-6. 
86. Castellano, J.M., et al., Effects of galanin-like peptide on luteinizing hormone 
secretion in the rat: sexually dimorphic responses and enhanced sensitivity at 
male puberty. Am J Physiol Endocrinol Metab, 2006. 291(6): p. E1281-9. 
87. Dungan Lemko, H.M., et al., Altered response to metabolic challenges in mice 
with genetically targeted deletions of galanin-like peptide. Am J Physiol 
Endocrinol Metab, 2008. 295(3): p. E605-12. 
88. Gundlach, A.L., Galanin/GALP and galanin receptors: role in central control of 
feeding, body weight/obesity and reproduction? Eur J Pharmacol, 2002. 440(2-
3): p. 255-68. 
89. Gearing, M. and E. Terasawa, The alpha-1-adrenergic neuronal system is 
involved in the pulsatile release of luteinizing hormone-releasing hormone in 
the ovariectomized female rhesus monkey. Neuroendocrinology, 1991. 53(4): p. 
373-81. 
90. Smith, M.J. and L. Jennes, Neural signals that regulate GnRH neurones directly 
during the oestrous cycle. Reproduction, 2001. 122(1): p. 1-10. 
91. Lee, A., et al., Characterization of alpha 2A-adrenergic receptors in GT1 
neurosecretory cells. Neuroendocrinology, 1995. 62(3): p. 215-25. 
92. Gallo, R.V., A. Bona-Gallo, and D. O'Sullivan, Adrenergic and noradrenergic 
regulation of pulsatile luteinizing hormone release. J Neuroendocrinol, 1989. 
1(3): p. 157-62. 
93. Bellefontaine, N., et al., Nitric oxide as key mediator of neuron-to-neuron and 
endothelia-to-glia communication involved in the neuroendocrine control of 
reproduction. Neuroendocrinology, 2011. 93(2): p. 74-89. 
94. Clasadonte, J., et al., Activation of neuronal nitric oxide release inhibits 
spontaneous firing in adult gonadotropin-releasing hormone neurons: a 
possible local synchronizing signal. Endocrinology, 2008. 149(2): p. 587-96. 
95. Hanchate, N.K., et al., Kisspeptin-GPR54 signaling in mouse NO-synthesizing 
neurons participates in the hypothalamic control of ovulation. J Neurosci, 2012. 
32(3): p. 932-45. 
96. d'Anglemont de Tassigny, X., et al., Coupling of neuronal nitric oxide synthase to 
NMDA receptors via postsynaptic density-95 depends on estrogen and 
contributes to the central control of adult female reproduction. J Neurosci, 
2007. 27(23): p. 6103-14. 
97. Bellefontaine, N., et al., Leptin-dependent neuronal NO signaling in the preoptic 
hypothalamus facilitates reproduction. J Clin Invest, 2014. 124(6): p. 2550-9. 
98. Thai, H., et al., Pretreatment with angiotensin receptor blockade prevents left 
ventricular dysfunction and blunts left ventricular remodeling associated with 
acute myocardial infarction. Circulation, 2006. 114(18): p. 1933-9. 
99. Kusano, K., et al., Electrical and synaptic properties of embryonic luteinizing 
hormone-releasing hormone neurons in explant cultures. Proc Natl Acad Sci U S 
A, 1995. 92(9): p. 3918-22. 
References 
 
 
 
161 
 
100. Han, S.K., I.M. Abraham, and A.E. Herbison, Effect of GABA on GnRH neurons 
switches from depolarization to hyperpolarization at puberty in the female 
mouse. Endocrinology, 2002. 143(4): p. 1459-66. 
101. Martinez de la Escalera, G., A.L. Choi, and R.I. Weiner, Biphasic gabaergic 
regulation of GnRH secretion in GT1 cell lines. Neuroendocrinology, 1994. 59(5): 
p. 420-5. 
102. Herbison, A.E. and S.M. Moenter, Depolarising and hyperpolarising actions of 
GABA(A) receptor activation on gonadotrophin-releasing hormone neurones: 
towards an emerging consensus. J Neuroendocrinol, 2011. 23(7): p. 557-69. 
103. Gallo, R.V., Kappa-opioid receptor involvement in the regulation of pulsatile 
luteinizing hormone release during early pregnancy in the rat. J 
Neuroendocrinol, 1990. 2(5): p. 685-91. 
104. Panerai, A.E., et al., Mainly mu-opiate receptors are involved in luteinizing 
hormone and prolactin secretion. Endocrinology, 1985. 117(3): p. 1096-9. 
105. Goodman, R.L., et al., Evidence that dynorphin plays a major role in mediating 
progesterone negative feedback on gonadotropin-releasing hormone neurons in 
sheep. Endocrinology, 2004. 145(6): p. 2959-67. 
106. Sannella, M.I. and S.L. Petersen, Dual label in situ hybridization studies provide 
evidence that luteinizing hormone-releasing hormone neurons do not synthesize 
messenger ribonucleic acid for mu, kappa, or delta opiate receptors. 
Endocrinology, 1997. 138(4): p. 1667-72. 
107. Allen, Y.S., et al., Neuropeptide Y distribution in the rat brain. Science, 1983. 
221(4613): p. 877-9. 
108. Campbell, R.E., et al., Hypothalamic circuitry of neuropeptide Y regulation of 
neuroendocrine function and food intake via the Y5 receptor subtype. 
Neuroendocrinology, 2001. 74(2): p. 106-19. 
109. Raposinho, P.D., et al., Evidence that the inhibition of luteinizing hormone 
secretion exerted by central administration of neuropeptide Y (NPY) in the rat is 
predominantly mediated by the NPY-Y5 receptor subtype. Endocrinology, 1999. 
140(9): p. 4046-55. 
110. Li, C., P. Chen, and M.S. Smith, Morphological evidence for direct interaction 
between arcuate nucleus neuropeptide Y (NPY) neurons and gonadotropin-
releasing hormone neurons and the possible involvement of NPY Y1 receptors. 
Endocrinology, 1999. 140(11): p. 5382-90. 
111. El Majdoubi, M., et al., Neuropeptide Y: A hypothalamic brake restraining the 
onset of puberty in primates. Proc Natl Acad Sci U S A, 2000. 97(11): p. 6179-84. 
112. Pralong, F.P., et al., Acceleration of pubertal development following central 
blockade of the Y1 subtype of neuropeptide Y receptors. Regul Pept, 2000. 95(1-
3): p. 47-52. 
113. Gonzales, C., et al., The neuropeptide Y Y1 receptor mediates NPY-induced 
inhibition of the gonadotrope axis under poor metabolic conditions. FASEB J, 
2004. 18(1): p. 137-9. 
114. Pierroz, D.D., et al., Chronic administration of neuropeptide Y into the lateral 
ventricle inhibits both the pituitary-testicular axis and growth hormone and 
insulin-like growth factor I secretion in intact adult male rats. Endocrinology, 
1996. 137(1): p. 3-12. 
References 
162 
 
115. Kaynard, A.H., et al., Third-ventricular infusion of neuropeptide Y suppresses 
luteinizing hormone secretion in ovariectomized rhesus macaques. 
Endocrinology, 1990. 127(5): p. 2437-44. 
116. McDonald, J.K., M.D. Lumpkin, and L.V. DePaolo, Neuropeptide-Y suppresses 
pulsatile secretion of luteinizing hormone in ovariectomized rats: possible site of 
action. Endocrinology, 1989. 125(1): p. 186-91. 
117. Minami, S. and D.K. Sarkar, Central administration of neuropeptide Y induces 
precocious puberty in female rats. Neuroendocrinology, 1992. 56(6): p. 930-4. 
118. Kalra, S.P. and W.R. Crowley, Norepinephrine-like effects of neuropeptide Y on 
LH release in the rat. Life Sci, 1984. 35(11): p. 1173-6. 
119. Waldhauser, F., et al., Fall in nocturnal serum melatonin during prepuberty and 
pubescence. Lancet, 1984. 1(8373): p. 362-5. 
120. Tsutsui, K., et al., A novel avian hypothalamic peptide inhibiting gonadotropin 
release. Biochem Biophys Res Commun, 2000. 275(2): p. 661-7. 
121. Yoshida, H., et al., Molecular properties of endogenous RFamide-related 
peptide-3 and its interaction with receptors. Biochim Biophys Acta, 2003. 
1593(2-3): p. 151-7. 
122. Clarke, I.J., et al., Potent action of RFamide-related peptide-3 on pituitary 
gonadotropes indicative of a hypophysiotropic role in the negative regulation of 
gonadotropin secretion. Endocrinology, 2008. 149(11): p. 5811-21. 
123. Bentley, G.E., K. Tsutsui, and L.J. Kriegsfeld, Recent studies of gonadotropin-
inhibitory hormone (GnIH) in the mammalian hypothalamus, pituitary and 
gonads. Brain Res, 2010. 1364: p. 62-71. 
124. Kriegsfeld, L.J., et al., Identification and characterization of a gonadotropin-
inhibitory system in the brains of mammals. Proc Natl Acad Sci U S A, 2006. 
103(7): p. 2410-5. 
125. Johnson, M.A., K. Tsutsui, and G.S. Fraley, Rat RFamide-related peptide-3 
stimulates GH secretion, inhibits LH secretion, and has variable effects on sex 
behavior in the adult male rat. Horm Behav, 2007. 51(1): p. 171-80. 
126. Pineda, R., et al., Characterization of the potent gonadotropin-releasing activity 
of RF9, a selective antagonist of RF-amide-related peptides and neuropeptide FF 
receptors: physiological and pharmacological implications. Endocrinology, 
2010. 151(4): p. 1902-13. 
127. Liu, X. and A.E. Herbison, RF9 Excitation of GnRH Neurons Is Dependent Upon 
Kiss1r in the Adult Male and Female Mouse. Endocrinology, 2014. 155(12): p. 
4915-24. 
128. Maeda, K., et al., Neurobiological mechanisms underlying GnRH pulse 
generation by the hypothalamus. Brain Res, 2010. 1364: p. 103-15. 
129. Herbison, A.E. and J.R. Pape, New evidence for estrogen receptors in 
gonadotropin-releasing hormone neurons. Front Neuroendocrinol, 2001. 22(4): 
p. 292-308. 
130. Young, W.C., R.W. Goy, and C.H. Phoenix, Hormones and Sexual Behavior. 
Science, 1964. 143(3603): p. 212-8. 
131. Mitra, S.W., et al., Immunolocalization of estrogen receptor beta in the mouse 
brain: comparison with estrogen receptor alpha. Endocrinology, 2003. 144(5): 
p. 2055-67. 
References 
 
 
 
163 
 
132. Nadal, A., M. Diaz, and M.A. Valverde, The estrogen trinity: membrane, 
cytosolic, and nuclear effects. News Physiol Sci, 2001. 16: p. 251-5. 
133. Smith, S.S., C. Aoki, and H. Shen, Puberty, steroids and GABA(A) receptor 
plasticity. Psychoneuroendocrinology, 2009. 34 Suppl 1: p. S91-S103. 
134. Adachi, S., et al., Involvement of anteroventral periventricular 
metastin/kisspeptin neurons in estrogen positive feedback action on luteinizing 
hormone release in female rats. J Reprod Dev, 2007. 53(2): p. 367-78. 
135. Smith, J.T., et al., Differential regulation of KiSS-1 mRNA expression by sex 
steroids in the brain of the male mouse. Endocrinology, 2005. 146(7): p. 2976-
84. 
136. Christian, C.A., et al., Classical estrogen receptor alpha signaling mediates 
negative and positive feedback on gonadotropin-releasing hormone neuron 
firing. Endocrinology, 2008. 149(11): p. 5328-34. 
137. Wintermantel, T.M., et al., Definition of estrogen receptor pathway critical for 
estrogen positive feedback to gonadotropin-releasing hormone neurons and 
fertility. Neuron, 2006. 52(2): p. 271-80. 
138. Robertson, D.M., et al., Isolation of inhibin from bovine follicular fluid. Biochem 
Biophys Res Commun, 1985. 126(1): p. 220-6. 
139. Tilbrook, A.J., D.M. de Kretser, and I.J. Clarke, Influence of the degree of 
stimulation of the pituitary by gonadotropin-releasing hormone on the action of 
inhibin and testosterone to suppress the secretion of the gonadotropins in rams. 
Biol Reprod, 2001. 64(2): p. 473-81. 
140. Corrigan, A.Z., et al., Evidence for an autocrine role of activin B within rat 
anterior pituitary cultures. Endocrinology, 1991. 128(3): p. 1682-4. 
141. Nakamura, Y., et al., Enamel matrix derivative promotes reparative processes in 
the dental pulp. Adv Dent Res, 2001. 15: p. 105-7. 
142. Nakamura, T., et al., Activin-binding protein from rat ovary is follistatin. Science, 
1990. 247(4944): p. 836-8. 
143. Gospodarowicz, D. and K. Lau, Pituitary follicular cells secrete both vascular 
endothelial growth factor and follistatin. Biochem Biophys Res Commun, 1989. 
165(1): p. 292-8. 
144. Ruiz, M., et al., Influence of thyroidectomy on serum and pituitary FSH in control 
and orchidectomized rats. Res Exp Med (Berl), 1989. 189(2): p. 85-90. 
145. Grumbach, M.M., The neuroendocrinology of human puberty revisited. Horm 
Res, 2002. 57 Suppl 2: p. 2-14. 
146. Ojeda, S.R. and M.K. Skinner, Puberty in the rat. In: The physiology of 
reproduction. Neill JD (ed). Academic, San Diego. p. 2061–2126, 2006. 2005. 
147. Ojeda, S.R., et al., Minireview: the neuroendocrine regulation of puberty: is the 
time ripe for a systems biology approach? Endocrinology, 2006. 147(3): p. 1166-
74. 
148. Ojeda, S.R., et al., Glia-to-neuron signaling and the neuroendocrine control of 
female puberty. Ann Med, 2003. 35(4): p. 244-55. 
149. Terasawa, E. and D.L. Fernandez, Neurobiological mechanisms of the onset of 
puberty in primates. Endocr Rev, 2001. 22(1): p. 111-51. 
150. Ojeda, S. and H. Urbanski, Puberty in the rat. En: Knobil E, Neil JD,editors. The 
Physiology of Reproduction. New York, 1994: p. p. 363-410. 
References 
164 
 
151. Navarro, V.M., et al., Advanced vaginal opening and precocious activation of 
the reproductive axis by KiSS-1 peptide, the endogenous ligand of GPR54. J 
Physiol, 2004. 561(Pt 2): p. 379-86. 
152. Ducret, E., G.M. Anderson, and A.E. Herbison, RFamide-related peptide-3, a 
mammalian gonadotropin-inhibitory hormone ortholog, regulates 
gonadotropin-releasing hormone neuron firing in the mouse. Endocrinology, 
2009. 150(6): p. 2799-804. 
153. Leon, S., et al., Physiological Roles of Gonadotropin-Inhibitory Hormone 
Signaling in the Control of Mammalian Reproductive Axis: Studies in the NPFF1 
Receptor Null Mouse. Endocrinology, 2014: p. en20141030. 
154. Ojeda, S.R., et al., Glia-to-neuron signaling and the neuroendocrine control of 
female puberty. Recent Prog Horm Res, 2000. 55: p. 197-223; discussion 223-4. 
155. Prevot, V., et al., Median eminence nitric oxide signaling. Brain Res Brain Res 
Rev, 2000. 34(1-2): p. 27-41. 
156. Knauf, C., et al., Variation of endothelial nitric oxide synthase synthesis in the 
median eminence during the rat estrous cycle: an additional argument for the 
implication of vascular blood vessel in the control of GnRH release. 
Endocrinology, 2001. 142(10): p. 4288-94. 
157. Prevot, V., Glial-neuronal-endothelial interactions are involved in the control of 
GnRH secretion. J Neuroendocrinol, 2002. 14(3): p. 247-55. 
158. Seminara, S.B. and W.F. Crowley, Jr., Perspective: the importance of genetic 
defects in humans in elucidating the complexities of the hypothalamic-pituitary-
gonadal axis. Endocrinology, 2001. 142(6): p. 2173-7. 
159. Roth, C.L., et al., Expression of a tumor-related gene network increases in the 
mammalian hypothalamus at the time of female puberty. Endocrinology, 2007. 
148(11): p. 5147-61. 
160. Ojeda, S.R., et al., Gene networks and the neuroendocrine regulation of puberty. 
Mol Cell Endocrinol, 2010. 324(1-2): p. 3-11. 
161. Lomniczi, A., et al., Epigenetic control of female puberty. Nat Neurosci, 2013. 
16(3): p. 281-9. 
162. Chekulaeva, M. and W. Filipowicz, Mechanisms of miRNA-mediated post-
transcriptional regulation in animal cells. Curr Opin Cell Biol, 2009. 21(3): p. 
452-60. 
163. Lynn, F.C., Meta-regulation: microRNA regulation of glucose and lipid 
metabolism. Trends Endocrinol Metab, 2009. 20(9): p. 452-9. 
164. He, C., et al., Genome-wide association studies identify loci associated with age 
at menarche and age at natural menopause. Nat Genet, 2009. 
165. Ong, K.K., et al., Genetic variation in LIN28B is associated with the timing of 
puberty. Nat Genet, 2009. 
166. Perry, J.R., et al., Meta-analysis of genome-wide association data identifies two 
loci influencing age at menarche. Nat Genet, 2009. 
167. Sulem, P., et al., Genome-wide association study identifies sequence variants on 
6q21 associated with age at menarche. Nat Genet, 2009. 
168. Viswanathan, S.R. and G.Q. Daley, Lin28: A microRNA regulator with a macro 
role. Cell, 2010. 140(4): p. 445-9. 
References 
 
 
 
165 
 
169. Schneider, J.E., Energy balance and reproduction. Physiol Behav, 2004. 81(2): p. 
289-317. 
170. Roa, J. and M. Tena-Sempere, Energy balance and puberty onset: emerging role 
of central mTOR signaling. Trends Endocrinol Metab, 2010. 21(9): p. 519-28. 
171. Kotani, M., et al., The metastasis suppressor gene KiSS-1 encodes kisspeptins, 
the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol 
Chem, 2001. 276(37): p. 34631-6. 
172. Parent, A.S., et al., The timing of normal puberty and the age limits of sexual 
precocity: variations around the world, secular trends, and changes after 
migration. Endocr Rev, 2003. 24(5): p. 668-93. 
173. Albright, D.L., et al., Seasonal characteristics of and age at menarche. 
Chronobiol Int, 1990. 7(3): p. 251-8. 
174. Rasier, G., et al., Female sexual maturation and reproduction after prepubertal 
exposure to estrogens and endocrine disrupting chemicals: a review of rodent 
and human data. Mol Cell Endocrinol, 2006. 254-255: p. 187-201. 
175. Pinilla, L., et al., Kisspeptins and reproduction: physiological roles and regulatory 
mechanisms. Physiol Rev, 2012. 92(3): p. 1235-316. 
176. Roa, J., et al., New frontiers in kisspeptin/GPR54 physiology as fundamental 
gatekeepers of reproductive function. Front Neuroendocrinol, 2008. 29(1): p. 
48-69. 
177. Oakley, A.E., D.K. Clifton, and R.A. Steiner, Kisspeptin signaling in the brain. 
Endocr Rev, 2009. 30(6): p. 713-43. 
178. Lee, J.H., et al., KiSS-1, a novel human malignant melanoma metastasis-
suppressor gene. J Natl Cancer Inst, 1996. 88(23): p. 1731-7. 
179. Lee, D.K., et al., Discovery of a receptor related to the galanin receptors. FEBS 
Lett, 1999. 446(1): p. 103-7. 
180. Muir, A.I., et al., AXOR12, a novel human G protein-coupled receptor, activated 
by the peptide KiSS-1. J Biol Chem, 2001. 276(31): p. 28969-75. 
181. Ohtaki, T., et al., Metastasis suppressor gene KiSS-1 encodes peptide ligand of a 
G-protein-coupled receptor. Nature, 2001. 411(6837): p. 613-7. 
182. de Roux, N., et al., Hypogonadotropic hypogonadism due to loss of function of 
the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A, 2003. 
100(19): p. 10972-6. 
183. Seminara, S.B., et al., The GPR54 gene as a regulator of puberty. N Engl J Med, 
2003. 349(17): p. 1614-27. 
184. Colledge, W.H., Transgenic mouse models to study Gpr54/kisspeptin physiology. 
Peptides, 2009. 30(1): p. 34-41. 
185. Gould, D.J., et al., Setopress vs Elastocrepe in chronic venous ulceration. Br J 
Nurs, 1998. 7(2): p. 66-70, 72-3. 
186. d'Anglemont de Tassigny, X., et al., Hypogonadotropic hypogonadism in mice 
lacking a functional Kiss1 gene. Proc Natl Acad Sci U S A, 2007. 104(25): p. 
10714-9. 
187. Lapatto, R., et al., Kiss1-/- mice exhibit more variable hypogonadism than 
Gpr54-/- mice. Endocrinology, 2007. 148(10): p. 4927-36. 
References 
166 
 
188. Funes, S., et al., The KiSS-1 receptor GPR54 is essential for the development of 
the murine reproductive system. Biochem Biophys Res Commun, 2003. 312(4): 
p. 1357-63. 
189. Dungan, H.M., et al., The role of kisspeptin-GPR54 signaling in the tonic 
regulation and surge release of gonadotropin-releasing hormone/luteinizing 
hormone. J Neurosci, 2007. 27(44): p. 12088-95. 
190. Luan, X., et al., Association study of the polymorphisms in the KISS1 gene with 
central precocious puberty in Chinese girls. Eur J Endocrinol, 2007. 157(1): p. 
113-8. 
191. West, A., et al., Chromosome localization and genomic structure of the KiSS-1 
metastasis suppressor gene (KISS1). Genomics, 1998. 54(1): p. 145-8. 
192. d'Anglemont de Tassigny, X. and W.H. Colledge, The role of kisspeptin signaling 
in reproduction. Physiology (Bethesda), 2010. 25(4): p. 207-17. 
193. Terao, Y., et al., Expression of KiSS-1, a metastasis suppressor gene, in 
trophoblast giant cells of the rat placenta. Biochim Biophys Acta, 2004. 1678(2-
3): p. 102-10. 
194. Gutierrez-Pascual, E., et al., In vivo and in vitro structure-activity relationships 
and structural conformation of Kisspeptin-10-related peptides. Mol Pharmacol, 
2009. 76(1): p. 58-67. 
195. Clarkson, J., et al., Distribution of kisspeptin neurones in the adult female mouse 
brain. J Neuroendocrinol, 2009. 21(8): p. 673-82. 
196. Smith, J.T., et al., Regulation of Kiss1 gene expression in the brain of the female 
mouse. Endocrinology, 2005. 146(9): p. 3686-92. 
197. Ramaswamy, S., et al., Neurokinin B stimulates GnRH release in the male 
monkey (Macaca mulatta) and is colocalized with kisspeptin in the arcuate 
nucleus. Endocrinology, 2010. 151(9): p. 4494-503. 
198. Wakabayashi, Y., et al., Neurokinin B and dynorphin A in kisspeptin neurons of 
the arcuate nucleus participate in generation of periodic oscillation of neural 
activity driving pulsatile gonadotropin-releasing hormone secretion in the goat. 
J Neurosci, 2010. 30(8): p. 3124-32. 
199. Lehman, M.N., L.M. Coolen, and R.L. Goodman, Minireview: 
kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central 
node in the control of gonadotropin-releasing hormone secretion. 
Endocrinology, 2010. 151(8): p. 3479-89. 
200. Kauffman, A.S., et al., Sexual differentiation of Kiss1 gene expression in the 
brain of the rat. Endocrinology, 2007. 148(4): p. 1774-83. 
201. Clarkson, J. and A.E. Herbison, Postnatal development of kisspeptin neurons in 
mouse hypothalamus; sexual dimorphism and projections to gonadotropin-
releasing hormone neurons. Endocrinology, 2006. 147(12): p. 5817-25. 
202. Backholer, K., J. Smith, and I.J. Clarke, Melanocortins may stimulate 
reproduction by activating orexin neurons in the dorsomedial hypothalamus 
and kisspeptin neurons in the preoptic area of the ewe. Endocrinology, 2009. 
150(12): p. 5488-97. 
203. Yeo, S.H. and A.E. Herbison, Projections of arcuate nucleus and rostral 
periventricular kisspeptin neurons in the adult female mouse brain. 
Endocrinology, 2011. 152(6): p. 2387-99. 
References 
 
 
 
167 
 
204. Iijima, N., et al., An immunohistochemical study on the expressional dynamics of 
kisspeptin neurons relevant to GnRH neurons using a newly developed anti-
kisspeptin antibody. J Mol Neurosci, 2011. 43(2): p. 146-54. 
205. Richard, N., et al., KiSS-1 and GPR54 genes are co-expressed in rat 
gonadotrophs and differentially regulated in vivo by oestradiol and 
gonadotrophin-releasing hormone. J Neuroendocrinol, 2008. 20(3): p. 381-93. 
206. Herbison, A.E., et al., Distribution and postnatal development of Gpr54 gene 
expression in mouse brain and gonadotropin-releasing hormone neurons. 
Endocrinology, 2010. 151(1): p. 312-21. 
207. Castellano, J.M., et al., Ontogeny and mechanisms of action for the stimulatory 
effect of kisspeptin on gonadotropin-releasing hormone system of the rat. Mol 
Cell Endocrinol, 2006. 257-258: p. 75-83. 
208. Liu, X., K. Lee, and A.E. Herbison, Kisspeptin excites gonadotropin-releasing 
hormone neurons through a phospholipase C/calcium-dependent pathway 
regulating multiple ion channels. Endocrinology, 2008. 149(9): p. 4605-14. 
209. Thompson, E.L., et al., Central and peripheral administration of kisspeptin-10 
stimulates the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol, 2004. 
16(10): p. 850-8. 
210. Gottsch, M.L., et al., A role for kisspeptins in the regulation of gonadotropin 
secretion in the mouse. Endocrinology, 2004. 145(9): p. 4073-7. 
211. Matsui, H., et al., Peripheral administration of metastin induces marked 
gonadotropin release and ovulation in the rat. Biochem Biophys Res Commun, 
2004. 320(2): p. 383-8. 
212. Navarro, V.M., et al., Developmental and hormonally regulated messenger 
ribonucleic acid expression of KiSS-1 and its putative receptor, GPR54, in rat 
hypothalamus and potent luteinizing hormone-releasing activity of KiSS-1 
peptide. Endocrinology, 2004. 145(10): p. 4565-74. 
213. Han, S.K., et al., Activation of gonadotropin-releasing hormone neurons by 
kisspeptin as a neuroendocrine switch for the onset of puberty. J Neurosci, 
2005. 25(49): p. 11349-56. 
214. Navarro, V.M., et al., Effects of KiSS-1 peptide, the natural ligand of GPR54, on 
follicle-stimulating hormone secretion in the rat. Endocrinology, 2005. 146(4): 
p. 1689-97. 
215. Dhillo, W.S., et al., Kisspeptin-54 stimulates gonadotropin release most potently 
during the preovulatory phase of the menstrual cycle in women. J Clin 
Endocrinol Metab, 2007. 92(10): p. 3958-66. 
216. Plant, T.M., S. Ramaswamy, and M.J. Dipietro, Repetitive activation of 
hypothalamic G protein-coupled receptor 54 with intravenous pulses of 
kisspeptin in the juvenile monkey (Macaca mulatta) elicits a sustained train of 
gonadotropin-releasing hormone discharges. Endocrinology, 2006. 147(2): p. 
1007-13. 
217. Irwig, M.S., et al., Kisspeptin activation of gonadotropin releasing hormone 
neurons and regulation of KiSS-1 mRNA in the male rat. Neuroendocrinology, 
2004. 80(4): p. 264-72. 
References 
168 
 
218. Patterson, M., et al., Administration of kisspeptin-54 into discrete regions of the 
hypothalamus potently increases plasma luteinising hormone and testosterone 
in male adult rats. J Neuroendocrinol, 2006. 18(5): p. 349-54. 
219. Navarro, V.M., et al., Characterization of the potent luteinizing hormone-
releasing activity of KiSS-1 peptide, the natural ligand of GPR54. Endocrinology, 
2005. 146(1): p. 156-63. 
220. McCann, S.M., et al., Hypothalamic control of gonadotropin secretion. Prog 
Brain Res, 2002. 141: p. 151-64. 
221. de Kretser, D.M., et al., Inhibins, activins and follistatin in reproduction. Hum 
Reprod Update, 2002. 8(6): p. 529-41. 
222. Seminara, S.B., et al., Continuous human metastin 45-54 infusion desensitizes G 
protein-coupled receptor 54-induced gonadotropin-releasing hormone release 
monitored indirectly in the juvenile male Rhesus monkey (Macaca mulatta): a 
finding with therapeutic implications. Endocrinology, 2006. 147(5): p. 2122-6. 
223. Roa, J., et al., Desensitization of gonadotropin responses to kisspeptin in the 
female rat: analyses of LH and FSH secretion at different developmental and 
metabolic states. Am J Physiol Endocrinol Metab, 2008. 294(6): p. E1088-96. 
224. Novaira, H.J., et al., Kisspeptin increases GnRH mRNA expression and secretion 
in GnRH secreting neuronal cell lines. Mol Cell Endocrinol, 2009. 311(1-2): p. 
126-34. 
225. Li, X.F., et al., Kisspeptin signalling in the hypothalamic arcuate nucleus 
regulates GnRH pulse generator frequency in the rat. PLoS One, 2009. 4(12): p. 
e8334. 
226. Takase, K., et al., Possible role of oestrogen in pubertal increase of 
Kiss1/kisspeptin expression in discrete hypothalamic areas of female rats. J 
Neuroendocrinol, 2009. 21(6): p. 527-37. 
227. Rometo, A.M., et al., Hypertrophy and increased kisspeptin gene expression in 
the hypothalamic infundibular nucleus of postmenopausal women and 
ovariectomized monkeys. J Clin Endocrinol Metab, 2007. 92(7): p. 2744-50. 
228. Smith, J.T., et al., KiSS-1 messenger ribonucleic acid expression in the 
hypothalamus of the ewe is regulated by sex steroids and season. 
Endocrinology, 2007. 148(3): p. 1150-7. 
229. Tomikawa, J., et al., Molecular characterization and estrogen regulation of 
hypothalamic KISS1 gene in the pig. Biol Reprod, 2010. 82(2): p. 313-9. 
230. Burke, M.C., et al., Coexpression of dynorphin and neurokinin B 
immunoreactivity in the rat hypothalamus: Morphologic evidence of 
interrelated function within the arcuate nucleus. J Comp Neurol, 2006. 498(5): 
p. 712-26. 
231. Mayer, C., et al., Timing and completion of puberty in female mice depend on 
estrogen receptor alpha-signaling in kisspeptin neurons. Proc Natl Acad Sci U S 
A, 2010. 107(52): p. 22693-8. 
232. Smith, J.T., et al., Kiss1 neurons in the forebrain as central processors for 
generating the preovulatory luteinizing hormone surge. J Neurosci, 2006. 
26(25): p. 6687-94. 
233. Roa, J., et al., Opposite roles of estrogen receptor (ER)-alpha and ERbeta in the 
modulation of luteinizing hormone responses to kisspeptin in the female rat: 
References 
 
 
 
169 
 
implications for the generation of the preovulatory surge. Endocrinology, 2008. 
149(4): p. 1627-37. 
234. Ojeda, S.R., A. Lomniczi, and U.S. Sandau, Glial-gonadotrophin hormone (GnRH) 
neurone interactions in the median eminence and the control of GnRH 
secretion. J Neuroendocrinol, 2008. 20(6): p. 732-42. 
235. Shahab, M., et al., Increased hypothalamic GPR54 signaling: a potential 
mechanism for initiation of puberty in primates. Proc Natl Acad Sci U S A, 2005. 
102(6): p. 2129-34. 
236. Clarkson, J., et al., Postnatal development of an estradiol-kisspeptin positive 
feedback mechanism implicated in puberty onset. Endocrinology, 2009. 150(7): 
p. 3214-20. 
237. Keen, K.L., et al., An increase in kisspeptin-54 release occurs with the pubertal 
increase in luteinizing hormone-releasing hormone-1 release in the stalk-
median eminence of female rhesus monkeys in vivo. Endocrinology, 2008. 
149(8): p. 4151-7. 
238. Pineda, R., et al., Critical roles of kisspeptins in female puberty and preovulatory 
gonadotropin surges as revealed by a novel antagonist. Endocrinology, 2010. 
151(2): p. 722-30. 
239. Mayer, C. and U. Boehm, Female reproductive maturation in the absence of 
kisspeptin/GPR54 signaling. Nat Neurosci, 2011. 14(6): p. 704-10. 
240. Frisch, R.E., Menarche and Fatness: Reexamination of the Critical Body 
Composition Hypothesis. Science, 1978. 200(4349): p. 1509-1513. 
241. Frisch, R.E. and J.W. McArthur, Menstrual cycles: fatness as a determinant of 
minimum weight for height necessary for their maintenance or onset. Science, 
1974. 185(4155): p. 949-51. 
242. Kennedy, G.C. and J. Mitra, Body weight and food intake as initiating factors for 
puberty in the rat. J Physiol, 1963. 166: p. 408-18. 
243. Frisch, R.E. and R. Revelle, Height and weight at menarche and a hypothesis of 
critical body weights and adolescent events. Science, 1970. 169(3943): p. 397-9. 
244. Bray, G.A., Obesity and reproduction. Hum Reprod, 1997. 12 Suppl 1: p. 26-32. 
245. Chehab, F.F., M.E. Lim, and R. Lu, Correction of the sterility defect in 
homozygous obese female mice by treatment with the human recombinant 
leptin. Nat Genet, 1996. 12(3): p. 318-20. 
246. Zhang, Y., et al., Positional cloning of the mouse obese gene and its human 
homologue. Nature, 1994. 372(6505): p. 425-32. 
247. Maffei, M., et al., Leptin levels in human and rodent: measurement of plasma 
leptin and ob RNA in obese and weight-reduced subjects. Nat Med, 1995. 1(11): 
p. 1155-61. 
248. Coleman, D.L., Obese and diabetes: two mutant genes causing diabetes-obesity 
syndromes in mice. Diabetologia, 1978. 14(3): p. 141-8. 
249. Casanueva, F.F. and C. Dieguez, Neuroendocrine regulation and actions of 
leptin. Front Neuroendocrinol, 1999. 20(4): p. 317-63. 
250. Chehab, F.F., et al., Early onset of reproductive function in normal female mice 
treated with leptin. Science, 1997. 275(5296): p. 88-90. 
251. Vogel, G., Leptin: a trigger for puberty? Science, 1996. 274(5292): p. 1466-7. 
References 
170 
 
252. Quennell, J.H., et al., Leptin indirectly regulates gonadotropin-releasing 
hormone neuronal function. Endocrinology, 2009. 150(6): p. 2805-12. 
253. Stephens, T.W., et al., The role of neuropeptide Y in the antiobesity action of the 
obese gene product. Nature, 1995. 377(6549): p. 530-2. 
254. Schwartz, M.W., et al., Identification of targets of leptin action in rat 
hypothalamus. J Clin Invest, 1996. 98(5): p. 1101-6. 
255. Sahu, A., Leptin decreases food intake induced by melanin-concentrating 
hormone (MCH), galanin (GAL) and neuropeptide Y (NPY) in the rat. 
Endocrinology, 1998. 139(11): p. 4739-42. 
256. Pralong, F.P., Insulin and NPY pathways and the control of GnRH function and 
puberty onset. Mol Cell Endocrinol, 2010. 324(1-2): p. 82-6. 
257. Leranth, C., et al., Immunohistochemical evidence for synaptic connections 
between pro-opiomelanocortin-immunoreactive axons and LH-RH neurons in 
the preoptic area of the rat. Brain Res, 1988. 449(1-2): p. 167-76. 
258. Jureus, A., et al., Galanin-like peptide (GALP) is a target for regulation by leptin 
in the hypothalamus of the rat. Endocrinology, 2000. 141(7): p. 2703-6. 
259. van Houten, M., et al., Insulin binding sites localized to nerve terminals in rat 
median eminence and arcuate nucleus. Science, 1980. 207(4435): p. 1081-3. 
260. Olson, B.R., et al., Effects of insulin-like growth factors I and II and insulin on the 
immortalized hypothalamic GTI-7 cell line. Neuroendocrinology, 1995. 62(2): p. 
155-65. 
261. Tanaka, T., et al., Central action of insulin regulates pulsatile luteinizing 
hormone secretion in the diabetic sheep model. Biol Reprod, 2000. 62(5): p. 
1256-61. 
262. Bruning, J.C., et al., Role of brain insulin receptor in control of body weight and 
reproduction. Science, 2000. 289(5487): p. 2122-5. 
263. Howard, A.D., et al., A receptor in pituitary and hypothalamus that functions in 
growth hormone release. Science, 1996. 273(5277): p. 974-7. 
264. Tschop, M., D.L. Smiley, and M.L. Heiman, Ghrelin induces adiposity in rodents. 
Nature, 2000. 407(6806): p. 908-13. 
265. Shuto, Y., et al., Hypothalamic growth hormone secretagogue receptor 
regulates growth hormone secretion, feeding, and adiposity. J Clin Invest, 2002. 
109(11): p. 1429-36. 
266. van der Lely, A.J., et al., Biological, physiological, pathophysiological, and 
pharmacological aspects of ghrelin. Endocr Rev, 2004. 25(3): p. 426-57. 
267. Martini, A.C., et al., Comparative analysis of the effects of ghrelin and 
unacylated ghrelin on luteinizing hormone secretion in male rats. 
Endocrinology, 2006. 147(5): p. 2374-82. 
268. Pinilla, L., et al., Stimulatory effect of PYY-(3-36) on gonadotropin secretion is 
potentiated in fasted rats. Am J Physiol Endocrinol Metab, 2006. 290(6): p. 
E1162-71. 
269. Brown, R.E., et al., KiSS-1 mRNA in adipose tissue is regulated by sex hormones 
and food intake. Mol Cell Endocrinol, 2008. 281(1-2): p. 64-72. 
270. Luque, R.M., R.D. Kineman, and M. Tena-Sempere, Regulation of hypothalamic 
expression of KiSS-1 and GPR54 genes by metabolic factors: analyses using 
mouse models and a cell line. Endocrinology, 2007. 148(10): p. 4601-11. 
References 
 
 
 
171 
 
271. Castellano, J.M., et al., Changes in hypothalamic KiSS-1 system and restoration 
of pubertal activation of the reproductive axis by kisspeptin in undernutrition. 
Endocrinology, 2005. 146(9): p. 3917-25. 
272. Smith, J.T., et al., KiSS-1 neurones are direct targets for leptin in the ob/ob 
mouse. J Neuroendocrinol, 2006. 18(4): p. 298-303. 
273. Backholer, K., et al., Kisspeptin cells in the ewe brain respond to leptin and 
communicate with neuropeptide Y and proopiomelanocortin cells. 
Endocrinology, 2010. 151(5): p. 2233-43. 
274. Castellano, J.M., et al., Early metabolic programming of puberty onset: impact 
of changes in postnatal feeding and rearing conditions on the timing of puberty 
and development of the hypothalamic kisspeptin system. Endocrinology, 2011. 
152(9): p. 3396-408. 
275. Caron, E., et al., Alteration in neonatal nutrition causes perturbations in 
hypothalamic neural circuits controlling reproductive function. J Neurosci, 2012. 
32(33): p. 11486-94. 
276. Donato, J., Jr., et al., Leptin's effect on puberty in mice is relayed by the ventral 
premammillary nucleus and does not require signaling in Kiss1 neurons. J Clin 
Invest, 2011. 121(1): p. 355-68. 
277. Aponte, Y., D. Atasoy, and S.M. Sternson, AGRP neurons are sufficient to 
orchestrate feeding behavior rapidly and without training. Nat Neurosci, 2011. 
14(3): p. 351-5. 
278. Brady, L.S., et al., Altered expression of hypothalamic neuropeptide mRNAs in 
food-restricted and food-deprived rats. Neuroendocrinology, 1990. 52(5): p. 
441-7. 
279. Lin, S., et al., Compensatory changes in [125I]-PYY binding in Y receptor 
knockout mice suggest the potential existence of further Y receptor(s). 
Neuropeptides, 2005. 39(1): p. 21-8. 
280. Celis, M.E., Release of LH in response to alpha-MSH administration. Acta Physiol 
Pharmacol Latinoam, 1985. 35(3): p. 281-90. 
281. Crown, A., D.K. Clifton, and R.A. Steiner, Neuropeptide signaling in the 
integration of metabolism and reproduction. Neuroendocrinology, 2007. 86(3): 
p. 175-82. 
282. Tachibana, T., et al., Gonadotropin-inhibiting hormone stimulates feeding 
behavior in chicks. Brain Res, 2005. 1050(1-2): p. 94-100. 
283. Clarke, I.J., et al., Gonadotropin-inhibitory hormone is a hypothalamic peptide 
that provides a molecular switch between reproduction and feeding. 
Neuroendocrinology, 2012. 95(4): p. 305-16. 
284. Murakami, M., et al., Hypophysiotropic role of RFamide-related peptide-3 in the 
inhibition of LH secretion in female rats. J Endocrinol, 2008. 199(1): p. 105-12. 
285. Johnson, M.A. and G.S. Fraley, Rat RFRP-3 alters hypothalamic GHRH expression 
and growth hormone secretion but does not affect KiSS-1 gene expression or 
the onset of puberty in male rats. Neuroendocrinology, 2008. 88(4): p. 305-15. 
286. Qi, Y., B.J. Oldfield, and I.J. Clarke, Projections of RFamide-related peptide-3 
neurones in the ovine hypothalamus, with special reference to regions 
regulating energy balance and reproduction. J Neuroendocrinol, 2009. 21(8): p. 
690-7. 
References 
172 
 
287. Fu, L.Y. and A.N. van den Pol, Kisspeptin directly excites anorexigenic 
proopiomelanocortin neurons but inhibits orexigenic neuropeptide Y cells by an 
indirect synaptic mechanism. J Neurosci, 2010. 30(30): p. 10205-19. 
288. Sakurai, T., et al., Orexins and orexin receptors: a family of hypothalamic 
neuropeptides and G protein-coupled receptors that regulate feeding behavior. 
Cell, 1998. 92(5): p. 1 page following 696. 
289. Porkka-Heiskanen, T., et al., Orexin A and B levels in the hypothalamus of 
female rats: the effects of the estrous cycle and age. Eur J Endocrinol, 2004. 
150(5): p. 737-42. 
290. Pu, S., et al., Orexins, a novel family of hypothalamic neuropeptides, modulate 
pituitary luteinizing hormone secretion in an ovarian steroid-dependent 
manner. Regul Pept, 1998. 78(1-3): p. 133-6. 
291. Furuta, M., T. Funabashi, and F. Kimura, Suppressive action of orexin A on 
pulsatile luteinizing hormone secretion is potentiated by a low dose of estrogen 
in ovariectomized rats. Neuroendocrinology, 2002. 75(3): p. 151-7. 
292. Tamura, T., et al., Orexins, orexigenic hypothalamic neuropeptides, suppress the 
pulsatile secretion of luteinizing hormone in ovariectomized female rats. 
Biochem Biophys Res Commun, 1999. 264(3): p. 759-62. 
293. Kohsaka, A., et al., A significant participation of orexin-A, a potent orexigenic 
peptide, in the preovulatory luteinizing hormone and prolactin surges in the rat. 
Brain Res, 2001. 898(1): p. 166-70. 
294. Pritchard, L.E., A.V. Turnbull, and A. White, Pro-opiomelanocortin processing in 
the hypothalamus: impact on melanocortin signalling and obesity. J Endocrinol, 
2002. 172(3): p. 411-21. 
295. Lee, T.H. and A.B. Lerner, Isolation of melanocyte-stimulating hormone from 
hog pituitary gland. J Biol Chem, 1956. 221(2): p. 943-59. 
296. Harris, J.I. and A.B. Lerner, Amino-acid sequence of the alpha-melanocyte-
stimulating hormone. Nature, 1957. 179(4574): p. 1346-7. 
297. Schioth, H.B., et al., Major pharmacological distinction of the ACTH receptor 
from other melanocortin receptors. Life Sci, 1996. 59(10): p. 797-801. 
298. Schioth, H.B., The physiological role of melanocortin receptors. Vitam Horm, 
2001. 63: p. 195-232. 
299. Wikberg, J.E., Melanocortin receptors: perspectives for novel drugs. Eur J 
Pharmacol, 1999. 375(1-3): p. 295-310. 
300. Desarnaud, F., et al., Molecular cloning, functional expression and 
pharmacological characterization of a mouse melanocortin receptor gene. 
Biochem J, 1994. 299 ( Pt 2): p. 367-73. 
301. Gantz, I., et al., Molecular cloning, expression, and gene localization of a fourth 
melanocortin receptor. J Biol Chem, 1993. 268(20): p. 15174-9. 
302. Dinulescu, D.M. and R.D. Cone, Agouti and agouti-related protein: analogies 
and contrasts. J Biol Chem, 2000. 275(10): p. 6695-8. 
303. Zhan, C., et al., Acute and long-term suppression of feeding behavior by POMC 
neurons in the brainstem and hypothalamus, respectively. J Neurosci, 2013. 
33(8): p. 3624-32. 
References 
 
 
 
173 
 
304. Ward, D.R., et al., Innervation of gonadotropin-releasing hormone neurons by 
peptidergic neurons conveying circadian or energy balance information in the 
mouse. PLoS One, 2009. 4(4): p. e5322. 
305. Roa, J. and A.E. Herbison, Direct regulation of GnRH neuron excitability by 
arcuate nucleus POMC and NPY neuron neuropeptides in female mice. 
Endocrinology, 2012. 153(11): p. 5587-99. 
306. Reid, R.L., N. Ling, and S.S. Yen, Gonadotropin-releasing activity of alpha-
melanocyte-stimulating hormone in normal subjects and in subjects with 
hypothalamic-pituitary dysfunction. J Clin Endocrinol Metab, 1984. 58(5): p. 
773-7. 
307. Matsuyama, S., et al., Activation of melanocortin receptors accelerates the 
gonadotropin-releasing hormone pulse generator activity in goats. Neurosci 
Lett, 2005. 383(3): p. 289-94. 
308. Begriche, K., et al., Genetic dissection of the functions of the melanocortin-3 
receptor, a seven-transmembrane G-protein-coupled receptor, suggests roles 
for central and peripheral receptors in energy homeostasis. J Biol Chem, 2011. 
286(47): p. 40771-81. 
309. Granholm, N.H., K.W. Jeppesen, and R.A. Japs, Progressive infertility in female 
lethal yellow mice (Ay/a; strain C57BL/6J). J Reprod Fertil, 1986. 76(1): p. 279-
87. 
310. Sandrock, M., et al., Reduction in corpora lutea number in obese melanocortin-
4-receptor-deficient mice. Reprod Biol Endocrinol, 2009. 7: p. 24. 
311. Hill, J.W., et al., Direct insulin and leptin action on pro-opiomelanocortin 
neurons is required for normal glucose homeostasis and fertility. Cell Metab, 
2010. 11(4): p. 286-97. 
312. Thornton, J.E., et al., Regulation of hypothalamic proopiomelanocortin mRNA 
by leptin in ob/ob mice. Endocrinology, 1997. 138(11): p. 5063-6. 
313. Chun, S.K. and Y.H. Jo, Loss of leptin receptors on hypothalamic POMC neurons 
alters synaptic inhibition. J Neurophysiol, 2010. 104(5): p. 2321-8. 
314. Watanobe, H., Leptin directly acts within the hypothalamus to stimulate 
gonadotropin-releasing hormone secretion in vivo in rats. J Physiol, 2002. 
545(Pt 1): p. 255-68. 
315. Israel, D.D., et al., Effects of leptin and melanocortin signaling interactions on 
pubertal development and reproduction. Endocrinology, 2012. 153(5): p. 2408-
19. 
316. Ojeda, S.R., et al., The transcriptional control of female puberty. Brain Res, 
2010. 1364: p. 164-74. 
317. Lee, R.C., R.L. Feinbaum, and V. Ambros, The C. elegans heterochronic gene lin-
4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993. 
75(5): p. 843-54. 
318. Wightman, B., I. Ha, and G. Ruvkun, Posttranscriptional regulation of the 
heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. 
elegans. Cell, 1993. 75(5): p. 855-62. 
319. Arasu, P., B. Wightman, and G. Ruvkun, Temporal regulation of lin-14 by the 
antagonistic action of two other heterochronic genes, lin-4 and lin-28. Genes 
Dev, 1991. 5(10): p. 1825-33. 
References 
174 
 
320. Pasquinelli, A.E. and G. Ruvkun, Control of developmental timing by micrornas 
and their targets. Annu Rev Cell Dev Biol, 2002. 18: p. 495-513. 
321. Siomi, H. and M.C. Siomi, Posttranscriptional regulation of microRNA biogenesis 
in animals. Mol Cell, 2010. 38(3): p. 323-32. 
322. Nilsen, T.W., Mechanisms of microRNA-mediated gene regulation in animal 
cells. Trends Genet, 2007. 23(5): p. 243-9. 
323. Lim, L.P., et al., The microRNAs of Caenorhabditis elegans. Genes Dev, 2003. 
17(8): p. 991-1008. 
324. Breving, K. and A. Esquela-Kerscher, The complexities of microRNA regulation: 
mirandering around the rules. Int J Biochem Cell Biol, 2010. 42(8): p. 1316-29. 
325. Hausser, J., et al., Relative contribution of sequence and structure features to 
the mRNA binding of Argonaute/EIF2C-miRNA complexes and the degradation 
of miRNA targets. Genome Res, 2009. 19(11): p. 2009-20. 
326. Hendrickson, D.G., et al., Concordant regulation of translation and mRNA 
abundance for hundreds of targets of a human microRNA. PLoS Biol, 2009. 
7(11): p. e1000238. 
327. Friedman, R.C., et al., Most mammalian mRNAs are conserved targets of 
microRNAs. Genome Res, 2009. 19(1): p. 92-105. 
328. Filipowicz, W., S.N. Bhattacharyya, and N. Sonenberg, Mechanisms of post-
transcriptional regulation by microRNAs: are the answers in sight? Nat Rev 
Genet, 2008. 9(2): p. 102-14. 
329. Schwarz, D.S., et al., Asymmetry in the assembly of the RNAi enzyme complex. 
Cell, 2003. 115(2): p. 199-208. 
330. Stark, A., et al., Systematic discovery and characterization of fly microRNAs 
using 12 Drosophila genomes. Genome Res, 2007. 17(12): p. 1865-79. 
331. Chang, T.C., et al., Widespread microRNA repression by Myc contributes to 
tumorigenesis. Nat Genet, 2008. 40(1): p. 43-50. 
332. Toyota, M., et al., Epigenetic silencing of microRNA-34b/c and B-cell 
translocation gene 4 is associated with CpG island methylation in colorectal 
cancer. Cancer Res, 2008. 68(11): p. 4123-32. 
333. Lujambio, A., et al., A microRNA DNA methylation signature for human cancer 
metastasis. Proc Natl Acad Sci U S A, 2008. 105(36): p. 13556-61. 
334. Egger, G., et al., Epigenetics in human disease and prospects for epigenetic 
therapy. Nature, 2004. 429(6990): p. 457-63. 
335. Wulczyn, F.G., et al., Post-transcriptional regulation of the let-7 microRNA 
during neural cell specification. FASEB J, 2007. 21(2): p. 415-26. 
336. Lee, E.J., et al., Systematic evaluation of microRNA processing patterns in 
tissues, cell lines, and tumors. RNA, 2008. 14(1): p. 35-42. 
337. Obernosterer, G., et al., Post-transcriptional regulation of microRNA expression. 
RNA, 2006. 12(7): p. 1161-7. 
338. Krol, J., I. Loedige, and W. Filipowicz, The widespread regulation of microRNA 
biogenesis, function and decay. Nat Rev Genet, 2010. 11(9): p. 597-610. 
339. Yang, W., et al., Modulation of microRNA processing and expression through 
RNA editing by ADAR deaminases. Nat Struct Mol Biol, 2006. 13(1): p. 13-21. 
340. Kawahara, Y., et al., RNA editing of the microRNA-151 precursor blocks cleavage 
by the Dicer-TRBP complex. EMBO Rep, 2007. 8(8): p. 763-9. 
References 
 
 
 
175 
 
341. Kawahara, Y., et al., Redirection of silencing targets by adenosine-to-inosine 
editing of miRNAs. Science, 2007. 315(5815): p. 1137-40. 
342. Bhattacharyya, S.N., et al., Relief of microRNA-mediated translational 
repression in human cells subjected to stress. Cell, 2006. 125(6): p. 1111-24. 
343. Kedde, M., et al., RNA-binding protein Dnd1 inhibits microRNA access to target 
mRNA. Cell, 2007. 131(7): p. 1273-86. 
344. Weinmann, L., et al., Importin 8 is a gene silencing factor that targets 
argonaute proteins to distinct mRNAs. Cell, 2009. 136(3): p. 496-507. 
345. Pasquinelli, A.E., et al., Conservation of the sequence and temporal expression 
of let-7 heterochronic regulatory RNA. Nature, 2000. 408(6808): p. 86-9. 
346. Lee, Y.S. and A. Dutta, The tumor suppressor microRNA let-7 represses the 
HMGA2 oncogene. Genes Dev, 2007. 21(9): p. 1025-30. 
347. Reinhart, B.J., et al., The 21-nucleotide let-7 RNA regulates developmental 
timing in Caenorhabditis elegans. Nature, 2000. 403(6772): p. 901-6. 
348. Roush, S. and F.J. Slack, The let-7 family of microRNAs. Trends Cell Biol, 2008. 
18(10): p. 505-16. 
349. Caygill, E.E. and L.A. Johnston, Temporal regulation of metamorphic processes 
in Drosophila by the let-7 and miR-125 heterochronic microRNAs. Curr Biol, 
2008. 18(13): p. 943-50. 
350. Schulman, B.R., A. Esquela-Kerscher, and F.J. Slack, Reciprocal expression of lin-
41 and the microRNAs let-7 and mir-125 during mouse embryogenesis. Dev 
Dyn, 2005. 234(4): p. 1046-54. 
351. Mansfield, J.H., et al., MicroRNA-responsive 'sensor' transgenes uncover Hox-
like and other developmentally regulated patterns of vertebrate microRNA 
expression. Nat Genet, 2004. 36(10): p. 1079-83. 
352. Sokol, N.S., et al., Drosophila let-7 microRNA is required for remodeling of the 
neuromusculature during metamorphosis. Genes Dev, 2008. 22(12): p. 1591-6. 
353. Esquela-Kerscher, A. and F.J. Slack, Oncomirs - microRNAs with a role in cancer. 
Nat Rev Cancer, 2006. 6(4): p. 259-69. 
354. Yu, F., et al., let-7 regulates self renewal and tumorigenicity of breast cancer 
cells. Cell, 2007. 131(6): p. 1109-23. 
355. Shi, X.B., C.G. Tepper, and R.W. deVere White, Cancerous miRNAs and their 
regulation. Cell Cycle, 2008. 7(11): p. 1529-38. 
356. Ambros, V. and H.R. Horvitz, Heterochronic mutants of the nematode 
Caenorhabditis elegans. Science, 1984. 226(4673): p. 409-16. 
357. Moss, E.G., R.C. Lee, and V. Ambros, The cold shock domain protein LIN-28 
controls developmental timing in C. elegans and is regulated by the lin-4 RNA. 
Cell, 1997. 88(5): p. 637-46. 
358. Moss, E.G. and L. Tang, Conservation of the heterochronic regulator Lin-28, its 
developmental expression and microRNA complementary sites. Dev Biol, 2003. 
258(2): p. 432-42. 
359. Guo, Y., et al., Identification and characterization of lin-28 homolog B (LIN28B) 
in human hepatocellular carcinoma. Gene, 2006. 384: p. 51-61. 
360. Pasquinelli, A.E., et al., Expression of the 22 nucleotide let-7 heterochronic RNA 
throughout the Metazoa: a role in life history evolution? Evol Dev, 2003. 5(4): p. 
372-8. 
References 
176 
 
361. Yang, D.H. and E.G. Moss, Temporally regulated expression of Lin-28 in diverse 
tissues of the developing mouse. Gene Expr Patterns, 2003. 3(6): p. 719-26. 
362. Polesskaya, A., et al., Lin-28 binds IGF-2 mRNA and participates in skeletal 
myogenesis by increasing translation efficiency. Genes Dev, 2007. 21(9): p. 
1125-38. 
363. Balzer, E. and E.G. Moss, Localization of the developmental timing regulator 
Lin28 to mRNP complexes, P-bodies and stress granules. RNA Biol, 2007. 4(1): p. 
16-25. 
364. Yu, J., et al., Induced pluripotent stem cell lines derived from human somatic 
cells. Science, 2007. 318(5858): p. 1917-20. 
365. Viswanathan, S.R., G.Q. Daley, and R.I. Gregory, Selective blockade of microRNA 
processing by Lin28. Science, 2008. 320(5872): p. 97-100. 
366. Newman, M.A. and S.M. Hammond, Lin-28: an early embryonic sentinel that 
blocks Let-7 biogenesis. Int J Biochem Cell Biol, 2010. 42(8): p. 1330-3. 
367. Thomson, J.M., et al., Extensive post-transcriptional regulation of microRNAs 
and its implications for cancer. Genes Dev, 2006. 20(16): p. 2202-7. 
368. Heo, I., et al., Lin28 mediates the terminal uridylation of let-7 precursor 
MicroRNA. Mol Cell, 2008. 32(2): p. 276-84. 
369. Newman, M.A., J.M. Thomson, and S.M. Hammond, Lin-28 interaction with the 
Let-7 precursor loop mediates regulated microRNA processing. RNA, 2008. 
14(8): p. 1539-49. 
370. Rybak, A., et al., A feedback loop comprising lin-28 and let-7 controls pre-let-7 
maturation during neural stem-cell commitment. Nat Cell Biol, 2008. 10(8): p. 
987-93. 
371. Sampson, V.B., et al., MicroRNA let-7a down-regulates MYC and reverts MYC-
induced growth in Burkitt lymphoma cells. Cancer Res, 2007. 67(20): p. 9762-
70. 
372. Chang, T.C., et al., Lin-28B transactivation is necessary for Myc-mediated let-7 
repression and proliferation. Proc Natl Acad Sci U S A, 2009. 106(9): p. 3384-9. 
373. Dangi-Garimella, S., et al., Raf kinase inhibitory protein suppresses a metastasis 
signalling cascade involving LIN28 and let-7. EMBO J, 2009. 28(4): p. 347-58. 
374. Viswanathan, S.R., et al., Lin28 promotes transformation and is associated with 
advanced human malignancies. Nat Genet, 2009. 41(7): p. 843-8. 
375. Sachdeva, M. and Y.Y. Mo, miR-145-mediated suppression of cell growth, 
invasion and metastasis. Am J Transl Res, 2010. 2(2): p. 170-80. 
376. Sangiao-Alvarellos, S., et al., Changes in hypothalamic expression of the 
Lin28/let-7 system and related microRNAs during postnatal maturation and 
after experimental manipulations of puberty. Endocrinology, 2013. 154(2): p. 
942-55. 
377. Lettre, G., et al., Identification of ten loci associated with height highlights new 
biological pathways in human growth. Nat Genet, 2008. 40(5): p. 584-91. 
378. Zhu, H., et al., Lin28a transgenic mice manifest size and puberty phenotypes 
identified in human genetic association studies. Nat Genet, 2010. 
379. Zheng, K., et al., The pluripotency factor LIN28 marks undifferentiated 
spermatogonia in mouse. BMC Dev Biol, 2009. 9: p. 38. 
References 
 
 
 
177 
 
380. Zhu, H., et al., Lin28a transgenic mice manifest size and puberty phenotypes 
identified in human genetic association studies. Nat Genet, 2010. 42(7): p. 626-
30. 
381. Shinoda, G., et al., Lin28a regulates germ cell pool size and fertility. Stem Cells, 
2013. 31(5): p. 1001-9. 
382. Chakraborty, P., et al., LIN28A marks the spermatogonial progenitor population 
and regulates its cyclic expansion. Stem Cells, 2014. 32(4): p. 860-73. 
383. Zhu, H., et al., The Lin28/let-7 Axis Regulates Glucose Metabolism. Cell, 2011. 
147(1): p. 81-94. 
384. Jorgensen, S., et al., Robust one-day in situ hybridization protocol for detection 
of microRNAs in paraffin samples using LNA probes. Methods, 2010. 52(4): p. 
375-81. 
385. Sachdeva, M., et al., p53 represses c-Myc through induction of the tumor 
suppressor miR-145. Proc Natl Acad Sci U S A, 2009. 106(9): p. 3207-12. 
386. La Rocca, G., et al., Regulation of microRNA-145 by growth arrest and 
differentiation. Exp Cell Res, 2011. 317(4): p. 488-95. 
387. Ojeda, S.R., et al., Recent advances in the endocrinology of puberty. Endocr Rev, 
1980. 1(3): p. 228-57. 
388. Navarro, V.M., et al., Persistent impairment of hypothalamic KiSS-1 system after 
exposures to estrogenic compounds at critical periods of brain sex 
differentiation. Endocrinology, 2009. 150(5): p. 2359-67. 
389. Sizonenko, P.C., et al., The pineal and pubertal development. Ciba Found Symp, 
1985. 117: p. 208-30. 
390. Leadem, C.A., Photoperiodic sensitivity of prepubertal female Fisher 344 rats. J 
Pineal Res, 1988. 5(1): p. 63-70. 
391. Boullu-Ciocca, S., et al., Postnatal diet-induced obesity in rats upregulates 
systemic and adipose tissue glucocorticoid metabolism during development and 
in adulthood: its relationship with the metabolic syndrome. Diabetes, 2005. 
54(1): p. 197-203. 
392. Lewis, B.P., et al., Prediction of mammalian microRNA targets. Cell, 2003. 
115(7): p. 787-98. 
393. John, B., et al., Human MicroRNA targets. PLoS Biol, 2004. 2(11): p. e363. 
394. Krek, A., et al., Combinatorial microRNA target predictions. Nat Genet, 2005. 
37(5): p. 495-500. 
395. Maragkakis, M., et al., DIANA-microT web server: elucidating microRNA 
functions through target prediction. Nucleic Acids Res, 2009. 37(Web Server 
issue): p. W273-6. 
396. Elias, C.F. and D. Purohit, Leptin signaling and circuits in puberty and fertility. 
Cell Mol Life Sci, 2013. 70(5): p. 841-62. 
397. Roa, J., Role of GnRH Neurons and Their Neuronal Afferents as Key Integrators 
between Food Intake Regulatory Signals and the Control of Reproduction. Int J 
Endocrinol, 2013. 2013: p. 518046. 
398. Roa, J., et al., The mammalian target of rapamycin as novel central regulator of 
puberty onset via modulation of hypothalamic Kiss1 system. Endocrinology, 
2009. 150(11): p. 5016-26. 
References 
178 
 
399. Heger, S., et al., Enhanced at puberty 1 (EAP1) is a new transcriptional regulator 
of the female neuroendocrine reproductive axis. J Clin Invest, 2007. 117(8): p. 
2145-54. 
400. Ojeda, S.R., et al., The Oct-2 POU domain gene in the neuroendocrine brain: a 
transcriptional regulator of mammalian puberty. Endocrinology, 1999. 140(8): 
p. 3774-89. 
401. Elks, C.E., et al., Thirty new loci for age at menarche identified by a meta-
analysis of genome-wide association studies. Nat Genet, 2010. 42(12): p. 1077-
85. 
402. Amar, L., et al., MicroRNA expression profiling of hypothalamic arcuate and 
paraventricular nuclei from single rats using Illumina sequencing technology. J 
Neurosci Methods, 2012. 209(1): p. 134-43. 
403. Piskounova, E., et al., Lin28A and Lin28B inhibit let-7 microRNA biogenesis by 
distinct mechanisms. Cell, 2011. 147(5): p. 1066-79. 
404. Kapsimali, M., et al., MicroRNAs show a wide diversity of expression profiles in 
the developing and mature central nervous system. Genome Biol, 2007. 8(8): p. 
R173. 
405. Denli, A.M., X. Cao, and F.H. Gage, miR-9 and TLX: chasing tails in neural stem 
cells. Nat Struct Mol Biol, 2009. 16(4): p. 346-7. 
406. Schmidt, C., et al., The population-specific distribution and frequencies of 
genomic variants in the SLC3A1 and SLC7A9 genes and their application in 
molecular genetic testing of cystinuria. Urol Res, 2004. 32(2): p. 75-8. 
407. Dissen, G.A., et al., Hypothalamic EAP1 (enhanced at puberty 1) is required for 
menstrual cyclicity in nonhuman primates. Endocrinology, 2012. 153(1): p. 350-
61. 
408. Kotaja, N., MicroRNAs and spermatogenesis. Fertil Steril, 2014. 101(6): p. 1552-
62. 
409. Tong, M.H., et al., Expression of Mirlet7 Family MicroRNAs in Response to 
Retinoic Acid-Induced Spermatogonial Differentiation in Mice. Biol Reprod, 
2011. 
410. Gaytan, F., et al., Distinct expression patterns predict differential roles of the 
miRNA-binding proteins, Lin28 and Lin28b, in the mouse testis: studies during 
postnatal development and in a model of hypogonadotropic hypogonadism. 
Endocrinology, 2013. 154(3): p. 1321-36. 
411. Cheng, Y., et al., MicroRNA-145, a novel smooth muscle cell phenotypic marker 
and modulator, controls vascular neointimal lesion formation. Circ Res, 2009. 
105(2): p. 158-66. 
412. Cordes, K.R., et al., miR-145 and miR-143 regulate smooth muscle cell fate and 
plasticity. Nature, 2009. 460(7256): p. 705-10. 
413. Barreiro, M.L., et al., Cellular location and hormonal regulation of ghrelin 
expression in rat testis. Biol Reprod, 2002. 67(6): p. 1768-76. 
414. Franca, L.R., et al., Hormonal regulation of spermatogenesis in the 
hypophysectomized rat: quantitation of germ-cell population and effect of 
elimination of residual testosterone after long-term hypophysectomy. J Androl, 
1998. 19(3): p. 335-40; discussion 341-2. 
 
